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IN THE UTAH SUPREME COURT
STATE OF UTAH,
Plaintiff/Appellee,
Case No. 20040566-SC
v.

Ct. Apps. Case No. 20030006-CA

HEATHER JO RODRIGUEZ,
Defendant/Appellant.
BRIEF OF AMICI CURIAE

JURISDICTION AND NATURE OF THE PROCEEDINGS
The Court granted the State's petition for certiorari to review the decision of the
court of appeals suppressing evidence derived from a warrantless blood draw*. Amici's
motion to appear and submit a brief was granted on February 22, 2005. This Court has
jurisdiction under Utah Code Ann. § 78-2-2(3)(a) (West 2004).
ISSUE PRESENTED ON APPEAL
Does the dissipation of blood alcohol, without more, create an exigent
circumstance justifying the taking of a blood from an impaired driving suspect without a
warrant?
CONSTITUTIONAL PROVISIONS, STATUTES AND RULES
This appeal requires the application of the Fourth Amendment of the United States
Constitution as quoted in plaintiffs brief and Utah Code Ann. § 76-5-207 (West 2004),

attached as Addendum A. The court's ruling also has application to Utah Code Ann. §§
41-6-44(2)(a)(i) and (iii) (West 2004) and 41-6-44.6 (West 2004)/ also attached in
addendum A.
STATEMENT OF THE CASE
The amici accepts the facts and statement of the proceedings below as set forth in
plaintiffs brief.
INTEREST OF THE AMICI
The amici represent all law enforcement officers and prosecutors throughout the
state of Utah. Utah law enforcement officers face daily the decision of whether to
perform a non-consensual chemical test on impaired drivers. During fiscal years 2001
through 2004, 60,806 citations were issued to impaired drivers.

Suspects refused

chemical tests in 8,795 cases, slightly more than 14% of all impaired driving citations
issued. Simple arithmetic reveals that there are in excess of 41 arrests of impaired drivers
per day, or 1.7 per hour. Thus, on average, five drivers per day refuse to consent to a
chemical test of their blood or breath. These statistics do not include situations such as
the instant case where citations are not issued at the scene, but the case is later screened
with a prosecutor to determine whether charges will be filed and at what level of offense,
including potential felony impaired driving and automobile homicide cases.
The ability of an officer to obtain a timely chemical test in a substantial number of
impaired driving cases will depend on this Court's decision. The amici thus have a
1

Traffic violations, including impaired driving, were recodified in the 2005 legislative
session. The new statute is UCA § 41-6a-502 (2005). The substantive provisions of the
statute relevant to this matter were not amended.
2

significant interest both in the outcome of this case and m a cle;ir 1 rective from this
Court as to when law enforcement can draw a suspect's blood without a warrant.
SUMMARY OF ARGUMENT
The court of appeals totality of the circumstances analysis failed to give due
weight to the nature of alcohol metabolism in determining exigency. It also gave too
much weight to factors that officers cannot realistically determine in alcohol-related
traffic investigations.
The requirement that officers determine how long they may wait before the
alcoL

issipates, ignores the reality of alcohol metabolism.

Alcohol is being

continuously eliminated from the body even before the cessation of drinking. It cannot be
stopped or slowed down merely because the person is secured while an officer seeks a
warrant. The rate of alcohol elimination is affected by numerous factors including the
amount of alcohol and the period of time over which il w as consumed, lion much food is
present in the stomach during drinking, the individual's experience with and tolerance to
alcohol, the individual's general health, as well as the individual's rate of alcohol
elimination.
The requirement that an officer decide how long it will take to obtain a warrant
and then determine whether the estimated delay will cause the destruction of viable
evidence Is also i inworkab1

-: •• officer may take li lto consideration the factors

listed by the court, such as time of day and location of the nearest magistrate, her
assessment of how long it will take to obtain the warrant is only a guess. The reality is
i

.1 inevitable change in the evidence and, in some cases,
3

delay will result in its complete loss. Without knowing beforehand the suspect's blood
alcohol concentration (BAC) and the rate at which the alcohol is being eliminated, it is
impossible to determine what impact the delay in obtaining a warrant will have on the
viability of the evidence.
ARGUMENT
BY ITS VERY NATURE, THE ELIMINATION OF BLOOD
ALCOHOL FROM THE BODY CREATES AN EXIGENT
CIRCUMSTANCE WHICH JUSTIFIES OBTAINING A SAMPLE
OF A SUSPECT'S BLOOD WITHOUT A WARRANT
A. Alcohol absorption and elimination rates are affected by a
variety of factors.
The body's metabolism of alcohol is unique. Alcohol is not digested but is
absorbed directly into the blood stream by diffusion, in an unaltered state, across cell
membranes as it passes through the mouth, the esophagus and into the gastrointestinal
track. Once ingested, the alcohol passes from the stomach into the small intestine where
it is rapidly absorbed into the blood and distributed throughout the body. Although some
of the alcohol is absorbed as it passes through the mouth and the stomach, the majority of
the alcohol is absorbed through the small intestine. Even though alcohol is not itself
digested, the rate at which it passes into the small intestine is affected by the presence of
food in the stomach thereby affecting both the absorption and elimination rate.2

2

K.M. Dubowski, Absorption, Distribution and Elimination of Alcohol: Highway Safety
Aspects, Supp. No. 10 J. STUD. ALCOHOL 98, passim, (1985), attached as Addendum B;
W. Neuteboom & A.W. Jones, Disappearance Rate of Alcohol from the Blood of Drunk
Drivers Calculated from Two Consecutive Samples; What Do the Results Really Mean?,
45 FORENSIC SCL INT'L 107, passim (1990), attached as Addendum C; A.W. Jones &
4

Alcohol passes through the system in an unaltered state. The liver is responsible
for the elimination of approximately 95% of the ingested alcohol. The remaining alcohol
is excreted through breath,

•.: a person drinks, alcohol is being

*

both absorbed and eliminated. His BAC rises when alcohol is consumed faster than it is
eliminated. Full absorption is generally assumed to occur approximately 30 minutes after
the cessation of drinking but may take longer depending on the presence of significant
quantities of food in the stomach and the individual's rate of alcohol elimination.3
On average a person burns off or eliminates approximately one drink per hour, or
approximately .013% :

)18%. This rate is only an average. Research has shown

variances fr<

; .uJQ%. In A !\\i:nt study in l!ic I'Uk High\\;i\ Patrol only one

of the six individuals tested fell within the average burn-off rate of .018%.

Ihe

remaining five participants had higher elimination rates ranging from .021% to .029%.4
There are a

]

ier of factors "\ v hich affect the elimination

i \u

• *•

ne

individual will not necessarily burn-off alcohol at the same rate every time alcohol is
consumed. The presence of food in the stomach has a significant affect on both the
absorptu

>'

JCI.S\ S passage of the alcohol from the

D.J. Pounder, Chapter 5: Alcohol, § 5.2.6.1 Clinical Pharmacokinetics of Ethanol, in
HANDBOOK OF DRUG AsusEpassim (S. Karch ed., 1998)5 attached as Addendum D.
3
R.L. Watkins & E.V. Alder, The Effect of Food on Alcohol Absorption and Elimination
Patterns, 38 J. FORENSIC SCI. 285, passim (1993), attached as Addendum E; Dukbowski,
supra note 2.
4
Blood Alcohol Testing Using the Intoxilyzer 5000 Series, Intoxilyzer 8000\ and Gas
Chromatography and Blood Alcohol Absorption and Metabolism Study, UTAH HIGHWAY
PATROL

&

UTAH PUBLIC HEALTH LABORATORY,

(Sept. 2003) (unpublished study

available upon request from Utah Department of Public Safety), attached as Addendum
F.
5

stomach into the small intestine. Other factors influencing the bum-off rate are the
drinker's gender and age, the drinker's overall health, the type of beverage consumed,
and the circumstances under which the drinks are consumed. The elimination rate may
also be affected by whether one is an alcoholic or a novice drinker. Chronic alcoholics
eliminate alcohol at significantly higher rates. The rate of elimination also tends to be
higher when the blood alcohol concentration in the body is either very high or very low.5
B. Without knowing a suspect's BAC and his rate of elimination, it
is impossible for an officer to determine how long he may wait
before losing the evidence.
The court of appeals held that for an officer to determine whether an exigency
exists, she must estimate how long she may wait before she risks losing the evidence.
In practice, this is impossible. For an officer to determine how long she may wait
before losing the evidence, she must know the suspect's approximate BAC and the
rate at which the alcohol is being eliminated.
The only legally accepted method for determining BAC is a chemical test result.
General observations and field sobriety tests assist an officer in determining whether the
suspect is impaired and the likelihood that the suspect will test above .08 BAC; however,
they do not establish BAC or elimination rates. For example, a novice drinker is likely to

5

A.W. Jones, Influence of Age, Gender, and Blood-Alcohol Concentration on the
Disappearance Rate of Alcohol from Blood in Drinking Drivers, 41(6) J. FORENSIC SCI.
922, passim (1996), attached as Addendum G; N.A. Pikaar et al., Influence of Several
Factors on Blood Alcohol Concentrations After Drinking Alcohol, 23 ALCOHOL &
ALCOHOLISM 289, passim (1988), attached as Addendum H; Alcohol Alert, NAT'L INST.
ON ALCOHOL ABUSE & ALCOHOLISM, NO. 25, Jan. 1997, at passim, available at
http://www.niaaa.nih.gov/publications/aa35.htm, attached as Addendum I.
6

exhibit signs of impairment at a much lower BAC than an experienced drinker even
though both are impaired. An incorrect assumption about the suspect's BAC would lead
to an incorrect decision about whether there was an exigency.
In addition, there are numerous cases in which officers are only able to make
limited personal observations of the suspect such as cases of injury accidents where the
suspect is transported to a hospital before the officer is able to complete the investigation.
During the investigation of a routine impaired driving case where there is not a crash, the
suspect may refuse to perform field sobriety tests, have physical conditions which limit
his ability to perform the tests, or the roadside and/or weather conditions make it
impractical to administer the tests. The officer may have probable cause to make the
arrest for impaired driving based on a driving pattern, witness statements, personal
observations of the suspect's appearance and behavior but be unable to hazard a guess as
to actual BAC.
Even if the officer is able to obtain a consensual preliminary breath test result, she
will rarely have accurate information regarding the suspects drinking history, actual
amount of alcohol consumed, when it was consumed, how much food was present in the
stomach, or the overall health of the individual, all of which are important factors in
assessing potential elimination rates . Furthermore, it is impossible for an officer to
know a suspect's actual elimination rate. An individual's elimination rate can only be

6

Many officers carry a portable breath testing device. These devices are generally not
accepted as evidentiary chemical tests and are used only to establish probable cause.
7

accurately determined by chemical tests administered over a period of time after drinking
ceases and the alcohol is fully absorbed.7
The following example illustrates how BAC is affected by combining various
elimination rates with projected time delays in obtaining a blood sample.
Example
Assume the suspect is a 6'0" tall, 180 lb. male with a .13 BAC at the time of the
stop.
Elimination Rate
.009 (low)
.015 (average)
.025 (high)

2 hour delay
.112
.10
.08

3 hour delay
.103
.085
.05

As illustrated above, there is a very real possibility when the BAC is relatively low that
the blood alcohol evidence will no longer support a conviction where there is a delay in
obtaining the blood sample.
A change in the suspect's BAC may affect a case even if it does not prevent a
conviction. For example, Utah Code Ann. § 41-6-44 requires the installation of an
ignition interlock device if the suspect's BAC is .16 or greater. Additionally, judges
routinely impose more severe penalties on defendants who drive with a high BAC. They
may impose jail instead of community service, supervised probation rather than
unsupervised probation, and alcohol treatment as opposed to the 16 hour state mandated
alcohol education course. Even in situations such as the current case, where the BAC is

7

See supra, n.2.
8

so high that alcohol would still be in the system for an extended period of time, the
change in the alcohol level may affect the charging decision or the outcome. In
automobile homicide cases, BAC is relevant to issue of criminal negligence versus
simple negligence.

The dissipation of alcohol in such cases may not prevent a

conviction, but it may cause the jury to find only negligence, a third degree felony, rather
than criminal negligence, a second degree felony. The prosecution, therefore, has a
substantial interest in obtaining evidence that represents the driver's true BAC, because
changes in the BAC may prevent a conviction, affect the level of conviction, or affect the
sentence.
All impaired driving investigations involve some delay. The initial traffic stop,
contact with the driver, verification of driver's license and registration information, the
administration of field sobriety tests, transporting the suspect to the site for the blood
draw, waiting for the phlebotomist all take time during which alcohol is being
metabolized. In addition to the routine delays, there may be any number of other delays
before a blood sample can be obtained. The longer the delay in obtaining a chemical test,
the less accurately the result will reflect the actual BAC at the time of driving. Utah's
statues defining impaired driving and automobile homicide recognize the inherent
difficulty in establishing BAC at the time of driving by defining the crime as having "a
blood or breath alcohol concentration of .08 grams or greater at the time of the test" or
"at the time of operation or actual physical control". Utah Code Ann. § 41-6-44(2)(a)(i)
and (iii) (emphasis added). See also UCA § 76-5-207(2)(a)(i) and (iii).

9

Delay does not inure only to the prosecution's detriment. Although peak alcohol
concentration is typically assumed to have taken place 30 minutes after drinking stops,
this is by no means universally true for reasons discussed previously. A common defense
in impaired driving cases is that the suspect's BAC was not over .08 while driving but
o

continued to rise after the stop until the time of the test. A sample obtained as close to
the time of driving as possible, before all of the alcohol was absorbed, may support this
defense by showing that BAC was in fact lower than .08 whereas a test taken later, after
all the alcohol was absorbed, would be substantially higher. In addition, a lower BAC
would have an impact on charging decisions and might raise defenses to a charge of
automobile homicide that would be unpersuasive in a case with a high BAC.
The court of appeals also suggested that because taking blood is a routine
procedure in impaired driving cases it cannot be exigent. The dissipation of the alcohol
creates the exigency, not the procedure by which the evidence is obtained. Hospital
emergency rooms routinely treat patients who have medical emergencies. The frequency
with which these types of emergencies occur does not make treatment any less exigent.
Because an officer cannot reliably determine a suspect's BAC in the absence of a
chemical test, know whether the suspect has reached peak absorption, or ascertain the
suspect's alcohol elimination rate, the officer cannot determine with any certainty
whether an exigency exists under the court of appeals' test. This Court should therefore

* A.W. Jones & B.K. Logan, Chapter 13.2: DUI Defenses, § 13.2.1.3 Rising BloodAlcohol Concentrations, in HANDBOOK OF DRUG ABUSE passim (S. Karch ed., 1998),
attached as Addendum J.
10

overrule the court of appeals' test and hold that the dissipation of alcohol from the blood
is an exigency that justifies a warrantless blood draw.
C. An officer cannot know with any decree of certainty how long it
will take to obtain a warrant.
The court of appeals also imposed a requirement that an officer estimate how
long it would take her to obtain a warrant before she could determine whether an
emergency existed. In its opinion, the court suggested that in the present case, all the
officer would have needed to do was present himself to a judge, relate the facts as he
knew them, and a warrant would be issued. The reality is slightly more complex. The
following example illustrates the reality.
Counsel for amici is the prosecutor for the City of South Salt Lake. In a recent
South Salt Lake case officers were dispatched to the scene of an injury accident at 3:08
p.mu on a Tuesday. The investigating officer had minimal contact with the suspect at the
scene as the suspect and victims were being attended to by emergency medical personnel.
After interviewing witnesses and determining that the suspect was likely intoxicated, the
officer called me to discuss the case. The officer was advised to go to the hospital and
request the suspect to submit to a blood draw. The suspect's refusal was recorded at 4:16
p.m., over an hour after the crash.
The officer contacted me again and an affidavit and warrant were prepared using a
preprinted form that only required the officer to fill in the appropriate information. The
justice court was still in session. The court took a brief recess to review the warrant. The
judge signed the warrant at 5:16 p.m. The officer then arranged to meet the blood

11

technician back at the hospital and the sample was finally obtained sometime after 5:30
p.m., more than two hours after the crash was first reported. Even with the crash
occurring during working hours while the court was in session and the prosecutor
available to assist in obtaining the warrant, it still took over two hours from the time of
the crash to secure the warrant and additional time to obtain the blood sample. During
the more than two hours lapse between the time of the crash and actual taking of the
blood sample, the suspect continued to metabolize the alcohol even though he was
detained at the hospital until the warrant could be secured.
Most impaired driving cases do not take place during standard working hours.
Consulting with a prosecutor or other officers, preparing a warrant and finding an
available magistrate are all significantly more difficult in the late night/early morning
hours, on weekends and holidays when the majority of impaired driving cases occur. It is
the amici's experience in obtaining warrants in thousands of cases, not just impaired
driving cases, that a delay of two or more hours to prepare, present and obtain a warrant
is common.
The court did not suggest a remedy for cases in which the officer wrongly
estimates the time it would take to get a warrant. Suppose the officer concludes, after
consideration of the factors cited by the court of appeals, that it will take her two hours to
get the warrant. Without knowing the BAC and whether the suspect has reached peak
absorption, how will she decide if a two hour delay will have a substantial impact on the
evidence?

If she chooses to get a warrant, she runs the risk that the BAC will have

dissipated to the point of being unusable or inconclusive as evidence. She also runs the
12

risk that it will take longer to secure a warrant than she estimated resulting in further
destruction of the evidence. On the other hand, if she chooses to take the blood sample
without a warrant, she runs the risk that the evidence will be suppressed if the reviewing
court disagrees with her assessment of how long it would have taken to obtain the
warrant. There are simply too many variables both in the dissipation of BAC and the
time it takes to secure a warrant for the officer to make any realistic estimate of how the
delay created in seeking a warrant will affect the viability of the evidence. Any estimate
is nothing more than a guess.
D. The court of appeals' decision has negative implications for
State's ability to apprehend and prosecute drug impaired
drivers.
Both UCA §§ 41-6-44(l)(a), Driving Under the Influence and 76-5-207(l)(a)f
Automobile Homicide, make it illegal to drive "while under the influence of alcohol, any
drug, or the combined influence of alcohol and any drug". UCA 41-6-44.6 makes it is
illegal to drive "with any measurable controlled substance or metabolite of a controlled
substance in the person's body. Although the court of appeals opinion does not address
drug impaired drivers, the court's reasoning has implications for the investigation of drug
impaired driver as well. Presumably the officer would be required to go through the
same analysis in deciding whether or not to seek a warrant when faced with a drug or
combined alcohol and drug impaired driver.
The investigation of a drug impaired driver is more complex than investigation
of an alcohol impaired driver.

The alcohol impaired driver usually exhibits some

standard signs familiar to even a layman: an odor of alcohol, bloodshot eyes, lack of
13

coordination, slurred speech, inappropriate demeanor, mental confusion. The signs of
drug impairment vary widely depending on the drug consumed, the amount, and whether
the suspect is in the absorption or elimination phase. Drug detection is hampered by the
reality that many drug users combine drugs with alcohol or other drugs. Little is known
about the metabolism of many drugs, particularly illicit drugs. Stimulant drugs such as
methamphetamine and cocaine pass out of the blood quickly. Traces of other drugs such
as opiates and marijuana last longer.9
Unless the parent drug, not the metabolite, is found in the blood it is
practically impossible to prosecute a possible drug impaired driver under the automobile
homicide statute or the even the driving under the influence statute. The presence of the
metabolite only shows that the drug was used but does not tell when. The metabolite also
does not correlate to an amount consumed. Therefore, a delay in obtaining the blood
0

sample of a drug impaired driver carries the substantial probability that the drug evidence
will be altered or destroyed.

Although § 41-6-44.6 allows evidence of refusal in the

prosecution of a metabolite case, in reality it is unlikely that driving with a measurable
amount of metabolite can be successfully prosecuted without a test result absent an
admission of drug use and the approximate time it was consumed.

9

Barry K. Logan, Effects of Drugs on Human Performance-Fact Sheets, Wash State
Toxicology Laboratory, Oct. 1999, at passim (unpublished reports available form
Washington State Toxicology Laboratory), attached as Addendum K.
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CONCLUSION
Impaired drivers remain the single biggest cause of property damage, injury
and death on America's highways. The Utah Crash Summary 2003 shows that there
were 1,947 alcohol and drug-related crashes in Utah resulting in 1,101 injuries and 46
fatalities during the reporting period. Alcohol and other drug-related crashes were 4
times more likely to be fatal than other types of crashes.10 The State has a compelling
interest in the apprehension and prosecution of impaired drivers. Without knowing the
suspect's BAC and elimination rate, no officer can determine whether an emergency
exists as defined by the court of appeals which would justify taking a blood sample
without a warrant. Furthermore, the requirement that an officer guess at the time it may
take to obtain a warrant ignores the reality that alcohol begins to be eliminated
immediately. Even in cases where the evidence is not totally destroyed, it is significantly
changed by delay. Therefore, amici respectfully request this Court to overturn the
decision below and find the evanescent nature of blood alcohol, in and of itself, creates
an exigent circumstance allowing an officer to take blood without a warrant.
Respectfully submitted this <^y day of March, 2005.

-Ai

JANICE L. FR(5§T
Attorney for Amici Curiae

10

Utah Crash Summary 2003, Utah Department of Public Safety, 51 (unpublished report
available at http://www.highwaysafety.utah.gov/crashdata/2003/index.htm).
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Addenda

Addendum A

§ 7 6 - 5 - 2 07.

Automobile homicide

(1) As used in this section, "motor vehicle" means any self-propelled vehicle
and includes any automobile, truck, van, motorcycle, train, engine, watercraft,
or aircraft.
(2)(a) Criminal homicide is automobile homicide, a third degree felony, if the
person operates a motor vehicle in a negligent manner causing the death of
another and:
(i) has sufficient alcohol in his body that a subsequent chemical test
shows that the person has a blood or breath alcohol concentration of .08
grams or greater at the time of the test;
(ii) is under the influence of alcohol, any drug, or the combined influence of alcohol and any drug to a degree that renders the person incapable
of safely operating a vehicle; or
(iii) has a blood or breath alcohol concentration of .08 grams or greater
&t the time of operation.
(b) A conviction for a violation of this Subsection (2) is a second degree
felony if it is subsequent to a conviction as defined in Subsection 41-6-44(1).
(c) As used in this Subsection (2), "negligent" means simple negligence,
the failure to exercise that degree of care that reasonable and prudent
persons exercise under like or similar circumstances.
(3)(a) Criminal homicide is automobile homicide, a second degree felony, if
the person operates a motor vehicle in a criminally negligent manner causing
the death of another and:
(i) has sufficient alcohol in his body that a subsequent chemical test
shows that the person has a blood or breath alcohol concentration of .08
grams or greater at the time of the test;
(ii) is under the influence of alcohol, any drug, or the combined influence of alcohol and any drug to a degree that renders the person incapable
of safely operating a vehicle; or
(iii) has a blood or breath alcohol concentration of .08 grams or greater
at the time of operation.
(b) As used in this Subsection (3), "criminally negligent" means criminal
negligence as defined by Subsection 76-2-103(4).
(4) The standards for chemical breath analysis as provided by Section
41-6-44.3 and the provisions for the admissibility of chemical test results as
provided by Section 41-6-44.5 apply to determination and proof of blood
alcohol content under this section.
(5) Calculations of blood or breath alcohol concentration under this section
shall be made in accordance with Subsection 41-6-44(2).
(6) The fact that a person charged with violating this section is or has been
legally entitled to use alcohol or a drug is not a defense.
(7) Evidence of a defendant's blood or breath alcohol content or drug content
is admissible except when prohibited by Rules of Evidence or the constitution.

§ 4 1 - 6 - 4 4 . Driving under the influence of alcohol, drugs, or a combination
of both or with specified or unsafe blood alcohol concentration—Measurement of blood or breath alcohol—Criminal punishment—Arrest without
warrant—Penalties—Suspension or revocation of license
(1) As used in this section:
(a) ''assessment' 1 means an in-depth clinical interview with a licensed
mental health therapist:
(i) used to determine if a person is in need of:
(A) substance abuse treatment that is obtained at a substance abuse
program;
(B) an educational series; or
(C) a combination of Subsections (l)(a)(i)(A) and (B); and
(ii) that is approved by the Board of Substance Abuse and Mental Health
in accordance with Section 62A-15-105.
(b)(i) "conviction" means any conviction for a violation of:
(A) this section;
(B) alcohol, any drug, or a combination of both-related reckless driving under Subsections (9) and (10);
(C) Section 41-6-44.6, driving with any measurable controlled substance that is taken illegally in the body;
(D) local ordinances similar to this section or alcohol, any drug, or a
combination of both-related reckless driving adopted in compliance with
Section 41-6-43;
(E) automobile homicide under Section 76-5-207;
(F) Subsection 5 8-37-8(2)(g);
(G) a violation described in Subsections (l)(b)(i)(A) through (F), which
judgment of conviction is reduced under Section 76-3-402; or
(H) statutes or ordinances in effect in any other state, the United
States, or any district, possession, or territory of the United States which
would constitute a violation of this section or alcohol, any drug, or a
combination of both-related reckless driving if committed in this state,
including punishments administered under 10 U.S.C. Sec. 815;
(ii) A plea of guilty or no contest to a violation described in Subsections
(l)(b)(i)(A) through (H) which plea is held in abeyance under Title 77,
Chapter 2a, Pleas in Abeyance, is the equivalent of a conviction, even if the
charge has been subsequently reduced or dismissed in accordance with the
plea in abeyance agreement, for purposes of:
(A) enhancement of penalties under:
(I) this Chapter 6, Article 5, Driving While Intoxicated and Reckless
Driving; and
(II) automobile homicide under Section 76-5-207; and
(B) expungement under Section 77-18-12.
r/
(c) educational series" means an educational series obtained at a substance abuse program that is approved by the Board of Substance Abuse and
Mental Health in accordance with Section 62A-15-105;

(d) "screening'' means a preliminary appraisal of a person:
(i) used to determine if the person is in need of:
(A) an assessment; or
(B) an educational series; and
(ii) that is approved by the Board of Substance Abuse and Mental Health
in accordance with Section 62A-15-105;
(e) "serious bodily injury" means bodily injury that creates or causes
serious permanent disfigurement, protracted loss or impairment of the function of any bodily member or organ, or creates a substantial risk of death;
(f) "substance abuse treatment'' means treatment obtained at a substance
abuse program that is approved by the Board of Substance Abuse and Mental
Health in accordance with Section 62A-15-105;
(g) "substance abuse treatment program" means a state licensed substance
abuse program;
(h) a violation of this section includes a violation under a local ordinance
similar to this section adopted in compliance with Section 41-6-43; and
(i) the standard of negligence is that of simple negligence, the failure to
exercise that degree of care that an ordinarily reasonable and prudent person
exercises under like or similar circumstances.
(2)(a) A person may not operate or be in actual physical control of a vehicle
within this state if the person:
(i) has sufficient alcohol in the person's body that a subsequent chemical
test shows that the person has a blood or breath alcohol concentration of
.08 grams or greater at the time of the test;
(ii) is under the influence of alcohol, any drug, or the combined influence of alcohol and any drug to a degree that renders the person incapable
of safely operating a vehicle; or
(iii) has a blood or breath alcohol concentration of .08 grams or greater
at the time of operation or actual physical control;
(iv)(A) is 21 years of age or older;
(B) has sufficient alcohol in the person's body that a subsequent
chemical test shows that the person has a blood or breath alcohol
concentration of .05 grams or greater at the time of the test;
(C) has a passenger under 16 years of age in the vehicle at the time of
operation or actual physical control; and
(D) committed the offense within ten years of a prior conviction; or
(v)(A) is 21 years of age or older;
(B) has a blood or breath alcohol concentration of .05 grams or
greater at the time of operation or actual physical control;
(C) has a passenger under 16 years of age in the vehicle at the time of
operation or actual physical control; and
(D) committed the offense within ten years of a prior conviction.
(b) The fact that a person charged with violating this section is or has been
legally entitled to use alcohol or a drug is not a defense against any charge of
violating this section.

(c) Alcohol concentration in the blood shall be based upon grams of
alcohol per 100 milliliters of blood, and alcohol concentration in the breath
shall be based upon grams of alcohol per 210 liters of breath.
(3)(a) A person convicted the first or second time of a violation of Subsections (2)(a)(i) through (iii) is guilty of a:
(i) class B misdemeanor; or
(ii) class A misdemeanor if the person:
(A) has also inflicted bodily injury upon another as a proximate result
of having operated the vehicle in a negligent manner;
(B) had a passenger under 16 years of age in the vehicle at the time of
the offense; or
(C) was 21 years of age or older and had a passenger under 18 years of
age in the vehicle at the time of the offense.
(b) A person convicted of a violation of Subsection (2) is guilty of a third
degree felony if the person has also inflicted serious bodily injury upon
another as a proximate result of having operated the vehicle in a negligent
manner.
(c) A person convicted of a violation of Subsection (2)(a)(iv) or (v) is guilty
of:
(i) a class B misdemeanor; or
(ii) a class A misdemeanor if the person has also inflicted bodily injury
upon another as a proximate result of having operated the vehicle in a
negligent manner.
(4)(a) As part of any sentence imposed the court shall, upon a first conviction, impose a mandatory jail sentence of not less than 48 consecutive hours,
(i) work in a compensatory-service work program for not less than 48
hours; or
(ii) participate in home confinement through the use of electronic monitoring in accordance with Subsection (13).
(c) In addition to the jail sentence, compensatory-service work program, or
home confinement, the court shall:
(i) order the person to participate in a screening;
(ii) order the person to participate in an assessment, if it is found
appropriate by a screening under Subsection (4)(c)(i);
(iii) order the person to participate in an educational series if the court
does not order substance abuse treatment as described under Subsection
(4)(d); and
(iv) impose a fine of not less than $700.
(d) The court may order the person to obtain substance abuse treatment if
the substance abuse treatment program determines that substance abuse
treatment is appropriate.
(e)(i) Except as provided in Subsection (4)(e)(ii), the court may order
probation for the person in accordance with Subsection (14).
(ii) If there is admissible evidence that the person had a blood alcohol
level of .16 or higher, the court shall order probation for the person in
accordance with Subsection (14).

(5)(a) If a person is convicted under Subsection (2) within ten years of a
prior conviction under this section, the court shall as part of any sentence
impose a mandatory jail sentence of not less than 240 consecutive hours.
(b) The court may, as an alternative to all or part of a jail sentence, require
the person to:
(i) work in a compensatory-service work program for not less than 240
hours; or
(ii) participate in home confinement through the use of electronic monitoring in accordance with Subsection (13).
(c) In addition to the jail sentence, compensatory-service work program, or
home confinement, the court shall:
(i) order the person to participate in a screening;
(ii) order the person to participate in an assessment, if it is found
appropriate by a screening under Subsection (5)(c)(i);
(iii) order the person to participate in an educational series if the court
does not order substance abuse treatment as described under Subsection
(5)(d); and
(iv) impose a fine of not less than $800.
(d) The court may order the person to obtain substance abuse treatment if
the substance abuse treatment program determines that substance abuse
treatment is appropriate.
(e) The court shall order probation for the person in accordance with
Subsection (14).
(6)(a) A conviction for a violation of Subsection (2) is a third degree felony if
it is:
(i) a third or subsequent conviction under this section within ten years of
two or more prior convictions; or
(ii) at any time after a conviction of:
(A) automobile homicide under Section 76-5-207 that is committed
after July 1, 2001; or
(B) a felony violation under this section that is committed after July 1
2001.
(b) Any conviction described in this Subsection (6) which judgment of
conviction is reduced under Section 76-3-402 is a conviction for purposes of
this section.
(c) Under Subsection (3)(b) or (6)(a), if the court suspends the execution of
a prison sentence and places the defendant on probation the court shall
impose:
(i) a fine of not less thai; $1,500; and
(ii) a mandatory jail sentence of not less than 1,500 hours.
(d) For Subsection (6)(a) or (c), the court shall impose an order requiring
the person to obtain a screening and assessment and substance abuse
treatment at a substance abuse treatment program providing intensive care
or inpatient treatment and long-term closely supervised follow-through after
treatment for not less than 240 hours.
(e) In addition to the penalties required under Subsection (6)(c), if the
court orders probation, the probation shall be supervised probation which

may include requiring the person to participate in home confinement through
the use of electronic monitoring in accordance with Subsection (13).
(7) The mandatory portion of any sentence required under this section may
not be suspended and the convicted person is not eligible for parole or
probation until any sentence imposed under this section has been served.
Probation or parole resulting from a conviction for a violation under this
section may not be terminated.
(8)(a)(i) The provisions in Subsections (4), (5), and (6) that require a sentencing court to order a convicted person to: participate in a screening; an
assessment if appropriate; and an educational series; obtain, in the discretion
of the court, substance abuse treatment; obtain, mandatorily, substance abuse
treatment; or do a combination of those things, apply to a conviction for a
violation of Section 41-6-44.6 or 41-6-45 under Subsection (9).
(ii) The court shall render the same order regarding screening, assessment, an educational series, or substance abuse treatment in connection
with applying respectively, the first, second, or subsequent conviction
requirements of Subsections (4), (5), and (6).
(b)(i) The court shall notify the Driver License Division if a person fails to:
(A) complete all court ordered:
(I) screening;
(II) assessment;
(III) educational series;
(IV) substance abuse treatment; and
(V) hours of work in compensatory-service work program; or
(B) pay all fines and fees, including fees for restitution and treatment
costs.
(ii) Upon receiving the notification described in Subsection (8)(b)(i), the
division shall suspend the person's driving privilege in accordance with
Subsections 53-3-221(2) and (3).
(9)(a)(i) When the prosecution agrees to a plea of guilty or no contest to a
charge of a violation of Section 41-6-45, of an ordinance enacted under
Section 41-6-43, or of Section 41-6-44.6 in satisfaction of, or as a substitute
for, an original charge of a violation of this section, the prosecution shall state
for the record a factual basis for the plea, including whether or not there had
been consumption of alcohol, drugs, or a combination of both, by the defendant
in connection with the violation.
(ii) The statement is an offer of proof of the facts that shows whether
there was consumption of alcohol, drugs, or a combination of both, by the
defendant, in connection with the violation.
(b) The court shall advise the defendant before accepting the plea offered
under this Subsection (9)(b) of the consequences of a violation of Section
41-6-44.6 or of Section 41-6-45.
(c) The court shall notify the Driver License Division of each conviction of
Section 41-6-44.6 or 41-6-45 entered under this Subsection (9).
(10) A peace officer may, without a warrant, arrest a person for a violation of

this section when the peace officer has probable cause to believe the violation
has occurred, although not in the peace officer's presence, and if the peace
officer has probable cause to believe that the violation was committed by the
person.
(1 l)(a) The Driver License Division shall:
(i) suspend for 90 days the operator's license of a person convicted for
the first time under Subsection (2);
(ii) revoke for one year the license of a person convicted of any subsequent offense under Subsection (2) or if the person has a prior conviction
as defined under Subsection (1) if the violation is committed within a
period of ten years from the date of the prior violation; and
(iii) suspend or revoke the license of a person as ordered by the court
under Subsection (12).
(b) The Driver License Division shall subtract from any suspension or
revocation period the number of days for which a license was previously
suspended under Section 53-3-223 or 53-3-231, if the previous suspension
was based on the same occurrence upon which the record of conviction is
based.
(12)(a)(i) In addition to any other penalties provided in this section, a court
may order the operator's license of a person who is convicted of a violation of
Subsection (2) to be suspended or revoked for an additional period of 90 days,
180 days, one year, or two years to remove from the highways those persons
who have shown they are safety hazards.
(ii) The additional suspension or revocation period provided in this
Subsection (12) shall begin the date on which the individual would be
eligible to reinstate the individual's driving privilege for a violation of
Subsection (2).
(b) If the court suspends or revokes the person's license under this Subsection (12)(b), the court shall prepare and send to the Driver License Division
an order to suspend or revoke that person's driving privileges for a specified
period of time.
(13)(a) If the court orders a person to participate in home confinement
through the use of electronic monitoring, the electronic monitoring shall alert
the appropriate corrections, probation monitoring agency, law enforcement
units, or contract provider of the defendant's whereabouts.
(b) The electronic monitoring device shall be used under conditions which
require:
(i) the person to wear an electronic monitoring device at all times;
(ii) that a device be placed in the home or other specified location of the
person, so that the person's compliance with the court's order may be
monitored; and
(iii) the person to pay the costs of the electronic monitoring.
(c) The court shall order the appropriate entity described in Subsection
(13)(e) to place an electronic monitoring device on the person and install
electronic monitoring equipment in the residence of the person or other
specified location.

(d) The court may:
(i) require the person's electronic home monitoring device to include a
substance abuse testing instrument;
(ii) restrict the amount of alcohol the person may consume during the
time the person is subject to home confinement;
(iii) set specific time and location conditions that allow the person to
attend school educational classes, or employment and to travel directly
between those activities and the person's home; and
(iv) waive all or part of the costs associated with home confinement if
the person is determined to be indigent by the court.
(e) The electronic monitoring described in this section may either be
administered directly by the appropriate corrections agency, probation monitoring agency, or by contract with a private provider.
(f) The electronic monitoring provider shall cover the costs of waivers by
the court under Subsection (13)(d)(iv).
(14)(a) If supervised probation is ordered under Section 41-6-44.6 or Subsection (4)(e) or (5)(e):
(i) the court shall specify the period of the probation;
(ii) the person shall pay all of the costs of the probation; and
(iii) the court may order any other conditions of the probation.
(b) The court shall provide the probation described in this section by
contract with a probation monitoring agency or a private probation provider.
(c) The probation provider described in Subsection (14)(b) shall monitor
the person's compliance with all conditions of the person's sentence, conditions of probation, and court orders received under this article and shall
notify the court of any failure to comply with or complete that sentence or
those conditions or orders.
(d)(i) The court may waive all or part of the costs associated with probation if the person is determined to be indigent by the court.
(ii) The probation provider described in Subsection (14)(b) shall cover
the costs of waivers by the court under Subsection (14)(d)(i).
(15) If a person is convicted of a violation of Subsection (2) and there is
admissible evidence that the person had a blood alcohol level of .16 or higher,
the court shall order the following, or describe on record why the order or
orders are not appropriate:
(a) treatment as described under Subsection (4)(d), (5)(d), or (6)(d); and
(b) one or both of the following:
(i) the installation of an ignition interlock system as a condition of
probation for the person in accordance with Section 41-6-44.7; or
(ii) the imposition of home confinement through the use of electronic
monitoring in accordance with Subsection (13).

§ 4 1 - 6 - 4 4 . 6 . Definitions—Driving with any measurable controlled substance in the body—Penalties—Arrest without warrant
(1) As used in this section:
(a) ''Controlled substance" means any substance scheduled under Section
58-37-4.
(b) "Practitioner" has the same meaning as provided in Section 58-37-2.
(c) "Prescribe" has the same meaning as provided in Section 58-37-2.
(d) "Prescription" has the same meaning as provided in Section 58-37-2.
(2) In cases not amounting to a violation of Section 41-6-44, a person may
not operate or be in actual physical control of a motor vehicle within this state
if the person has any measurable controlled substance or metabolite of a
controlled substance in the person's body.
(3) It is an affirmative defense to prosecution under this section that the
controlled substance was involuntarily ingested by the accused or prescribed by
a practitioner for use by the accused.
(4) A person convicted of a violation of Subsection (2) is guilty of a class B
misdemeanor.
(5) A peace officer may, without a warrant, arrest a person for a violation of
this section when the officer has probable cause to believe the violation has
occurred, although not in the officer's presence, and if the officer has probable
cause to believe that the violation was committed by the person.
(6) The Driver License Division shall:
(a) suspend, for 90 days, the driver license of a person convicted under
Subsection (2);
(b) revoke, for one year, the driver license of a person convicted of a
second or subsequent offense under Subsection (2) or if the person has a
prior conviction as defined under Subsection 41-6-44(1), if the violation is
committed within a period of ten years after the date of the prior violation;
and
(c) subtract from any suspension or revocation period the number of days
for which a license was previously suspended under Section 53-3-223 or
53-3-231, if the previous suspension was based on the same occurrence upon
which the record of conviction is based.
(7) If a person fails to complete all court ordered screening and assessment,
educational series, and substance abuse treatment, or fails to pay all fines and
fees, including fees for restitution and treatment costs, the court shall notify the
Driver License Division of a failure to comply. Upon receiving the notification,
the division shall suspend the person's driving privilege in accordance with
Subsections 53-3-221(2) and (3).
(8) The court shall order supervised probation in accordance with Subsection
41-6-44(14) for a person convicted under Subsection (2).
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T IS well established and universally accepted that
"the concentration~of "alcohol1"in~ blood o r breath,
properly determined and interpreted, constitutes the best
and most objective indicator of the absence or presence
and degree of acute alcohol-induced impairment of
driving ability in living subjects. Hence, understanding
and appreciation of the major physiological and pharmacological factors affecting such alcohol concentrations
are important to appropriate use and interpretation of
chemical tests for alcohol in traffic law enforcement,
and in research on driving impairment by alcohol.
Recognition of the complexity of the relationships between dose of alcohol, time and pharmacological effect
is also essential to both research and public education
in this field.
Most of the relevant factors and considerations affecting the alcohol contents of various body tissues and
fluids and the dose-time-effect relationships fall into
the field of pharmacokinetics, which broadly concerns
the absorption, distribution, biotransformation and excretion of drugs. The interrelationship of the alcohol
concentrations of different body fluids and tissues, such
as the blood : breath ratio of alcohol as a prime
example, is an important and complex consideration in
alcohol determination. Further, in the use of chemical
tests for alcohol in traffic law enforcement, a sufficient
time interval often elapses between the significant event,
such as a crash or an alleged violation, and sample
collection to produce a marked and very significant
difference in the respective alcohol concentrations of
blood or other specimen materials. Time relationships
involving ingestion, distribution, storage and elimination
of alcohol are, therefore, important in relation to
highway safety and evidentiary use of chemical test
results, sometimes overwhelmingly so.
Pharmacokinetic parameters thus affect both the validity and usefulness of alcohol determinations as indi-

cators of driver impairment by alcohol in such resp&
as" choice of" sample - materials-and the probative yJJ
and interpretation of results of alcohol analysis^
understanding of alcohol pharmacokinetics is also neSJ
for the proper evaluation and assessment of the vafll
and significance of studies correlating alcohol concc
trations in body fluids with driver performances
impairment, and for proper appreciation of different
between studies. In the present paper, several o l j
more relevant and problematic aspects of alcohol ^pS
macokinetics are considered from the aspect of higHl
safety.
i^
Several of these matters have become critically]!
portant with the advent and""wide adoption of p e |
drinking-driving laws,2 also called absolute or b j |
alcohol concentration offense laws. Body fluid algp
concentrations constitute an element of the offenj|
per se laws, and are often the controlling evidj|
irrespective of driver impairment. The onus 01Q
accuracy of the alcohol analysis and the validity qfj
blood or breath alcohol concentration at the reMjjl
time is vastly greater in such settings than in the pre
traditional evidentiary use of alcohol analysis resul^
document presence of alcohol to an extent corroboj
of the observed driver impairment and sufficiej
explain the crash involvement or moving violati^
to establish a rebuttable presumption of the exist
of the influence of alcohol to an impermissible *~
Aspects of Absorption, Distribution
and Elimination of Alcohol
Alcohol is unusual, if not unique, among'dQB
2

Per se statutes are generally modeled after Section _- Jj&
the Uniform Vehicle Code and employ a speed limit c 0 ^ s | p
element of the offense being motor vehicle operation y ^ | | | |
whose blood or breath alcohol concentration equals or
|||
specified limit, commonly 0 10 g/dl of blood or 0 10 g ^ § |
breach

The unmodified term alcohol in this article refers to ethanol
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PHARMACOLOGY OF ALCOHOL: IMPAIRMENT OF DRIVER PERFORMANCE
pects of its pharmacokinetics. Particularly
e the great biological intersubject variabilities
consumption tolerance and in alcohol elimithe pattern of short-term fluctuations from
line of the time course of the blood and
ohol concentrations and in alcohol partition
>lood and other body fluids and tissues even
rium. Also significant is that alcohol is abd distributed in an unaltered state and is not
proteins or complexed with other transport

bsorption
'ration of the variability and anomalies of the
ad elimination of alcohol is facilitated by
to the theoretical schematic ~~time"course~of~
alcohol concentration often termed the Wid~
"ve (Elbel and Schleyer, 1956; Wallgren and
70; Widmark, 1932) illustrated in Figure 1,
e many limitations of this schematic represention of alcohol from the gastrointestinal tract,
the stomach, occurs by simple passive difful concentration gradients and does not involve
transport system. A small, weakly charged
alcohol readily penetrates cell membranes and
i
s. Its distribution is largely governed by the
itent of the various organs and tissues, espe>quilibrium, because it is polar and completely
uble (Wallgren and Barry, 1970). The distri-
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bution process is much speeded by vascularization and
blood flow. Organs with a rich blood supply, such as
the brain and the lungs, achieve the highest initial
concentrations of alcohol. A positive differential, which
may be as great as 50-100% (Forney, 1971), persists
between the arterial and venous blood alcohol concentrations during the active absorption and prior to equilibration (Forney et al., 1964; Harger and Hulpieu,
1956). The time lag from initial absorption of alcohol
to the beginning of the postabsorptive phase is a key
variable in relation to highway safety. It brings about
significant differences in the magnitude and timing of
alcohol concentrations in different organs. The resultant
effects on the central nervous system are earlier and
more marked than those on the skeletal musculature
and other somatic systems.
The rate of alcohol absorption after oral intake is
greatly influenced by the nature and concentration of
the alcoholic beverage, food intake and a multitude of
other physical, biological, psychological and time factors
that combine with the individual's sex, body weight and
body water, and related habitus characteristics as well
as offsetting metabolic disposition to determine the
ultimate peak blood alcohol concentration and other
characteristics of the time course of the blood alcohol
concentration. The term consumption tolerance is often
applied to all of these combined factors and effects, in
distinction to the constitutional tolerance, which denotes
the differences between persons in the effects of alcohol
at the tissue and organ level and in individual resistance
to those effects at identical blood and tissue alcohol
concentrations.
The peak blood alcohol concentration and the time
for its achievement are important parameters in various
respects. The peak often marks, for example, the
changeover between the rising and falling blood alcohol
concentrations, reflecting the absorption (a) and elimination ((3) phases of distribution—a matter related to
acute adaptation to the effects of alcohol (Mitchell,
1985).
These two variables also illustrate splendidly the substantial biological variability in alcohol pharmacokinetics, even under controlled experimental conditions. In
single-dose experiments with both men and women,
Dubowski (1976a) found elapsed time from end of
alcohol intake to peak blood alcohol concentration
varying from 14 to 138 min, a nearly 10-fold variation,
with mean times for men and women 57 and 42 min,
respectively. In subsequent additional studies on men,
with a different experimental protocol (Dubowski, 1976b),
the data summarized in Table 1 were obtained. A 14fold variation between absorption times to the peak
blood alcohol concentrations in different subjects was
demonstrated even in a reasonably homogeneous healthy
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\BLE 1. Time to reach peak blood alcohol concentrations and peak
ood alcohol : dose relationship in healthy adult men

Pharmacokinetic
factor
me to peak blood alcohol
concentration, min°
me to peak blood alcohol
concentration, min*
ak blood alcohol
concentration dose,
mg/dl
i7ki~
0
b

N

Mean ± SD

Coefficient
of
variation
(°7o)

Range

79

29.3 ± 17 1

58.5

9-114

69

52.0 ± 34 6

66 5

12-166

145

121.5 ± 2 1 1

16.5

78-192

Subjects ingesting 0.5 g alcohol/kg body weight.
Subjects ingesting 1.0 g alcohol/kg body weight.

>puiation. Total population variability is obviously
uch greater. Other investigators have reported comrable intersubject variability of experimentally meased peak blood alcohol times after the end of drinking
r
aeve, 1973).
Peak blood alcohol concentrations reached after inges>n of identical weight-adjusted doses of alcohol typilly also vary two- to threefold, even in homogeneous
perimental subject populations and under identical
perimental conditions (Dubowski, 1976a; O'Neill et
, 1983). Of healthy men given an alcohol dose of
) g/kg, 95% can be expected to reach peak blood
•ohol concentrations of 85-170 mg/dl; the remaining
bjects will fall outside that range. For a given total
•ohol dose, divided-dose drinking, as commonly occurs
social settings, typically produces slower stepwise
:reases in blood alcohol concentrations than the single
se often ingested experimentally (Forney and Hughes,
63). Accumulation of alcohol in the blood and other
sues occurs whenever the rates of alcohol intake and
sorption exceed the drinker's rate of alcohol elimition.
cohol

elimination

Blimination of alcohol occurs principally through
!:ymatic oxidation in the liver, with usually minor
nhepatic oxidation pathways and minor excretion of
altered alcohol in the urine, breath and perspiration
awkins and Kalant, 1972; Khanna and Israel, 1980;
ber, 1977; Majchrowicz, 1975). The pharmacokinetics
olved have been explained variously as corresponding
a one compartment open model with zero-order
nstant rate) elimination, a one compartment open
del with Michaelis-Menten (1913) elimination kinetics
indquist and Wolthers, 1958), and a two compartment
m model with Michaelis-Menten elimination kinetics.
e first-listed theory was initially advanced by Mel-

lanby (1919) and is the original basis for the schematic
Widmark Curve (Figure 1).
However, zero-order kinetics, characterized by constant-rate elimination independent of alcohol dose or
initial blood alcohol concentration, is an inappropriate
description for the elimination of alcohol in humans,
at least in a significant portion of the population
(Dubowski, 1976a, 1976b; Lundquist and Wolthers,
1958; Wilkinson, 1980). In most subjects and circumstances, the decrease in blood alcohol concentration per
unit time in the fully postabsorptive state is a valid
reflection of the instant rate of alcohol elimination. It
is most appropriately described by a one compartment
open model with Michaelis-Menten (1913) elimination
kinetics when only a single specimen material (e.g.,
expired alveolar breath) or blood from a single site
(e.g., vein, capillary or arteryjT is examined. Such a
process describes a mixed pattern of zero-order (constant
elimination rate) kinetics, which occurs when the ratelimiting enzymatic alcohol oxidation step is saturated,
with first-order kinetics when there is an excess of
enzyme and which is characterized by an exponential
rate of change (i.e., a constant fraction of alcohol is
eliminated per unit time). The usual graphical presentation of the Michaelis-Menten equation is that of a
rectangular hyperbola. The characteristics of this process
include a slope of the apparent or pseudolinear decline
rate in blood alcohol concentration, which increases
with increases in body dose of ingested alcohol and in
initial blood alcohol concentration (Wagner and Patel,;
1972; Wagner et al., 1976). Both the absorption and.
elimination rates of alcohol are significantly subject to^
the effects of food (Sedman et al., 1976; Vitale et al.,5
1953), and to a much smaller extent to the effects of,
type and dilution of the ingested alcoholic beverage(Dubowski, 1976b).
:
Quantitative data on alcohol elimination have been;
obtained in profusion, mostly from repeated measured
ment of blood or breath alcohol concentrations. In
addition to these controlled pharmacokinetic studies/^
considerable information has been published on blood
alcohol concentration changes with time in drivers who2
drink, usually by calculation from testing at two points^
along the elimination curve. The number of subjects
tested and the variability of the results encountered
have been much greater than in the laboratory studies.
Moreover, the blood alcohol concentrations involved
were usually much higher in the studies of drivers who
drink. For example, in 922 men traffic offenders, Abete
(1955) found a blood alcohol decrease rate range of °
to 40 mg/dl/hr, with a mean of 18.4 and a mode of
18.0. In other studies in which two samples were tested,
ranges of 1 to 80 mg/di/hr (mean ± SD, 20.4 ± 10.5)
among 1512 subjects (Schweitzer, 1968), 0 to 26 mg/
dl/hr (mean, 17.2 ± 9.1) among 1655 subjects (Ponsold
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>60), and 9 to 30 mg/dl/hr (mean, 18.6 ± 6)
jects (Hilgermann and Schleyer, 1971) were
16 traffic offenders, the breath alcohol
It measured by two tests was 7 to 17 mg/
nean, 11.1 ± 2.8) (Loomis, 1974). Several
I other authors found alcohol elimination
normally distributed (Lund, 1979), as has
iuthor.
observations limited to two points on the
urve have many obvious shortcomings and
Dr determining functional blood or breath
*ase rates, but they do illustrate the wide
ntered. The other extreme of studies is
by controlled pharmacokinetic experiments
rate of alcohol decrease in blood or breath
d by appropriate individual mathematical
each multipoint alcohol concentration verve. In 134 adult men in the postabsorptive
wski (1976b) obtained the data shown in
i illustrated in Figure 2. The data were
>y infrared spectrometry and computer modi subject curve.
lying data follow a Gaussian distribution.
data, it can be estimated that the mean
h alcohol concentration decrease for 95%
3pulation lies between 5.9 and 23.9 mg/230
>r 99.7% of such a population lies between
% mg/230 L/hr.
studies have been variously reported as
ood alcohol decrease rates to be independent
;ohol concentrations or positively correlated
blood alcohol concentrations, thus correzero-order and first-order pharmacokinetics,
Abele (1955) reported dependence of mean
10I decrease rates on the blood alcohol
n, as did others (Dubowski, 1976a, 1976b;
1968; Wagner et al., 1976). Dose dependence
d alcohol decrease rate was found by Alha
tie et al. (1953) and others. No significant
lood alcohol concentration on alcohol dewas reported by Ponsold and Heite (1960)
'arly investigators. The term acute metabolic
as been recently applied to an increase in
10I elimination rate within a few hours for
:ts after a second dose of alcohol (Wilson
es emphasis that the rate of decrease of
10I concentration does not directly and ex,'flect the metabolic disposition of alcohol
• changes in concentration are also, in part,
}f alcohol elimination through urine, breath,

TABLE 2 Rates of breath alcohol decrease in the postabsorptive state
for healthy adult men, determined from individual subject breath
alcohol concentration vs time regressions
Breath alcohol concentration decrease, mg/230 L/hr
Coefficient
of variation
N

Mean ± SD

134

14 94 ± 4 50

%

Range

30 1

5 9-27 9

perspiration and other routes. Excretion through those
routes would be expected to be positively correlated
with the plasma alcohol concentration because it involves
passive diffusion of alcohol in accordance with its
concentration gradients for the route involved.
Aspects of alcohol

distribution

Most state drinking-driving laws limit reference to
alcohol concentrations to those in blood regardless of
the specimen material actually analyzed, although an
increasing number of jurisdictions are adopting the
definition of alcohol concentration of the Uniform
Vehicle Code, 4 which relates that term to the analyzed
specimen. Common statutory terminology refers to "the
amount of alcohol in the person's blood at the time
alleged as shown by chemical analysis of the person's
blood, urine, breath or other bodily substances." Consequently, the alcohol distribution process and the partition ratios for alcohol between blood and other
specimen materials are of great practical importance.
Often they are the subject of vigorous attacks against
trial evidence of "blood" alcohol concentrations derived
from the analysis of other body fluids.
Breath alcohol analysis is by far the most commonly
employed form of chemical testing in traffic law enforcement. Hence the true blood : breath ratio for alcohol, originally used to calibrate breath alcohol analyzers
to indicate the supposedly corresponding blood alcohol
concentration, has been a subject of much scientific
investigation and debate for about 50 years. It is evident
from considerations of quantitative human biology that
a single ratio or conversion factor will not apply to all
persons (Mason and Dubowski, 1974, 1976). Nevertheless, for half of that period, there was general acceptance of 2100 : 1 as the partition ratio of alcohol between
blood and alveolar breath, as a population mean (Borkenstein et al., 1972; Harger et al., 1950; National
Safety Council, 1953). Quantitative evidential breathalcohol analyzers are still currently factory-calibrated in

4

-rsion factor is. 1 L of blood = 2100 L of expired
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As changed in 1979, Uniform Vehicle Code Section 11-902 1(a)(5)
reads "Alcohol concentration shall mean either grams of alcohol per
100 milliliters of blood or grams of alcohol per 210 liters of breath."
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ams of alcohol per 210 L of breath. Some official
idelines incorporate this calibration (National Highway
affic Safety Administration, 1984), thus in effect
taining a 2100 : 1 blood alcohol : breath alcohol conntration ratio for those jurisdictions statutorily reiring the reporting of evidentiary alcohol concentrations
terms of blood.
Later studies on larger subject groups, with more
phisticated chemical analyses of blood and breath for
:ohol and more extensive data treatment, indicated
it the mean alcohol partition factor between blood
d breath in the postabsorptive phase in healthy adult
m is very close to 2300 : 1 (Dubowski, 1975; Duwski and O'Neill, 1979; Jones, 1976; Jones et al.,
75). However, significant variations from this popuion mean~ exist during _active_alcoJhol_ absorption and„
some individuals even in the postabsorptive phase,
e typical biological variability of human alcohol
armacokinetic parameters is well illustrated by the
ta from studies of Dubowski and O'Neill (1979).
ese are summarized in Table 3, for the ratio of
ohol concentrations in whole blood and end-expiray breath in healthy adult men in the fully postab•ptive phase.
These experimentally determined ratios have a Gausn distribution. Hence a postabsorptive blood alcohol:
>ath alcohol concentration ratio range of 1797 : 1
2763 : 1 can be estimated for 95°7o and 1555 : 1 to
)5 : 1 for 99.7°/o of such a population. Those statisal projections agree closely with the experimentally
md range of values.
The various scientific, technical and forensic aspects
this complex matter have been reviewed in detail by
ison and Dubowski (1976). They proposed that the
ense of driving under the influence of alcohol be
tutorily defined in terms of the concentration of
ohol in the breath and in the blood, that breath
ohol analysis continue to be employed in traffic law
orcement but that conversion of breath alcohol conizations to blood alcohol concentrations be abanled for forensic purposes. These recommendations
fc been implemented in an increasing number of
isdictions.
There is massive documentation that the blood alcohol

LE 3. Functional ratio of alcohol concentrations in venous whole
>d and end-expiratory breath in the postabsorptive phase, in healthy
t men
Blood alcohol concentration

Breath alcohol concentration

Coefficient
of variation
N

Mean ± SD

93

2280 ± 241 5

Sex, age and tune-related
Range

106

concentration cannot be established sufficiently reliable
for forensic purposes from the alcohol concentration of
a pooled bladder urine specimen because of the extensive"
variability of the blood : urine ratio of alcohol. Partition
ratios of 0.21 : 1 to 2.66 : 1 have been reported (Flag,
agan et al., 1977; Kaye and Cordona, 1969; Morgan"1965; Stevens et al., 1966). From the data reported by
Kaye and Cordona (1969), it can be determined that
the urine : blood alcohol concentration ratios are normally distributed and it can be estimated that 95% of
such ratios in the population will fall between 0.36 :1
and 2.20: 1, and 99.7% between near 0 and 2.66 : If
These problems have been recognized in policy statements of the National Safety CounciPs Committee on
Alcohol and Drugs (1979) and of the National Highway
Traffic Safety Administration (1975), which list blood
and breath as specimens of choice for alcohol analysis
and discourage use of urine for alcohol determinatiol
in law enforcement.
£
Analysis of alcohol in saliva has been limited to
research applications because of the inherent problems
in field collection of specimens. Modern studies using
refined analytical methods and small sample volumes
have shown mean partition ratios for alcohol of 1.04 :1
for parotid saliva : plasma (DiGregorio et al., 1978) and
1.08 : 1 for pooled saliva : blood (Jones, 1979).
ft
Alcohol is excreted in part in sweat. Based on that
fact, an adhesive pad for sweat collection from the skin
for periods up to 8 days has been suggested as aj
indicator of alcohol consumption (Phillips and Mg
Aloon, 1980). The validity and usefulness of alcoho]
measurement in sweat thus collected by sweat patcl
over a period of days as an indicator of alcoh'a
abstention or use is still under evaluation, with divergenj
results (Phillips, 1984; Phillips et al., 1984).
J
For historical reasons, and because drinking-driviril
laws uniformly refer to blood alcohol in the whol?
blood sense, studies of driving impairment by alcoho
and of alcohol distribution between body fluids haVj
mostly used whole blood as the specimen when blodj
was sampled. Because alcohol is not uniformly distri|
uted between the cellular and noncellular component
of blood and because of the relative frequency |
hematological abnormalities in the population as wd
as circadian and other shifts of fluid volumes, use o
whole blood alcohol concentrations further complicate
the physical, chemical and biological factors involv|
in alcohol distribution and partition (Mason and DJ
bowski, 1976). Plasma is a physiologically and ph#
macokineticaliy more appropriate specimen.

1706-3063

differences

In many of the pharmacokinetic parameters fof ^
cohol, marked differences related to sex and age eX1^-
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the former, differences in body composily in body water and adipose tissue prousually cited to explain the documented
ifferences, with less frequent attention to
menstrual cycle and use of oral contracep1983). Some of the differences are signifallel studies of oral alcohol intake in men
ising identical weight-adjusted alcohol doses
times, Dubowski (1976a) found the mean
blood alcohol concentration after end of
e 1.35 times as long in men as in women,
ak blood alcohol concentration : dose rebe 12.8°7o higher in women than in men
n hourly rate of decrease of the blood
mtration to be 23.6% greater in women
Women during the premenstru^phase_qf
cycle reached significantly higher peak
1 concentrations for identical weight-adate acute doses and showed greater abthan men, or than women tested during
n and around the time of ovulation (Jones
976). Women taking oral contraceptives
peak blood alcohol concentrations and
ltly lower body alcohol elimination rates
ohol disappearance rates than women not
aceptives (Jones and Jones, 1984; Zeiner,
*lis-Menten maximum velocity values for
)earance from the blood, reflecting alcohol
:apacity, have been found to be 1.9 times
omen as in men (Sutker et al., 1983).
differences in alcohol pharmacokinetics
i studied extensively in humans. Data for
;e groups showed consistent and significant
3od alcohol elimination rates with increaseitzer, 1968). Intravenous alcohol infusion
djusted dose produced slightly higher alrations in blood water in older subjects
*er men and the peak alcohol concentra1 water were age correlated. The rate of
)earance from the blood water, however,
Icantly correlated with age (Vestal et al.,
fferences were considered mostly attributlated changes in body composition, such
i lean body mass and total body water in
le effects of time of day on alcohol
ics as well as on effects of alcohol have
ed, although not studied extensively in
ts. Circadian rhythms have been claimed
k blood alcohol concentrations (Zeiner,
hoi elimination rates (Jones, 1974; Wilson
Others were unable to demonstrate sigof day-related differences in these pharirameters (Lawrence et al., 1983). Reviews
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of the relationship of time of day to alcohol pharmacokinetics have appeared (Minors and Waterhouse, 1980;
Sturtevant, 1976).
Anomalies and Short-Term Fluctuations
of Blood Alcohol Curves
For many purposes, the fitting of regression lines to
experimental data points by manual or computerized
mathematical modeling is satisfactory. The complete
blood alcohol or breath alcohol versus time curve usually
requires nonlinear regression analysis, in keeping with
the pharmacokinetic phenomena discussed above. However, for some purposes, a trend-line curve is markedly
inappropriate or useless. That is especially true for
attempts _to engage in retrograde—or- forward- e x t r a p o lation of blood or breath alcohol concentrations beyond
observed values. Among the major reasons for the
infeasibility of retrograde extrapolation, three stand out:
(7) lack of knowledge, usually, about the timing of the
alcohol concentration peak and absorption-postabsorption status; (2) ignorance about the mathematical characteristics (e.g., linear, pseudolinear, exponential) and
the mean rate of change of the individual's blood or
breath alcohol elimination curve; and (J) unpredictable
irregularities of the curve, especially short-term fluctuations from the best-fit trend line of the blood or breath
alcohol curve.
The nature, extent and frequency of the breath alcohol
curve irregularity and especially the short-term fluctuations have been illustrated in other reports (Loomis,
1974; Schmutte et al., 1972; Shumate et al., 1967;
Terfloth and Wuermeling, 1968). The same phenomena
of blood alcohol curves have been exemplified elsewhere
(Ditt and Forster, 1964; Leithoff, 1964; Naeve et al.,
1971; Schleyer, 1959; Schmutte et al., 1972; Wehner,
1972). The reports by Leithoff and by Wehner are
particularly persuasive of the existence and extent of
short-term blood alcohol fluctuations because these investigators employed automated analysis of blood continuously sampled through an indwelling venous catheter.
The same phenomenon is illustrated in Figure 2,
which consists of six representative breath alcohol versus
time curves obtained in the studies of Dubowski (1976b).
Under highly standardized conditions, healthy adult
men ingested alcohol doses of 0.5, 0.8 or 1.0 g/kg
body weight after a 4-hr fast, according to a Latinsquare design, by rapid (20 min) or slow (40 min)
drinking of one of four alcoholic beverages (champagne,
Deer, diluted whisky, straight whisky), accompanied by
mack foods. Alcohol concentrations of end-expiratory
Dreath were measured at frequent intervals, usually every
5 min, by infrared spectrometry with an Intoxilyzer
apparatus, calibration of which was closely monitored
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IGURE 2 Experimental human breath alcohol curves showing a typical Widmark pattern (2A) and various anomalies and short-term breath alcoho
uctuations (2B-2F) Each plotted point represents a separate breath alcohol measurement in g/230 L The dotted line near the left ordinate indicate
le end of alcohol ingestion The arrow shows the apparent peak breath alcohol concentration at least 15 min after the end of alcohol ingestion
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ysis of vapor-alcohol samples and was verified
uent comparison with simultaneous blood sames 2A-F reflect the following protocol conditions,
tvidual breath alcohol curve characteristics as deterYom family regression analysis of breath alcohol
ration vs time during the postabsorptive eliminaise of each curve. The notations used for all regreslations are the following: y = breath alcohol conon in g/230 L, x = hour after apparent peak of
alcohol concentation, R1 = coefficient of detern for the regression, SEE = standard error of the
*, i.e., square root of the residual variance.
*ure 2A, alcohol intake is straight 86-proof whisky,
:g, fast drinking. The curve displays a typical
Widmark pattern with minimal fluctuations from
d line. The most appropriate mathematical descripf the elimination period is a linear model:
116 - 0.017x, R2 = 0.981, SEE = 0.003. In
2B, alcohol intake is straight whisky, 0.8 g/kg,
inking. The curve displays moderate positive and
2 fluctuations from the trend line. The most apte description of the elimination period is an exial
model:
y = 0.113e 0 2 4 7 x , R2 = 0.958,
0.052. In Figure 2C, alcohol intake is champagne,
g, fast drinking. The curve displays minimal flucs from the trend line and the breath alcohol conion remains in a narrow range for several hours.
>st appropriate description of the elimination period
rabolic model: y = 0.061 - 0.006x - 0.003x\
0.966, SEE = 0.001.
igure 2D, alcohol intake is champagne, 1.0 g/kg,
nking. The curve displays a markedly delayed peak,
narked fluctuations from the trend line. No
latical model provides excellent correlation, but the
ppropriate description of the elimination period is
ibolic model: y = 0.115 4- 0.005x - 0.012x2,
0.564, SEE = 0.007. The most appropriate
tion for the entire curve is also a better correlated
Dlic model: y = 0.005 + 0.72x - O.Ollx 2 ,
0.927, SEE = 0.007. In Figure 2E, alcohol intake
", 1.0 g/kg, fast drinking. The curve generally
J a Widmark pattern, but with significant fluctua"om the trend line and marked positive and negative
; thoughout the entire curve. The most appropriate
natical description of the elimination period is a
model: y = 0.129 - 0.013x, R2 = 0.891,
= 0.005. In Figure 2F, alcohol intake is straight
of whisky, 1.0 g/kg, slow drinking. The curve
r
s marked irregularities and positive and negative
I as great as 0.030 g/230 L in less than 10 min.
Lthematical model provides excellent correlation, but
>st appropriate description of the elimination period
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is a linear model: y = 0.107 - 0.017x, R2 = 0.652,
SEE = 0.008.
All of these curves share the fluctuations phenomenon
to an extent and degree varying considerably between
subjects. Particularly striking are portions of the curves
in Figures 2D, E and F around the 100 mg/230 L
concentration region. It is evident from these rather
typical curves that breath alcohol analysis results even
under highly controlled conditions can and do rapidly
oscillate in short time periods above or below any given
concentration. This should be recognized in both research on alcohol and in evidentiary use of blood or
breath alcohol concentrations in the prosecution of per
se law violations.
These phenomena are not limited to breath alcohol
analysis, as shown by comparable curve patterns for
discrete or continuous blood alcohol monitoring in the
studies cited, and by the very close correlation of
numerous separately measured simultaneous blood alcohol and breath alcohol concentrations in the course
of the experiments that yielded the curves in Figures
2A-F (Dubowski and O'Neill, 1979).
Summary and Conclusions
Key aspects of the pharmacokinetics of alcohol are
highly relevant to highway safety. Of particular pertinence are the partition of alcohol between various body
tissues and fluids and the resulting alcohol concentration
ratios for blood : breath and other body fluids, as well
as the irregularity and short-term fluctuations of the
blood and breath alcohol curves.
Most alcohol pharmacokinetics parameters are subject
to wide intersubject variability, as exemplified by peak
blood alcohol concentrations reached on ingestion of
identical weight-adjusted doses, time to peak after end
of drinking and the rate of alcohol elimination from
the blood. This great biological intersubject variability,
when combined with sex-, age- and time-related differences, makes the blood alcohol information in widely
distributed alcohol consumption nomograms and tables
based on mean data inappropriate as a guide for the
drinking behavior of individuals.
Although there is good statistical correlation between
the alcohol concentration of different body tissues and
fluids in the fully postabsorptive state, wide individual
variations from the population mean alcohol partition
values exist. It is often impossible to determine whether
the postabsorptive state has been reached at any given
time. Those factors make it impossible or infeasible to
convert the alcohol concentration of breath or urine to
the simultaneous blood alcohol concentration with forensically acceptable certainty, especially under per se
or absolute alcohol concentration laws. Inclusion of
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ath alcohol concentrations in drinking-driving stats, as definitions or per se offense elements, makes
lecessary the conversion of breath alcohol analysis
alts into equivalent blood alcohol concentrations,
ne alcohol concentrations are inadequately correlated
h blood alcohol concentrations or with driver imrment, and analysis of bladder urine is, therefore,
ppropriate in traffic law enforcement,
ignificantly large sex-related differences in pharmainetic parameters have been demonstrated (e.g., in
k blood alcohol concentrations for weight-adjusted
es). The effects of age and time of day have been
extensively studied and are less clear,
reath and blood alcohol time curves are subject to
rt-term fluctuations from the trend line and other
gularities, and often do not follow the typical Widk- pattern- Fronr"the~existing information on pharokinetics of alcohol and the characteristics and
ability of blood and breath alcohol versus time
r
es, the following conclusions can be reached. First,
all blood and breath alcohol curves follow the
mark pattern, nor is the elimination phase necesy linear. Second, alcohol absorption is not always
plete within 60 to 90 min, as often claimed. Third,
peak alcohol concentration cannot be validly pre)d or established in an individual instance without
uent and timely measurement of alcohol concentra>. Fourth, it is not possible to establish whether an
ddual is in the absorption or elimination phase, or
;tablish the mean overall rate of alcohol elimination
i the blood or breath, from the results of two
ecutive blood or breath alcohol measurements, howtimed. Fifth, significantly large short-term fluctuaoccur in some subjects and result in marked
ive and negative departures from the alcohol conation trend line. Sixth, short-term, marked oscili of the blood or breath alcohol concentration can
r at various points of the curve, resulting in
Lted excursions of the alcohol concentration above
below a given concentration (such as 80 or 100
11) within a few minutes or for hours. Finally, no
Lsically valid forward or backward extrapolation of
1 or breath alcohol concentrations is ordinarily
ble in a given subject and occasion solely on the
of time and individual analysis results.
Future Research Needs
ist research on alcohol pharmacokinetics and on
ffects of alcohol on driving has been conducted
low or moderate quantities of alcohol ingested in
gle dose. Research subjects have been predomi/ young and middle-aged adult men. Because "of
larmacokinetics considerations reviewed above, there
m uncertainty about whether and when the subjects

are in the postabsorptive phase. These limitations and
extreme variability in previous experimental protocols
and conditions make comparisons among the results of
different studies as difficult as practical application of
many of those findings to alcohol and highway safety
settings.
There is need for standardization of research protocols, especially for studies of alcohol-relating driving
impairment. Because of the many factors and variables
involved, it may be best to develop consensus on the
most appropriate protocol(s) through one or more conferences of experienced investigators, under the sponsorship of a cognizant body such as the National
Institute on Alcohol Abuse and Alcoholism or the
National Research Council. The protocol(s) should make
suitable provision for alcohol dosing (e.g., by divideddose drinking); "for "study"of s"exV~age- "and time-related
effects; and for frequent enough, accurate alcohol measurement (preferably by proper breath alcohol analysis)
to provide valid information for correlation with observed subject effects. Because results of studies on
normal, healthy subjects who use alcoholic beverages
lightly or moderately may not be equally applicable to
heavy drinkers, separate provisions are needed to investigate the applicability of general findings and conclusions to the latter group.
The major shortcomings of currently available alcohol
consumption charts, graphs and nomograms for general
public use include the likelihood of dangerous underestimation for many persons of the blood alcohol
concentration reached by ingesting a given quantity of
alcohol. Self-test devices for breath alcohol measurement
are similarly flawed. There is need, therefore, to develop
and validate alternate and better means of providing
valid information to the public on blood alcohol concentrations likely to be reached, or actually achieved,
for a given amount of alcohol intake.
The proliferation of per se or absolute alcohol concentration offense laws makes it likely that the results
of blood and breath alcohol analyses will continue to
constitute a primary form of evidence in trials of
alcohol-related traffic offenses. Testing of suspected
violators under forensically acceptable standards is infeasible at the time of first contact. Extrapolation of a
later alcohol test result to the time of the alleged
offense is always of uncertain validity and therefore
forensically unacceptable. The laws of different jurisdictions address this problem in various ways, as by
specifying that the analysis result at the time of the
test shall govern, or by judicially approving retrograde
extrapolation of results, or by defining the offense to
consist of driving a vehicle after having consumed
sufficient alcohol to reach a specified alcohol concentration "at any relevant time after the driving.'' There
is need to develop one or more legally acceptable and
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cally valid schemes for specifying the alcohol
ration element of alcohol-related traffic offenses,
obtaining forensically reliable alcohol analysis
while avoiding the pitfalls and dilemmas of
practices.
needed are further studies on some methodologDblems. The nature, extent and population freof the anomalies and fluctuations of blood and
alcohol time curves should be established by
y controlled large-scale studies at appropriate
concentrations in men and women, and the
mg mechanisms need elucidation. The utility of
eat-patch test for alcohol consumption requires
investigation.
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Summary
SfBased on a large material IN" = 2354) of double blood specimens from drunk drivers appreF#^
hended in The Netherlands, we selected 1314 cases for further evaluation. The difference BAC2
was used as index of alcohol elimination rate from the blood. The results ranged from
IjeiowpD.lO to 0.64 mg/ml/h, with a mean of 0.22 mg/ml/h. At least about 2% of drivers were still
absorbing alcohol as indicated by a rising BAC. Some likely mechanisms are discussed that
^account for the wide range of alcohol elimination rates observed.
e^^brds: Alcohol; Elimination; Pharmacokinetics; Drunk drivers; Double sampling; Widmark
bquatiorii Back calculation.

tion

^Sh^^mnan pharmacokinetics of alcohol** have been studied extensively
^ ^ I ^ ^ L 9 3 0 s [1], Several reviews have appeared [2 — 6] and general agree^ ^ ^ x i s t s that the fate of alcohol in the body is more complicated than the
^^^mplartment model with zero order elimination first proposed by Wid" ffi(^^£seems that the rate of disappearance of alcohol from the blood
^^^^^dC/dt)
is best described by Michaelis-Menten kinetics rather
first-order processes [3,4].
|ss;-the notion of zero-order elimination of alcohol from blood
"Jn forensic practice when BAC profiles are evaluated in quanti45]:. This implies a constant rate of elimination (/?60) independent
|o£ alcohol consumed and the range of BAC. But some investiga^ . ^ P g l P ^ d e n c e should be adressed.
nmod, f,
* 'wJerm alcohol refers to ethanol in this article.

t — J ^ S S & t ^ c Publishers Ireland Ltd.
^ H & 4 in Ireland
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tors maintain that Michaelis-Menten parameters, Km and Vmax, are more
appropriate as index of alcohol elimination from blood [7,8]. Opinions on this
point remain divided [9,10].
The rate of alcohol elimination from blood, particularly the value of /J60, is
important information when expert opinions are given about the presumed
BAC at the time of offence based on the BAC at the time of sampling [2].
Three requirements must be met before back calculation can be justified for
legal purposes. First, the individual's BAC profile must have reached the
post-absorptive state at the time of driving and blood sampling. Second, the
rate of elimination of alcohol from blood (/360) should be known or a range of
probable values calculated. Third, the main alcohol metabolising enzyme,
alcohol dehydrogenase (ADH), should be saturated with substrate [11].
The elimination of alcohol from the blood of drunk drivers is a difficult
process to study under real-life conditions. Some investigators have therefore reported the rate of change of BAC calculated from analysis of two
blood specimens obtained 30 — 60 min apart [12 — 15]. The /?60 values derived
in this way show large inter-individual variation and the frequency distributions are skewed to the right; some drunk drivers have abnormally high /?60
elimination rates. Moreover, some drivers might still be absorbing alcohol
from the last drink and therefore a rising BAC is likely for these individuals.
Abnormally low rates of alcohol elimination from blood suggest that drivers
are near their maximum BAC at the time of sampling. If alcohol is consumed
together with a meal, a flat-topped profile is obtained instead of a sharp
peaked BAC curve.
This article reports rates of elimination of alcohol from the blood of drunk
drivers derived from a large material of double blood specimens. Some
underlying mechanisms are discussed that might account for the wide range
of /360 values observed.
Materials and Methods
Blood specimens
All blood samples collected from drunk drivers in The Netherlands are|
sent for quantitative determination of alcohol to one central forensic labor£-§
tory. Each specimen is accompanied by a standard police protocol which coi||
tains the name of the suspect, his or her address, time of arrest, time'*of|
blood sampling. Two Vacutainer tubes are filled consecutively from the samej
stick in a cubital vein and sent to the laboratory for analysis. Each tube conjf
tains 4 ml of heparinized blood and 40 mg sodium fluoride as preservative^
The concentration of alcohol is determined by a semi-automated APK1|
method and duplicate assays are made by two different laboratory workers*.^
The accuracy of analysis is about ± 2% [16].
From 1st February 1982 to 1st September 1987, a total of 209,661 Wo?B|
samples were submitted for determination of alcohol. In 2354 cases ] L 1 ^ |
two sets of two blood specimens were taken from the same suspect. The J | 2 | |
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son for taking blood on two occasions from the same suspect is not always
obvious although this probably reflects a special rule in the Dutch drunk
driving legislation. At least 60 min should elapse between the time of arrest
and the time of blood sampling. This safeguard gives more equality before
the law for those apprehended in town and country. If the time taken by a
doctor to travel to the police station to take blood differed greatly between
town and country, this might give an unfair advantage to those who are
apprehended in rural areas. This is because their BAC could decrease
through metabolism. If every suspect is given the option for a 60-mm waiting period, the effect of this geographical factor is minimized.
In practice obtaining blood specimens within 60 min of arrest is rare and
if this happens, the suspect must be given the option of leaving a second
specimen. The lowest result of the two determinations is used for prosecution. The suspect is kept under constant surveillance by the police from the
time of arrest to the time of obtaining both specimens of blood. The
consumption of alcohol after arrest is virtually impossible.
Procedure
The information contained on the drunk driving protocols (N = 2354)
were entered into a data-base (dBASE III plus). The items of interest were;
the time of first blood sample (tx), the time of second blood sample (£2), BAC
at first sampling (BAC^ and BAC at the time of second sampling (BAC2). The
apparent rate of elimination of alcohol from the blood of drunk drivers
(-dC/dt), was calculated simply as:
(BAC2 - B A C ^ - tj mg/ml/h.
In 25 individuals, the time between first and second blood (t2 - tx) was
less than 10 min and these cases were evaluated separately. Also when the
BAC difference between the first and second sample (BAC2 - BACX) was
less than 0.05 mg/ml the results were evaluated separately (N = 349).
Finally, cases in which the time difference (t2 - tx) exceeded 40 min were
considered suspect because the reason for this unusually long delay is not
obvious {N = 661). These three restrictions diminished the data base to 1314
double blood samples obtained 10 — 40 mm apart and this material was used
*'0 examine the rate of alcohol elimination in drunk drivers.
Results
IJ1 Table 1 shows the distribution of BAC at intervals pf 0.5 mg/ml for the
^original data base (N = 2354). This distribution agrees completely with the
p$al annual number of blood samples. We can therefore assume that the
fegACjoieasured in the present material of double samples is a representative
patnple for the Netherlands during this 5.5-year period.
m}n 47 cases (2%), a negative elimination rate was obtained which suggests
l o s i n g BAC in these individuals.
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TABLE 1
DISTRIBUTION
OF BLOOD-ALCOHOL
CONCENTRATIONS
AMONG
DRIVERS
APPREHENDED IN THE NETHERLANDS (N = 2354, MEAN BAC = 1.55 mg/ml, RANGE
0.12-3.99 mg/ml)
Range of BAC
(mg/ml)

N

Percent

0.0-0.49
0.5-0.99
1.0-1.49
1.5-1.99
2.0-2.49
Above 2.5

107
365
664
632
417
169

15.5
28.2
26.8
17.7

4.5

7.2

The elimination rates based on the restricted data base (N = 1314),
showed a mean of 0.22 mg/ml/h and a wide range of values (0.10 — 0.64 mg/ml/
h). A more detailed breakdown of the elimination rates is shown is Table 2.
Table 3 lists the elimination rates arranged as a function of underlying mean
BAC. Higher rates seem to be associated with a higher initial BAC.

TABLE 2
FREQUENCY DISTRIBUTION OF APPARENT RATES OF DISAPPEARANCE OF ALCOHOL FROM THE BLOOD OF DRUNK DRIVERS
Elimination rate
(mg/ml/h)

N

0.10-0.119
0.12-0.139
0.14-0.159
0.16-0.179
0.18-0.199
0.20-0.219
0.22-0.239
0.24-0.259
0.26-0.279
0.28-0.299
0.30-0.319
0.32-0.339
0.34-0.359
0.36-0.379
0.38-0.399
0.40-0.419
0.42-0.439
0.44-0.459
0.46-0.479
Above 0.48

30
69
127
174
167
207
151
102
106
52
47
27
17
6
11
5
5
2
4
5

Percent
2.3
5.2
9.7
13.2
12.7
15.7
11.5

7.8
8.1
4.0
3.6
2.0
1.3
0.5
0.8
0.4
0.4
0.1
0.3
0.4

Ill
TABLE 3
THE ELIMINATION OF ALCOHOL FROM BLOOD OF DRUNK DRIVERS AS A FUNCTION
OF THE BAC OF THE SPECIMEN
Range of BAC
(mg/mU

N (percent)

Mean

Range

0.0-0 49
0.5-0.99
1.0-1.49
1.5-199
2.0-2.49
Above 2.5

58 (4.4%)
197 (15.0%)
377 (28.7%)
351 (26.7%)
247 (18.8%)
84 (6 4%)

0.19
0.20
0.21
0.22
0.23
0.26

0.10-0.19
0.10-0.36
0.10-0.43
0.10-0.47
0.11-0.57
0.10-0.64

Total

1314 (100%)

0.22

0.10-0.64

Discussion
j|LApplication of the Michaelis-Menten equation to describe the kinetics of
;SIcohol indicates that the maximum rate of elimination from blood is
Jfeiween 0.19 and 0.22 mg/ml/h when BAC ranges from 0.5-3.0 mg/ml [17,18].
/This agrees with the mean rate of elimination in drunk drivers of 0.22 mg/
-ml/h that we have reported. Based on Widmark's linear approximation, P60
^acEording to results of controlled experiments in fasting subjects, falls
gwitliin the range 0.13-0.15 mg/ml/h [19,20].
l||iSeyeral other investigators have determined the rate of elimination of
^lcbjfpl from blood of drunk drivers by analysis of double blood specimens.
^ ^ < d [15] evaluated this problem in drivers who claimed they had consumed
^^ohbjv after driving but before the first blood specimen was taken. If
|ile|gd|drinking after the offence was true then a rising BAC at the time of
" ^ ^ ^ T might be expected. Analysis of both bloods will furnish objective
p^^^'evidence to support or challenge the claim of drinking after the of||nce|^one of the double samples evaluated by Lund showed a rising BAC
W ^ m p l i e s that peak BAC was already passed. The alleged drinking after
^jomnce^ was either untrue or absorption and distribution of the after
T
' ' ^ ^ x t r e m e l y fast.
^l^M-Dabbs [21] reported a wide range of apparent rates of alcohol
IJI^ttcH^based on the analysis of two consecutive breath specimens. This
j | e d ^ W g e material of drunk drivers apprehended in Great Britain. An
l^^gSreath-analyser Intoximeter infrared (IR) 3000 was used for analjreath alcohol measurements must therefore be translated into
miM!^Jt£^0 c o m P a r e directly with our work. For this calculation, one
^ ^ ^ k ^ c o n s t a n t blood/breath distribution ratio of alcohol of 2300; the
SiJ^kcfiSfc accepted in Great Britain for legal purposes
^ | ^ ^ ^ o f alcohol elimination from blood in our study, 0.22 mg/
mmffi lfflE§Ser* than the result derived from breath measurements pub-

m
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lished by Cobb and Dabbs [21] of 0.20 mg/ml/h. A rate of 0.22 mg/ml/h is also
higher than the average reported by Lund (0.17 mg/ml/h) [15] as well as a
smaller Swedish material (0.18 mg/ml/h) [22]. Several studies from Germany
have focused on rates of alcohol elimination in drunk drivers based on double
blood sampling. The mean elimination rate of alcohol determined in this way
was 0.18 mg/ml/h (range 0.13 — 0.24) and less than 2% of drivers had a rising
BAC [12-14].
Our study, as well as other reports, confirm a wide range of alcohol elimination rates in drunk drivers. What do these results really mean? The
extremely high elimination, highest 0.64 mg/ml/h, as well as 4 other drunk
drivers with values above 0.50 mg/ml/h, can hardly represent the rate of
hepatic metabolism of alcohol in human beings. The results certainly reflect
the change in BAC over the time period studied but this might be influenced
by on-going distribution and equilibration of alcohol between blood and tissue water. The high average BAC of drunk drivers (Table 1) suggests an
over-representation of problem drinkers and alcoholics. A man with a
body weight of 75 kg and a BAC of 1.5 mg/ml must have consumed at least
80 g pure alcohol which is equivalent to 250 ml whisky (40% v/v). Moreover,
30 — 40% of apprehended drunk drivers have abnormal activity of various
serum enzymes such as gamma-glutamyltransferase (GGT) which serve as a
biochemical marker for overconsumption of alcohol [23,24].
Long-term exposure to alcohol will boost the rate of alcohol combustion in
the liver as a consequence of enzyme induction [18]. The microsomal ethanol
oxidizing system (MEOS), becomes more important as a mechanisn of alcohol
combustion particularly at high BAC. This might explain non-linear elimination rates of alcohol in drunk drivers but not in controlled drinking^
experiments where it is unusual for subjects to reach BAC exceeding about1.2 mg/ml. A few studies with emergency service patients poisoned with*
alcohol confirm the high rates of elimination at high initial BAG"
[25 — 27]. Indeed, some workers suggest that first-order kinetics might;
apply under these conditions [28]. This implies that the elimination curve o£|
alcohol is an exponential function and therefore an elimination half-life timV$
should be used to describe the process [29].
^f§|
The much higher elimination rates of alcohol in drunk drivers and alcbjjj
holic patients confirms observations made by others. In our study (Table^2;l
we found that BAC decreased by 0.30 mg/ml/h or more in 9.8% of drunk?
drivers and was above 0.45 mg/ml/h in 0.7%. The corresponding results*'*
reported by Cobb and Dabbs were 5.1% and 0.5%, respectively [21]. At firs£|
glance, our lower-limit of 0.10 mg/ml/h seems at variance with other studiesjj
But this can be explained by the restrictions placed on the originaL^datf|
base. We excluded BAC-differences below 0.05 mg/ml and time difference^
less than 10 min.
ItitM^
A faster rate of elimination at high BAC (Table 3) fits with the predictioB|
from Michaelis-Menten kinetics. However, the observed values in the"BAQ|
intervals 2.0 — 2.5 and over 2.5 mg/ml are even higher than those calcul
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from the Michaelis-Menten equation. One possible explanation might be overrepresentation of problem drinkers and alcoholics for whom the MEOS system plays an increasingly important role. Furthermore, as BAC increases,
removal of alcohol by excretion mechanisms, mainly breath and urine, make
a bigger contribution because these are first-order processes.
We found that 2% of drunk drivers have a rising BAC in The Netherlands
and these individuals are therefore still absorbing alcohol from the gut. Note
that this conclusion is drawn from the times of blood sampling and not from
the moment of arrest. Some drunk drivers have not fully entered the elimination phase when samples are taken. Support for this comes from the 349
double specimens (14.8%) analysed separately and deleted from the original
material of N = 2354 because BAC2 - BACX was less than 0.05 mg/ml.
These individuals might have a flat-topped BAC profile which can result if
alcohol is consumed together with food. Under these conditions, there is a
more gradual transition from absorption to elimination phase which accounts
for the abnormally low apparent rate of elimination of alcohol from blood.
More research is needed to establish the BAC profile and time of occurrence
of the peak or plateau under realistic drinking conditions with moderately
high alcohol intake together with various kinds of food.
Based on evaluation of double blood samples about 2% of drivers in The
Netherlands are still absorbing alcohol at the time of blood sampling. This
compares with 0.0% in Denmark, less than 2% in Germany and 3.8% in the
United Kingdom. This latter study, however, involved the use of evidential
breath analysers, so the delay between time of arrest and the time of sampling might have been shorter than if a doctor had been called to take blood.
Indeed, Cobb and Dabbs [21] stated that if 0.115 mg/ml/h is reasonable as a
minimum rate of alcohol disappearance from blood then about 20% of subjects had not fully entered the elimination phase. Police procedures in different countries might influence the fraction of drivers at or near the peak
J3AC,when samples are taken for medicolegal alcohol determinations.
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5.2 MEASURING BLOOD-ALCOHOL CONCENTRATION
FOR CLINICAL AND FORENSIC PURPOSES
A. WAYNE JONES
DEPARTMENT OF FORENSIC TOXICOLOGY, UNIVERSITY HOSPITAL, LINKOIWC, SWEDEN

DERRICK J. POUNDER
DEPARTMENT or FORENSIC MEDICINE, UNIVERSITY OF DUNDEE, SCOTLAND, UK

Measuring the concentration of alcohol in biological specimens (whole blood, serum, plasma,
urine, saliva, and breath) involves the use of relatively simple analytical procedures. The first
qualitative methods, albeit primitive, were used inforensictoxicology more than a century ago
when deathsfromgross intoxication were investigated.1 Over the years, the methods available
for measuring alcohol in blood and other bodyfluidshave become increasingly refined.2*3
Unlike the resultsfromother laboratory methods of analysis, the concentration of ethanol
in bodyfluidshas deep-rooted social-medical andforensicimplications. This follows because
of the commonly accepted association between a person's blood-alcohol concentration (BAC)
and the degree of impairment/4*5 Indeed, heavy drinking represents a major cause of accidents
on the roads, in the workplace, and within the home, and alcohol abuse and drunkenness are
contributing factor in many suicides, trauma deaths, violent crimes, and other kinds of deviant
behavior.6*9 The analysis of alcohol in body fluids has, therefore, emerged as the most
frequently requested procedure inforensicscience and toxicology.20 .
Furthermore, fast and reliable methods of alcohol analysis are needed in clinical and
emergency medicine whenever a patient is admitted unconscious smelling of alcohol, because
in these acute situations it is imperative to decide whether gross intoxication or head trauma
or both are involved.11-12 The presence of intracranial blood dots or hemorrhage resulting from
head injuries requires swift diagnosis and treatment.***25 Moreover, overconsumption of ethanol needs to be quickly distinguishedfromintoxication caused by drinking a more dangerous
alcohol such as methanol or ethylene glycol16 so that a decision can be made to use invasive
therapy including hemodialysis to dear from the blood the toxic metabolites of methanol
(formic add) and ethylene glycol (glycolare and oxalate).174*
The role of alcohol intoxication in traffic accidents is well recognized19*21 and threshold
concentration limits have been defined by statute known as per se alcohol limits.22 This legal
framework means that a certain concentration of alcohol in a specimen of blood, breath, or
urine is sufficient to dedde a person's guilt or innocence and places extremely high demands
on accuracy, precision, and selectivity of the methods of analysis used.23 Betides threshold
blood-alcohol concentration limits for driving, testing for alcohol in the workplace is now
regulated by statutes in the VS. (1991 Omnibus Transportation Employee Testing Act), and
similar legislation can be expected tofollowin other countries. The act permits conducting pre*
employment testing as well as testing individuals engaged with safety-sensitive duties, including
random testing, post-accident testing, probable cause testing, return-to-duty, and follow-up
testing.24 Two important concentration limits exist in connection with workplace alcohol
testing and these are currently fixed at 20 mg/dL in blood (0.02 g/210 L breath), below
which no action IB taken. However, drinking on duty or having a blood-alcohol concentration
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above 40 mg/dL (0.04 g/210 L breath) are prohibited and the offending individual will be
removed from participating in safety-sensitive work.24
Punishment and sanctions for driving under the influence of alcohol (DUI) are becoming
increasingly severe and includefines,suspension of the driving license, and sometimes a period
of mandatory imprisonment or even dismissal and loss of salary in connection with workplace
alcohol testing. Moreover, the validity of accident and insurance claims might be null and void
ifa person's blood-alcohol concentration exceeds some critical threshold limit. The connection
between ingestion of alcohol, the person's BAC, and various penalties for over-consumption
emphasizes die need to use highly reliable methods for measuring alcohol in blood and other
body fluids.
This review deals with clinical and forensic aspects of measuring alcohol when the blood
samples are obtained from living subjects. In post-mortem work, the choice of specimens, the
method of collection, and, in particular, the interpretation of the analytical results require
special considerations. These autopsy issues are covered in more detail in Section 5.3.
5.2.1 UNITS OF CONCENTRATION — PLASMA/SERUM VS. WHOLE BLOOD
One difference between reporting results of alcohol measurements made for dinical purposes
and those made for forensic science purposes concerns the units of concentration used. In
dinical chemistry laboratories, the SI system is the norm where the mole is the unit of mass
and the liter is die unit of volume.25 The concentration of alcohol in dinical biochemistry is
therefore reported as mmol/L or mol/L. By contrast, in forensic sdence laboratories, the
concentrations of ethanol in bodyfluidsare reported in terms of mass per unit volume (mg/
dL, g/L, g/dL or mg/mL) or mass per unit mass (g/kg o r mg/g). Th c mass/mass unit of
concentration is numerically less than the mass/volume unit by 5.5% because the specific
weight ofwhole blood is 1.055 on the average (I mL whole blood wrighs 1.055 g), so a bloodalcohol concentration of 100 mg/dL is the same as 95 mg/100 g or 21.7 mmoL/L
When blood samples are analyzed for forensic purposes, a standard procedure is to make
duplicate determinations because dose agreement between the two results gives the added
assurance that a mishap has not occurred when the first determination was made. Besides
reporting the mean concentration of alcohol, an allowance should be made to compensate for
uncertainty in the method of analysis. This is easily done by making a deduction from the mean
BAC to allow for analytical errors and thereby reporting a confidence limit such as 95%, 99%,
or 99.9% depending on requirements.26
In Sweden, for example, a triplicate blood-alcohol determination is made in all DUI
investigations and the lower 99.9% confidence limit on die mean is the value used for
prosecution. The amount deducted is given by 3.09 (SOS"2} where SD is the standard
deviation of a single determination at the prevailing BAC for an analytical process under
statistical control. Although the mean result gives the best estimate of a person's BAC at the
time of sampling, the value that remains after making the deduction is not more than the true
BAC with a probability of 99.9%. This means that the risk of reporting a false high result is 1
in 1000 and any remaining uncertainty has relevance only for those individuals with a BAC very
dose to the critical legal limit for driving.
This practice of reporting analytical results together with confidence intervals for the
individual blood-sample analyzed is uncommon in dinical laboratories where single determinations of an anaiyte are made. Instead, in dinical chemistry laboratories, variability or
imprecision ofan analytical method is monitored by calculating a coefikient ofvariation (CV%)
derived from analyzing calibration standards or spiked biological specimens along with the
unknowns.27
Another difference between the analytical work of forensic laboratories as opposed to
dinical laboratories concerns the condition of the specimens submitted for analysis. Forensic
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Figure 5.2.1a Concentration-time profiles of ethanol in specimens of whole Mood and plasma from four
healthy men who drank a bolus dose of ethanol 030 gfrg mixed with oiange juice in S min after an
overnight fast.
laboratories normally receive samples of whole blood and these are often hemolyzed and
sometimes contain dots,2* whereas clinical laboratories receive samples of plasma or serum.29
The amounts of water in these specimens are not tbe same, with mean values of 91.8 % w / w
(SD 0.49) for plasma/serum and 80.1 % w/w (SD 1.03) for whole blood.30 The results of
analyzing alcohol at a clinical laboratory should not be cited in legal proceedings concerning
DUI or work-related accidents without an appropriate correction being made or seeking expert
help with interpretation of the results.31*32
Figure 5 Jt.la shows examples of die concentration-time profiles of ethanol in plasma and
whole blood. Four healthy men fasted overnight before drinking, within 5 min, ethanol diluted
with orange juice in a dose of 030 g ethanol per kg body weight. Note that the plasma curves
run systemadcaliy higher than the whole-blood curves as expectedfromthe water-content, of
the specimens analyzed. In these 4 subjects, the mean plasma/whole blood ratio of alcohol was
1.10:1 with a rangefrom1.08 to 1.13. In drinking drivers, the distribution of ethanol between
plasma and whole blood had a mean of 1.14:1 (standard deviation 0.041) according to a recent
study.33 Table 5.2.1b compares the concentrations of alcohol in plasma with values expected
to exist in whole blood based on a mean plasma/whole blood concentration ratio of 1.14:1.
The results are reported in different units of concentration including SI units.
As discussed by Rainey,29 if die concentration of alcohol in plasma or serum is used to
estimate the concentration in whole blood for law enforcement purposes, it is advisable to
consider inherent analytical and biological sources of variations in the plasma/blood relationship. A plasma/blood ratio of 1.22:1 corresponds to the mean 4- 2SD, and this higher
conversion factor should be used inforensicwork instead of a mean value of 1.14:1. This gives
a more conservative estimate of BAC for use in criminal litigation if and when drunk drivers
are prosecuted on the basis of die concentration of alcohol determined in plasma or serum. In
criminal law, a beyond a reasonable doubt standard is necessary to obtain a verdict of guilty,
whereas in civil litigation a preponderance of die evidence is sufficient to determine the
outcome.29
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Table 5.2.1b Comparison of the Concentrations of Ethanol in Whole Blood with Values Expected
in Plasma or Serum when Expressed in Different Units of Concentration*
Concentration units
mg/ml org/L
Plasma/
Blood serum
0.10
0.114
0.50
0.57
1.00
1.14
2.00
2.28
5.00
5.70

Concentration units
ng/tfL or ing/100 ml
Plasma/
Blood serum
10
11.4
57
50
100
114
200
228
500
570

Concentration units
g/% w/v or s/100mL
Plasma/
Blood serum
0.010 0.114
0.050 0.057
0.100 0.114
0.200 0.228
0.50
0.S70

Concentration units
mmol/l
Plasma/
Blood serum
2.17
2.47
10.7
12.2
21.7
24.7
43
49.0
107 • 122

'The concentrations in whole blood were derivedfromthe concentration in plasma by dividing by 124. If due results
are intendedforuse inforensiccasework where a tbresboM Umit in wtote bfacd operates, thm a more conservative
conversion factor such as 132:1 should be used.

5*2.2 METHODS OF MEASURING ALCOHOL IN BODY FLUIDS
SJL2.1 Chemical Oxidation Methods
The first quantitative method of blood-alcohol analysis to gain general acceptance in forensic
science and toxicology was published in 192234 and was known as Widmaxk's microxnethod
(developed by Erik MP Widmark of Sweden). A specimen of capillary blood (100 mg) was
sufficient for making a single determination and this could be obtained by pricking a fingertip
or eariobe. Ethanol was determined by wet-chemistry oxidation with a mixture of potassium
dichromate and sulphuric add in excess. The amount of oxidizing agent remaining after the
reaction was determined by iodometric titration. Specially designed diffusion flasks allowed
exuacnon of ethanol from the biological matrix by heating to 50°C before making the final
titrimetrie analysis. The Widmark method was not specific for measuring blood-ethanol
because if other voiatQes were present, such as acetone, methanol, or ether, these were oxidized
and falsely reported as being ethanol. Evidence for the presence or absence of potential
interfering substances was sometimes obtained by qualitative screening tests such as observation of various color changes after adding reagents to test for urinary ketones, methanol,
formaldehyde, or acetaldehyde.35
By the 1950s, chemical mediods were modified in various ways such as by the use of
photometry to determine the endpoinr ofthe oxidation reaction instead ofvolumetric titration.
However, analytical procedures based on wet-chemistry oxidation are now virtually obsolete
in clinical and forensic laboratories for measuring the concentration of alcohol in body fluids.
The history, development, and application of chemical oxidation methods of alcohol analysis
have been well covered in several review articles.2*35-3*
5JJLZ Enzymatic Methods
Shortly after the enzyme alcohol dehydrogenase (ADH) was purified from horse liver and yeast
in the late 1940s, the way was dear for developing biochemical methods for measuring alcohol
in body fluids.3942 These became known as ADH mediods and the milder conditions for
oxidation of ethanol gave enhanced selectivity compared with wet-chemistry oxidation methods.40*42 However, other primary alcohols such as isoprppanol or n-propanol, if these are
present in die blood samples, are also oxidized by ADH and this leads to false high concentrations of ethanol being reported.43 By optimising the reaction conditions in terms of pH,
time, and temperature, methanol was not oxidized by yeast ADH and this source ofthe enzyme
became widely used for clinical and forensic alcohol analysis.42 In a typical manual ADH
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method, blood-proteins were precipitated with HCI0 4 or CCI3COOH and after adjusting pH
of the supernatant to 9.6 with semicarbazide buffer, the enzyme and coenzyme (NAD*) were
added to start the reaction. The NAD* is reduced to NADH in direct proportion to the
concentration of ethanol present in the sample being analyzed and after about 1 h the amount
of reduced coenzyme is monitored by its absorption of UV radiation at 340 nm.
Later developments in ADH methods meant that proteins in the blood could be separated
from the aqueous phase on-line, either by dialysis or micro-distillation.44 With this modification
and the use ofan AutoAnalyzer instrument, several hundred blood samples could be analyzed
daily. Scores of publications were produced describing various modifications and improvements to the original ADH method and dedicated reagent kits soon became commercially
available. These kits were ideal for use at* hospital laboratories and elsewhere where the
throughput of samples was relatively low. Otherwise, most efforts were directed towards
automating the sample preparation and the dispensing of reagents to increase sample throughput and several batch analyzers appeared including a micro-centrifugal analyzer making use of
fluorescence Hght scattering for quantitative analysis.45'46
Interest in the use of ADH methods for measuring alcohol in blood and urine have
expanded greatly over the past decade owing to the development of methods for drug-abuse
testing. In these new procedures, a technique known as enzyme multiplied immunoassay
(EMIT) is used whereby an enzyme-labeled antigen reacts with ethanol and the color change
of an added substrate is measured by spectrophotometry and die result translated into the
concentration of ethanol. Fluorescence polarization immunoassay (FPIA) and the spin-off
method known as radiative energy attenuation (REA) detection are other examples ofanalytical
technologies developed to meet the increasing demand for drugs of abuse testing in urine and
also for therapeutic drug monitoring. These analytical systems include options for measuring
ethanol in biological specimens and results reported in several publications show good agreement in terms of accuracy and precision compared with those obtained by gas chromatography.47'$0 The principles and practice of various immunoassay systems suitable for clinical
laboratory analysis were recently reviewed.51
Despite these new developments in analytical technology for blood-alcohol testing, particularly EMIT, FPIA, and REA methods, gas chromatography still is die instrument of choice
at forensic laboratories owing to its superior selectivity. Indeed, some recent work has shown
that serum lactate and lactate dehydrogenase might interfere with the analysis of alcohol by
ADH methods.52 This problem was traced to various side-reactions in which the coenzyme
NAD* was reduced to NADH which could not be distinguished from the NADH produced
during the oxidation of ethanol. This resulted in undesirable false positive results when plasma
specimens from alcohol-free patients were analyzed.
5.2.2.3 Gas Chromatographic Methods
In die early 1960s, physical-chemical methods were applied to the analysis of alcohol in body
fluids such as infrared spectrometry, electrochemical oxidation, and gas-liquid chromatography
(GLC).2 For the analysis ofbiological liquids, GLC has become the method of choice in clinical
and forensic laboratories whereas electrochemistry and infrared methods are used for analyzing
breath alcohol.2*3 The first GLC methods required that ethanol was extracted from blood by
use of a solvent (n-propyi acetate) or by distillation, but later die blood sample was amply
diluted (1:5 or 1:10) with an aqueous solution of an internal standard (n-propanol or tbutanoi).5**57 This initial dilution step eliminated matrix effects so that aqueous alcohol
standards could be used for calibration and standardization of the detector response. The use
of an internal standard meant that any unexpected variations in die GC operating conditions
during an analysis influenced the response of ethanol and the standard alike so the ratio of peak
heights or peak areas (ethanol/standard) remained constant.57
&ZMJ^^J^,Z?-'
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Figure 5.2 23a Gas chromatographic trace obtained
from analysis of a blood sample containing eight
volatile substances. The analysis was done by
headspace gas chromatography using a packed
column (2 m x 3 mm id.) containing Carbopack C
(0.2% Carbowax 1500 on Carbopack 80-100 mesh)
as the stationary phase. The components of the
mixture were identified asfollows:1 - methanol,
2 = Ethanol, 3 » acetone, 4 = isopropano!, 5 » tbutanol, 6 = methyl ethyl ketone, 7 * 2-butanoL
About 1 to 5 fil of die diluted blood specimen was vapourized in a stream of nitrogen, as
a carrier gas (mobile phase), which flowed
through a glass or metal column having the
dimensions 2 m long by 0.3 mm i.d. and which
contained the liquid stationary phase spread as a
thin film over an inert solid support material to
provide a large surface area. The volatile components of a mixture distribute between the moving phase (carrier gas) and die liquid phase and
1
depending on physicocbemical properties such
as the boiling point, the functional groups
present, and the relative solubility in the liquid
phase, either partial or complete separation occurs during passage through the column. Polar
stationary phases were an obvious choice for the
analysis ofalcohols and polyethylene glycol with
L
6 min.
average molecular weights of 400, 600,1500,
etc. becoming widely available and known as
RETENTION TIME
Carbowax phases.57 Otherwise, porous polymer
materials such as Poropak Q and S served as
packing materials for the GC columns when low-molecular weight alcohols were analyzed.
The effluent from the column was monitored continuously as a function of time with a
thermal conductivity (TC) detector, but this was later replaced by a flame ionization (H)
detector, which was more sensitive and gave only a very small response to water vapor present
in body fluids. The concentration of ethanol in blood was determined by comparing the
detector response (peak height or peak area) obtained by analyzing identically treated known
strength aqueous alcohol standards and making a calibration plot. Methodological details of
many of the older GC methods of blood-alcohol analysis have been reviewed elsewhere.5**9 A
manual prepared by iDubowski60 as a report to the U.S. Government is particularly detailed and
makes a useful reference source for more information about GC methods of blood-alcohol
analysis.
Gas chromatographic headspace (GC-HS) analysis (Figure 5.2 23a) is now the method of
choice for the analysis of alcohol and other volatile substances in blood and tissue in forensic
science and toxicology laboratories.61*63 HS-GC requires that die blood samples and aqueous
standards are first diluted (1:5 or 1:10) with an aqueous solution of an internal standard and
the mixture is then allowed to equilibrate at 50 or 60°C in glass vials kept airtight with
crimped-on rubber septums. Prolonged heating of the blood specimen at 60°C converts some
of the ethanol into acetaldehyde by a non-enzymatic oxidation reaction involving oxyhemoglobin. This undesirable effect can be avoided by pretreating the blood specimen with sodium
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Figure S.? 2 3b Schematic diagram of the headspace sampling procedure lor gas chromatographic
analysis. The biological sample isfirstdiluted 1:10 with an aqueous solution ofan internal standard such
as n-propano! or t-butanoi and then made air-tight in a small glass Bask with crimped on rubber
membrane. After reaching equilibration at 50°Cfor15 to 20 min, a sample of the vapor above the
diluted blood specimen is removed with a gas-tight syringe or by an automated sampling arrangement
and mjeacd into the earner ga^
stationary phase. The resulting trace on a strip-chart recorder shows a peakforethanolfollowedby a
peak for the internal standard (n-propanol).
azide or sodium ditbionite***65 or using a lower equilibrium temperature (40 or 50°C) also
hinders this oxidation reaction.
The headspace sampling procedure is shown schematically in Figure 5.2.2.3b where a
portion of the vapor in equilibrium with the diluted blood sample is removed with the aid of
a gas-tight syringe or by an automated headspace sampling device and a highly reproducible
injection made onto the chromatographic column. Several manufacturers offer dedicated
equipment for headspace analysis and the Perfcin-Eimer company has dominated dais market
since the early 1960s. Various GC headspace instruments have been produced and, in chronological order, these were denoted Mnltiftact HS-40, HS-42, HS-45, and more recently HS100 mounted on a Sigma 2000 gas chromatography This latter combination allows batch
analysis of up to 100 samples in a angle run but uxifcntunatelydiis option is no longer available
because the HS-GC units currendy marketed have the capacity to hold only 40 specimens. This
seriously limits the number of blood specimens that can be analyzed in a single run because
several calibration control standards and blanks must also be included.
Packed, wide-bore, and capillary columns are feasible66 for use with headspace gas chromatography. For high resolution work such as when complex mixtures are being analyzed,
capillary columns are essential. Traditional packed columns are, however, more robust and
those made of glass or stainless steel with dimensions such as 2 m long x 3 mm Ld. are still
widely used for routine blood-alcohol analysis because the number ofvolatile components that
might be present is fairiy limited.2*3 Figure 5.2.2.3a shows an example of a gas chromatogram
obtained by headspace analysis of an eight-component mature of low-molecular volatile
substances including ethanol with a glass column packed with Carbopak C (0.2% Carbowax
1500 on graphitized carbon black 80 to 100 mesh).
Because HS-GC involves sampling the vapor in equilibrium with the blood specimen, the
non- volatile constituents of the biological matrix do not accumulate and dog the GC column
or contaminate the packing material. Sensitivity of the assayed
matrix effects
eliminated in another way, namely by saturating the blood samples and aqueous ethanol
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standards with an inorganic salt such as NaCI or K 2 C0 3 , e.g., 0.5 ml blood + 1 g salt.67-6* This
salting-out technique has proven useful for analyzing trace concentrations of volatiles in blood.
such as the endogenous alcohols.69 The advantages ofsalting-out methods have been discussed
in many publications including the comprehensive review by Dubowski.60*4
Analysis of blood by headspace GC was combined with a cryofocusing technique, or freeze
trap, to concentrate the specimen prior to chromatographic separation of the volatile components with a capillary column. This modification was applied to the assay of complex mixtures
of volatiles, for example, the congeners present in alcoholic beverages to determine whether
these might be identified in blood samples after drinking.70
Gas chromatographic methods of analysis offer the unique advantage of combining a
qualitative screening analysis of the components of a mixture based on the time after injection
to the appearance of the peak (retention time) with simultaneous quantitative analysis by
measuring the detector response as reflected in the height or area under the peak. Several recent
reviews have dealt with the use ofgas chromatography inforensicscience including applications
for blood- alcohol analysis.71^3 Another good review looked at more general applications of
headspace analysis when applied to biological specimens for analysis of organic volatile substances, including alcohols.73
In forensic work, it is advisable for duplicate determinations to be made on two different
column packing materials, thus furnishing different retention times for ethanol. This is important if the blood or tissue samples are putrefied and therefore might contain interfering
substances having the same retention times as ethanol when a single stationary phase is used.
The risk of obtaining coincident retention times on two or more stationary phases is reduced
considerably. Otherwise, two different methodologies such as GC and chemical oxidation or
GC and enzymatic oxidation could be used to analyze duplicate aliquots from die same blood
sample.74 HS-GC with two different detectors (flame ionization and electron capture) has been
used to screen biological fluids for a large number of volatiles. This dual-detector system was
recommended for use in clinical toxicology to aid in the diagnosis of acute poisoning when a
host of unknown substances might be responsible for the patients condition.75'
5JL&4 Other Methods
A multitude of other analytical methods has been described for blood-alcohol analysis but none
of these can match HS-GC which has become the gold standard in forensic and clinical
toxicology laboratories. Methods of measuring blood-alcohol concentration by headspace
analysis with electrochemical sensing76 or a metal oxide semiconductor device77 were reported,
but these are not sufficiently selective when interfering substances might be present. These
procedures could be useful to rapidly screen biological samples and thus eliminate specimens
that do not contain any alcohol. A modified headspace procedure with a fuel-cell sensor was
described for measuring the sircngik of alcoholic beverages and the results obtained compared
favorably with a standard gas chromatographic method 78
Several novel methods for analysis of alcohol make use of biosensors prepared from
immobilized enzymes. These constructions, called biodectrodes, have found several applications in clinical laboratory analysis.79 The end-point of the enzymatic reactions can be monitored cither by amperometry, cdorimetry, or spectrophotometry.*0"*2 The enzyme alcohol
oxidase has attracted attention for analysis of alcohol in body fluids and gives reasonably good
semi-quantitative results.*3-*5 These systems are similar in principle to measuring blood glucose
with a glucose oxidase electrode and open-up the possibility for self-testing applications such
as the glucose dipstick technology.86 Fourier Transform infrared spectrometry (FIIR.) was
recently applied to the determination of alcohol in beer87 and when a purge-and-trap capillary
GC separation stage was included, FTIRcould also be adopted to measure a wide range oflowmolecular weight volatiles including ethanol.*8 A method based on proton nuclear magnetic
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5.2 MEASURING BLOOD-ALCOHOL CONCENTRATION
FOR CLINICAL AND FORENSIC PURPOSES
A. WAYNE JONES
DEPARTMENT OF FORENSIC TOXICOLOGY, UNIVERSITY HOSPITAL, LINKOFING, SWEDEN

DERRICK J. POUNDER
DEPARTMENT OF FORENSIC MEDICINE, UNIVERSITY OF DUNDEE, SCOTLAND, UK

Measuring the concentration of alcohol in biological specimens (whole blood, serum, plasma,
urine, saliva, and breath) involves the use of relatively simple analytical procedures. The first
qualitative methods, albeit primitive, were used inforensictoxicology more than a century ago
when deathsfromgross intoxication were investigated.1 Over the years, die methods available
for measuring alcohol in blood and other bodyfluidshave become increasingly refined2*5
Unlike the resultsfromother laboratory methods of analysis, the concentration of ethanol
in bodyfluidshas deep-rooted social-medical andforensicimplications. This follows because
of the commonly accepted association between a person's blood-alcohol concentration (BAG)
and the degree of impairment.*-5 Indeed, heavy drinking represents a major cause of accidents
on die roads, in the workplace, and within the home, and alcohol abuse and drunkenness are
contributing factor in many suicides, trauma deaths, violent crimes, and other kinds of deviant
behavior.6*9 The analysis of alcohol in body fluids has, therefore, emerged as the most
frequently requested procedure inforensicscience and toxicology.10 .
Furthermore, fist and reliable methods of alcohol analysis are needed in clinical and
emergency medicine whenever a patient is admitted unconscious smelling of alcohol, because
in these acute situations it is imperative to decide whether gross intoxication or head trauma
or both are involved.11-12 The presence of intracranial blood dots or hemorrhage resulting from
head injuries requires swift diagnosis and treatment.1**15 Moreover, overconsumption of ethanol needs to be quickly distinguishedfromintoxication caused by drinking a more dangerous
alcohol such as methanol or ethylene glycol16 so that a decision can be made to use invasive
therapy including hemodialysis to clear from the blood die toxic metabolites of methanol
(formic add) and ethylene glycol (giycolate and oxalate).17*18
The role of alcohol intoxication in traffic accidents is well recognized19*21 and threshold
concentration limits have been defined by statute known as per se alcohol limits.22 This legal
framework means that a certain concentration of alcohol in a specimen of blood, breath, or
urine is sufficient to dedde a person's guilt or innocence and places extremely high demands
on accuracy, precision, and selectivity of the methods of analysis used.23 Besides threshold
blood-alcohol concentration limits for driving, testing for alcohol in the workplace is now
regulated by statutes in the tLS. (1991 Omnibus Transportation Employee Testing ACT), and
similar legislation can be expected tofollowin other countries. The act permits conducting preemployment testing as well as testing individuals engaged with safety-sensitive duties, including
random testing, post-accident testing, probable cause testing, return-to-duty, and follow-up
testing.24 Two important concentration limits exist in connection with workplace alcohol
testing and these are currcndy fixed at 20 mg/dL in blood (0.02 g/210 L breath), below
which no action is taken. However, drinking on duty or having a blood-alcohol concentration

Measuring Blood-Alcohol Concentration

328 / Drug Abuse Handbook
above 40 mg/dL (0.04 g/210 L breath) are prohibited and the offending individual will be
removed from participating in safety-sensitive work.24
Punishment and sanctions for driving under the influence of alcohol (DUI) are becoming
increasingly severe and includefines,suspension of the driving license, and sometimes a period
of mandatory imprisonment or even dismissal and loss of salary in connection with workplace
alcohol testing. Moreover, the validity of accident and insurance claims might be null and void
if a person's blood-alcohol concentration exceeds some critical threshold limit. The connection
between ingestion of alcohol, the person's BAC, and various penalties for over-consumption
emphasizes the need to use highly reliable methods for measuring alcohol in blood and other
body fluids.
This review deals with clinical andforensicaspects of measuring alcohol when the blood
samples are obtainedfromliving subjects. In post-mortem work, the choice of specimens; the
method of collection, and, in particular, the interpretation of the analytical results require
special considerations. These autopsy issues are covered in more detail in Section 5.3.
5.2.1 UNITS OF CONCENTRATION —PLASMA/SERUM VS. WHOLE BLOOD
One difference between reporting results of alcohol measurements made for clinical purposes
and those made forforensicscience purposes concerns the units of concentration used. In
clinical chemistry laboratories, the SI system is the norm where the mole is the unit of mass
and the liter is the unit of volume.25 The concentration of alcohol in dinical biochemistry is
therefore reported as mmol/L or mol/L. By contrast, in forensic science laboratories, the
concentrations of ethanoi in bodyfluidsare reported in terms of mass per unit volume (mg/
dL, g/L, g/dL or mg/xnL) or mass per unit mass (gAg or mg/g). The mass/mass unit of
concentration is numerically less than the mass/volume unit by 5.5% because the specific
weight ofwhole blood is 1.055 on the average (I xnL whole blood weighs 1.055 g), so a bloodalcohol concentration of 100 mg/dL is the same as 95 mg/100 g or 21.7 mmoL/L
When blood samples are analyzed forforensicpurposes, a standard procedure is to make
duplicate determinations because dose agreement between the two results gives the added
assurance that a mishap has not occurred when the first determination was made. Besides
reporting the mean concentration of alcohol, an allowance should be made to compensate for
uncertainty in the method ofanalysis. This is easily done by making a deductionfromthe mean
BAC to allow for analytical errors and thereby reporting a confidence limit such as 95%, 99%,
or 99.9% depending on requirements.26
In Sweden, for example, a triplicate blood-alcohol determination is made in all DUI
investigations and the lower 99.9% confidence limit on the mean is the value used for
prosecution. The amount deducted is given by 3.09 ( S D ^ ) where SD is the standard
deviation of a single determination at the prevailing BAC for an analytical process under
statistical control. Although the mean result gives the best estimate of a person's BAC at the
time of sampling, the value that remains after making the deduction is not more than the true
BAC with a probability of 99.9%. This means that theriskof reporting a false high result is 1
in 1000 and any remaining uncertainty has relevance only for those individuals with a BAC very
close to the critical legal limit for driving.
This practice of reporting analytical results together with confidence intervals for the
individual blood-sample analyzed is uncommon in dinical laboratories where single determinations of an analyte are made. Instead, in dinical chemistry laboratories, variability or
imprecision ofan analytical method is monitored by calculating a coeffident ofvariation (CV%)
derived from analyzing calibration standards or spiked biological specimens along with the
unknowns.27
Another difference between the analytical work of forensic laboratories as opposed to
clinical laboratories concerns the condition of the specimens submitted for analysis. Forensic
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Figure 5.2.1a Concentration-time profiles of ethanol in specimens of-whole blood and plasma from four
healthy men who diank a bolus dose of ethanol 030 g/kg mixed with orange juice in S nun alter an
overnight fast.
laboratories normally receive samples of whole blood and these are often hcmolyzed and
sometimes contain dots,23 whereas clinical laboratories receive samples of plasma or serum.29
The amounts of water in these specimens are not the same, with mean values of 91.8 % w / w
(SD 0A9) for plasma/serum and 80.1 % w/w (SD 1.03) for whole blood.30 The results of
analyzing alcohol at a clinical laboratory should not be cited in legal proceedings concerning
DUI or work-related accidents without an appropriate correction being made or seeking expert
help with interpretation of the results.31*52
Figure 5*2»la shows examples of die concentration-time profiles of ethanol in plasma and
whole blood. Four healthy menfitstedovernight before drinking, within 5 nrin, ethanol diluted
with orange juice in a dose of 030 g ethanol per kg body weight. Note that the plasma curves
run systematically higher than the whole-blood curves as expectedfromthe water-content, of
the specimens analyzed. In these 4 subjects, the mean plasma/whole blood ratio of alcohol was
1.10:1 with a rangefrom1.08 to 1.13. In drinking drivers, the distribution of ethanol between
plasma and whole blood had a mean of 1.14:1 (standard deviation 0.041) according to a recent
study.33 Table 5*2.1 b compares the concentrations of alcohol in plasma with values expected
to exist in whole blood based on a mean plasma/whole blood concentration ratio of 1.14:1.
The results are reported in different units of concentration including SI units.
As discussed by Rainey,29 if the concentration of alcohol in plasma or serum is used to
estimate the concentration in whole blood for law enforcement purposes, it is advisable to
consider inherent analytical and biological sources of variations in the plasma/blood relationship, A plasma/blood ratio of 1.22:1 corresponds to die mean + 2SD, and this higher
conversion factor should be used inforensicwork instead of a mean value of 1.14:1. This gives
a more conservative estimate of BAC for use in criminal litigation if and when drunk drivers
are prosecuted on the basis of the concentration of alcohol determined in plasma or serum. In
criminal law, a beyond a reasonable doubt standard is necessary to obtain a verdict of guilty,
whereas in civil litigation a preponderance of the evidence i$ sufficient to determine the
outcome.29
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Table 5.2.1b Comparison of the Concentrations of Ethanol in Whole Blood with Values Expected
in Plasma or Serum when Expressed in Different Units of Concentration*
Concentration ante Concentration units
sng/m or s/L
mg/dL or as/100 ml
Plasma/
Plasma/
Blood serum
Mood serum
0.10
0.114
10
11.4
0.50
037
50
57
1.00
1.14
100
114
2.00
2.28
200
228
5.00
5.70
500
570

Concentration units
g/% w/v or g/IOOmL
Plasma/
Blood serum
0.010 0.114
0.050 0.0S7
0.100 0.114
0.200 QJ228
0.50
0.570

Concentration units
mmol/l
Plasma/
Blood serum
2.17
2.47
10.7
12-2
21.7
24.7
43
49.0
107 - 122

'The concentrations in whole blood were derivedfromthe concentration in plasma by dividing by 124. Ifthe results
are intendedforuse in forensic casework where a threshold limit in whole blood operates, then a more conservative
conversion factor such as 132:1 should be used-

5JL2 METHODS OF MEASURING ALCOHOL IN BODY FLUIDS
5JL2.1 Chemical Oxidation Methods
The first quantitative method of blood-alcohol analysis to gain general acceptance in forensic
science and toxicology was published in 192234 and was known as Widmark's miaromethod
(developed by Erik MP Widmark of Sweden). A specimen of capillary blood (100 mg) was
sufficient for making a single determination and this could be obtained by pricking a fingertip
or eariobe. Ethanol was determined by wet-chemistry oxidation with a mixture of potassium
dichromatc and sulphuric add in excess. The amount of oxidizing agent remaining after the
reaction was determined by iodometric titration. Specially designed diffusion flasks allowed
extraction of ethanol from the biological matrix by heating to 50°C before making the final
ritrimetric analysis. The Widmark method was not specific for measuring blood-cthanol
because if other volatiles were present, such as acetone, methanol, or ether, these were oxidized
and falsely reported as being ethanol. Evidence for the presence or absence of potential
interfering substances was sometimes obtained by qualitative screening tests such as observation of various color changes after adding reagents to test for urinary ketones, methanol,
formaldehyde, or aeetaldehyde.85
By the 1950s, chemical methods were modified in various ways such as by the use of
photometry to determine die endpoint ofthe oxidation reaction instead ofvolumetric titration.
However, analytical procedures based on wet-chemistry oxidation are now virtually obsolete
in clinical and forensic laboratories for measuring die concentration of alcohol in body fluids.
The history, development, and application of chemical oxidation methods of alcohol analysis
have been well covered in several review articles.2*35***
5JLZ2 Enzymatic Methods
Shortly after the enzyme alcohol dehydrogenase (ADH) was purified from horsefiverand yeast
in the late 1940s, the way was dear for developing biochemical methods for measuring alcohol
in body fluids.39"42 These became known as ADH methods and the milder conditions for
oxidation of ethanol gave enhanced selectivity compared with wet-chemistry oxidation methods.40*42 However, other primary alcohols such as isoprppanol or n-propanol, if these are
present in die blood samples, are also oxidized by ADH and this leads to false high concentrations of ethanol bong reported.43 By optimizing the reaction conditions in terms of pH,
time, and temperature, methanol was not oxidized by yeast ADH and this source ofthe enzyme
became widely used for clinical and forensic alcohol analysis.42 In a typical manual .ADH

A. Wayne Jones and Derrick /» Pounder

Alcohol/331
method, blood-proteins were precipitated with HC104 or Cd3COOH and after adjusting pH
of the supernatant to 9.6 with semicarbazide buffer, the enzyme and coenzyme (NAD*) were
added to start the reaction. The NAD* is reduced to NADH in direct proportion to rite
concentration of ethanol present in the sample being analyzed and after about 1 h the amount
of reduced coenzyme is monitored by its absorption of UV radiation at 340 nm.
Later developments in ADH methods meant that proteins in the blood could be separated
from the aqueous phase on-line, either by dialysis or micro-distillation.44 With this modification
and the use ofan AutoAnalyzer instrument, several hundred blood samples could be analyzed
daily. Scores of publications were produced describing various modifications and improvements to the original ADH method and dedicated reagent kits soon became commercially
available. These kits were ideal for use at'hospital laboratories and elsewhere where the
throughput of samples was relatively low. Otherwise, most efforts were directed towards
automating the sample preparation and the dispensing of reagents to increase sample throughput and several batch analyzers appeared including a micro-centrifugal analyzer making use of
fluorescence light scattering for quantitative analysis.45-4*
Interest in the use of ADH methods for measuring alcohol in blood and urine have
expanded greatly over the past decade owing to the development of methods for drug-abuse
testing. In these new procedures, a technique known as enzyme multiplied immunoassay
(EMIT) is used whereby an enzyme-labeled antigen reacts with ethanol and the color change
of an added substrate is measured by spectrophotometry and the result translated into die
concentration of cthanoL Fluorescence polarization immunoassay (FP1A) and the spin-off
method known as radiative energy attenuation (REA) detection are other examples ofanalytical
technologies developed to meet the increasing demandfordrugs of abuse testing in urine and
also for therapeutic drug monitoring. These analytical systems include options for measuring
ethanol in biological specimens and results reported in several publications show good agreement in terms of accuracy and precision compared with those obtained by gas chromatography.47"50 The principles and practice of various immunoassay systems suitable for clinical
laboratory analysis were recently reviewed.51
Despite these new developments in analytical technology for blood-alcohol testing, particularly EMIT, FPIA, and REA methods, gas chromatography still is the instrument of choice
atforensiclaboratories owing to its superior selectivity. Indeed, some recent work has shown
that serum lactate and lactate dehydrogenase might interfere with the analysis of alcohol by
ADH methods.52 This problem was traced to various side-reactions in which the coenzyme
NAD* was reduced to NADH which could not be distinguished from the NADH produced
during the oxidation of ethanol. This resulted in undesirable false positive results when plasma
specimens from alcohol-free patients were analyzed.
53*23 Gas Chromatographic Methods
In die early 1960s, physical-chemical methods were applied to the analysis of alcohol in body
fluids such as infrared spectrometry, electrochemical oxidation, and gas-liquid chromatography
(GLC).2 For the analysis of biological liquids, GLC has become the method of choice in clinical
andforensiclaboratories whereas electrochemistry and infrared methods are usedforanalyzing
breath alcohol.2*3 ThefirstGLC methods required that ethanol was extracted from blood by
use of a solvent (n-prqpyl acetate) or by distillation, but later the blood sample was simply
diluted (1:5 or 1:10) with an aqueous solution of an internal standard (n-propanol or tbutanol).5*"57 This initial dilution step eliminated matrix effects so that aqueous alcohol
standards could be usedforcalibration and standardization of the detector response. The use
of an internal standard meant that any unexpected variations in the GC operating conditions
during an analysis influenced the response of ethanol and the standard alike so the ratio of peak
heights or peak areas (ethanol/standard) remained constant.57
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Figure 5.2 2.3a Gas chromatographic trace obtained
from analysis of a blood sample containing eight
volatile substances. The analysis was done by
headspace gas chromatography using a packed
column (2 m x 3 mm id,) containing Carbopack C
{0.2% Caibowax 1500 on Carbopack 80-100 mesh)
as the stationaiy phase. The components of the
mixture were identified as follows: 1 = methanol.
2 = Ethanol, 3 * acetone, 4 « isopropanol, 5 « tbutanol, 6 & methyl ethyl ketone, 7 * 2-butanoL
About 1 to 5 jud of the diluted blood specimen was vapourized in a stream of nitrogen, as
a carrier gas (mobile phase), which flowed
through a glass or metal column having the
dimensions 2 m long by 0.3 mm i.d. and which
contained the liquid stationary phase spread as a
thin film over an inert solid support material to
provide a large surface area. The volatile components of a mixture distribute between the moving phase (carrier gas) and the liquid phase and
depending on physicochemical properties "such
as the boiling point, the functional groups
present, and the relative solubility in the liquid
phase, either partial or complete separation occurs during passage through the column. Polar
stationary phases were an obvious choiceforthe
analysis ofalcohols and polyethylene glycol with
6 min.
average molecular weights of 400, 600,1500,
1
etc. becoming widely available and known as
RETENTION TIME
Carbowax phases.57 Otherwise, porous polymer
materials such as Poropak Q and S served as
packing materials for the GC columns when low-molecular weight alcohols were analyzed.
The effluent from the column was monitored continuously as a function of time with a.
thermal conductivity (TC) detector, but this was later replaced by a flame ionization (H)
detector, which was more sensitive and gave only a very small response to water vapor present
in body fluids. The concentration of ethanol in blood was determined by comparing the
detector response (peak height or peak area) obtained by analyzing identically treated known
strength aqueous alcohol standards and making a calibration plot. Methodological details of
many of the older GC methods of blood-alcohol analysis have been reviewed elsewhere.5**59 A
manual prepared by Dubowski60 as a report to the U.S. Government is particularly detailed and
makes a useful reference source for more information about GC methods of blood-alcohol
analysis.
Gas chromatographic headspace (GC-HS) analysis (Figure 5.2 23a) is now die method of
choice for the analysis of alcohol and other volatile substances in blood and tissue in forensic
science and toxicology laboratories.61'63 HS-GC requires that the blood samples and aqueous
standards arefirstdiluted (1:5 or 1:10) with an aqueous solution of an internal standard and
the mixture is then allowed to equilibrate at 50 or 60°C in glass vials kept airtight with
crimped-on rubber septums. Prolonged heating of the blood specimen at 60°C converts some
of the ethanol into aceraldehyde by a non-enzymatic oxidation reaction involving oxyhemoglobin. This undesirable effect can be avoided by pretreating the blood specimen with sodium
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Figure 5.7 7 3b Schematic diagram of the headspace sampling procedure for gas chromatographic
analysis. The biological sample isfirstdiluted l:10with an aqueous solution ofan internal standard such
as n-propano! or t-butanol and then made air-tight in a small glassflaskwith crimped on rubber
membrane. After reaching equilibration at 50°Cfor15 to 20 min. a sample of the vapor above the
diluted blood specimen is removed with a gas-tight syringe orfayan automated sanipling arrangement
and injected into the carrier gas (Nyfortransport through the chrorrutographic
stationary phase. The resulting trace on a strip-chart recorder shows a peakforethanolfollowedby a
peak for the internal standard (n-propano!).
azide or sodium dithionite***65 or using a lower equilibrium temperature (40 or 50°C) also
hinders this oxidation reaction.
The headspace sampling procedure is shown schematically in Figure 5.2.2.3b where a
portion of the vapor in equilibrium with the diluted blood sample is removed with the aid of
a gas-tight syringe or by an automated headspace sampling device and a highly reproducible
injection made onto the chromatographic column. Several mannftcturcis offer dedicated
equipment for headspace analysis and die Pcridn-Elmcr company has dominated this market
since the early 1960s. Various GC headspace instruments have been produced and, in chronological order, these were denoted Muinftact HS-40, HS-42, HS-45, and more recently HS100 mounted on a Sigma 2000 gas chromatography This latter combination allows batch
analysis of up to 100 samples in a angle run but unfortunately this oprion is no longer available
because the HS~GC units currently marketed have die capacity to hold only 40 specimens. This
seriously limits the number of blood specimens that can be analyzed in a single run because
several calibration control standards and blanks must also be included.
Packed, wide-bore, and capillary columns are feasible66 for use with headspace gas chromatography. For high resolution work such as when complex mixtures are being analyzed,
capillary columns are essential. Traditional packed columns are, however, more robust and
those made of glass or stainless steel with dimensions such as 2 m long x 3 mm i.d. are still
widely used for routine blood-alcohol analysis because the number ofvolatile components that
might be present is fairly limited.2-3 Hgure 5.2.2.3a shows an example of a gas chromatogram
obtained by headspace analysis of an eight-component mixture of low-molecular volatile
substances including ethanol with a glass column packed with Carbopak C (0.2% Carbowax
1500 on graphitized carbon black 80 to 100 mesh).
Because HS-GC involves sampling the vapor in equilibrium with die blood specimen, the
non- volatile constituents of the biological matrix do not accumulate and dog the GC column
or contaminate die packing material. Sensitivity of the assay can be enhanced and matrix effects
eliminated in another way, namely by saturating the blood samples and aqueous ethanol
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standards with an inorganic salt such as NaCI or K 2 C0 3 , e.g., 0,5. ml blood + 1 g salt.67'68 This
salting-out technique has proven useful for analyzing trace concentrations of volatiles in blood.
such as the endogenous alcohols.69 The advantages ofsalting-out methods have been discussed
in many publications including the comprehensive review by DubowskL60*4
Analysis of blood by headspace GC was combined with a cryofocusing technique, or freeze
trap, to concentrate the specimen prior to chromatographic separation of the volatile components with a capillary column. This modification was applied to the assay of complex mixtures
of volatiles, for example, the congeners present in alcoholic beverages to determine whether
these might be identified in blood samples after drinking.70
Gas chromatographic methods of analysis offer the unique advantage of combining a
qualitative screening analysis of the components of a mixture based on the time after injection
to the appearance of the peak (retention time) with simultaneous quantitative analysis by
measuring the detector response as reflected in the height or area under the peak. Several recent
reviews have dealt with die use ofgas chromatography in forensic science including applications
for blood- alcohol analysis.71*72 Another good review looked at more general applications of
headspace analysis when applied to biological specimens for analysis of organic volatile substances, including alcohols.73
In forensic work, it is advisable for duplicate determinations to be made on two different
column packing materials, thus furnishing different retention times for ethanol. This is important if the blood or tissue samples are putrefied and therefore might contain interfering
substances having the same retention times as ethanol when a single stationary phase is used.
The risk of obtaining coincident retention times on two or more stationary phases is reduced
considerably. Otherwise, two different methodologies such as GC and chemical oxidation or
GC and enzymatic oxidation could be used to analyze duplicate aliquots from the same blood
sample.74 HS-GC with two different detectors (flame ionization and electron capture) has been
used to screen biological fluids for a large number of volatiles. This dual-detector system was
recommended for use in clinical toxicology to aid in the diagnosis of acute poisoning when a
host of unknown substances might be responsible for the patients condition.73
SJL2A Other Methods
A multitude of other analytical methods has been described for blood-alcohol analysis but none
of these can match HS-GC which has become the gold standard in forensic and clinical
toxicology laboratories. Methods of measuring blood-alcohol concentration by headspace
analysis with electrochemical sensing76 or a metal oxide semiconductor device77 were reported,
but these are not sufficiently selective when interfering substances might be present. These
procedures could be useful to rapidly screen biological samples and thus eliminate specimens
that do not contain any alcohol. A modified headspace procedure with a fuel-cell sensor was
described for measuring the strength of alcoholic beverages and the results obtained compared
favorably with a standard gas chromatographic method.78
Several novel methods for analysis of alcohol make use of biosensors prepared from
immobilized enzymes. These constructions, called biodectrodes, have found several applications in clinical laboratory analysis.79 The end-point of the enzymatic reactions can be monitored either by amperomeixy, cdorimetry, or spectrophotometry.80-*2 The enzyme alcohol
oxidase has attracted attention for analysis of alcohol in bodyfluidsand gives reasonably good
semi-quantitative results.23*5 These systems are similar in prindple to measuring blood glucose
with a glucose oxidase dectrode and open-up the possibility for sdf-testing applications such
as die glucose dipstick technology.86 Fourier transform infrared spectrometry (FITR.) was
recently applied to the determination of alcohol in beer87 and when a purge-and-trap capillary
GC separation stage was included, FTIR could also be adopted to measure a wide range of lowmolecular wright volatiles induding ethanol.*8 A method based on proton nudear magnetic
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resonance spectroscopy proved suitable in pharmacokinetic studies to analyze ethanol, acetone,
and isopropanol in plasma samples.*9'90
In clinical and emergency medicine, freezing point depression osmometry has a long
history as a screening test for certain pathological states.91 Diabetes mellitus and uraemia, often
associated with abnormally high concentrations of plasma-glucose and plasma-urea, respectively, cause discrepancies between the osmolality expected from the inorganic ions Na+ and
K+ and the values measured by depression of die freezing point. Dedicated equipment is
available for measuring freezing-point depression and the test can be done on as little as 02
ml plasma. Moreover, the method is non-destructive which means that the same specimen of
plasma can be used later for making a toxicological confirmatory analysis if necessary.
The most common cause of finding an increased osmolal gap in plasma samples from
emergency service patients is a high concentration of ethanoL91 Ethanol carries an appreciable
osmotic effect because of its low molecular weight (46.05), high solubility in water, and the
feet that large quantities are ingested to produce intoxication.92 Finding a normal osmolal gap
speaks against the presence ofhigh concentrations ofplasma-etbanol but the reverse conclusion
does not hold because ingestion of other solvents such as acetone, methanol, isopropanol, or
ethylene glycol, also lowers die freezing point resulting in increased serum or plasma osmolality. The principal limitation offreezingpoint osmometry as a rapid screening test for plasmaethanol is obviously the lack of selectivity because other non-electrolytes could be falsely
reported as ethanol. Nevertheless, articles continue to be published dealing with the principles
and practice of freezing point osmometry in emergency toxicology.93
Considerable interest has developed in point-of-catc or near patient testing and this
treatment paradigm speaks in favor of noninvasive methods of biochemical analysis. Nearinfrared spectrometry is a technique with huge prospects and possibilitiesforthe future because
drawing blood or puncturing the skin is not necessary.94 Infrared light is beamed through a
subjeer's fingertip or eariobc and after processing the absorption bands ofthe emitted light into
specific wavelengths, various constituents in the bloodstream can be identified and for some
substances a quantitative analysis is possible. However, disentangling the signals of interest
from the background noise generated by other biological molecules has proven a challenging
problem but progress is rapidly being made with die help of sophisticated computer-aided
pattern recognition techniques. Near-infrared spectroscopy has already been successfully applied to die analysis of blood glucose95 and it will not be long before attention is given to the
analysis of drugs of abuse including ethanol.
Thefeasibilityofcombining gas chromatography (GC) to separate the volatile components
in a mixture and mass spectrometry (MS) as the detector was demonstrated many years ago. 96
GC-MS provides an unequivocal qualitative analysis of ethanol from its three major mass
fragments m/z 32 (base peak), m/z 45, and xn/z 46 (molecular ion).96 Selected ion monitoring and deuterium labelled ethanol was used to distinguish between ethanol formed postmortem by die action of bacteria on blood glucose.97*9* Also, in clinical pharmacokinetics,
ordinary ethanol was analyzed in blood along with its deuterium-labeled analogue to investigate the bioavailability of ethanol and the role of first-pass metabolism in die gut.99
5JL3 BREATH ALCOHOL ANALTOS
A small amount of the alcohol a person drinks is expelled unchanged in the breath and breathalcohol measurements provide a fist and non-invasive way to monitor alcohol in the body. A
large literature base exists describing the principles and practice of breath-alcohol analysis and
die design and evaluation ofa multitude of breath-testing instruments for research, Htnigal^ and
forensic purposes.10*"102 Analysis of the expired air is also an indirect way to monitor die
concentration of other volatile endogenous substances in the pulmonary blood and this
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approach has found many interesting applications in clinical and diagnostic medicine.103*104
However, the main application of breath-alcohol analysis is in the field of traffic law enforcement for testing drunk drivers and more recently also for workplace alcohol testing.2*24'102 Two
categories of instruments for breath-alcohol analysis are available depending on whether the
results are intended as a qualitative screening test for alcohol or for quantitative evidential
purposes.
Various hand-held devices are being used for roadside pre-arrest screening of drinking
drivers to indicate whether their BAC or BrAC exceeds a certain threshold statutory concentration limit for driving.2*102*105406 The instruments used for evidential purposes provide a
quantitative analysis of BrAC and the result is used as binding evidence for prosecuting drunk
drivers.107*109 Breath-alcohol instruments have also found applications in clinical pharmacokinetic studies of ethanol and drug-alcohol interactions.110 Hand-held breath-alcohol analyzers
are very practical for use in emergency medicine as a quick and easy way to monitor whether
patients have been drinking and to estimate the alcohol load in the body.11?"113
Most of the hand-held screening devices incorporate electrochemical fuel-cell sensors that
oxidize ethanol to acetaidehyde and in the process producefreeelectrons. The electric current
generated is directly proportional to the amount of ethanol consumed by the cell. Acetone,
which is the most abundant endogenous volatile exhaled in breath, is not oxidized at the
electrode surface so this ketone does not give false-positive responses.114*125 However, if high
concentrations of methanol or isoprqpanol are present in exhaled breath, these are oxidized in
the same electrochemical reaction but at different rates compared with ethanol.113 Care is
sometimes needed when-the results are interpreted because isopropanol might be produced
naturally in the body by die reduction of endogenous acetone.115 The concentration ofacetone
in blood reaches abnormally high levels during food deprivation, prolonged fasting (dieting),
or during diabetic ketoacidosis.114
Most of the evidential breath-testing instruments used today identify and measure the
concentration of alcohol by its absorption of infrared energy at wavelengths of 3.4 or 9£
microns, which correspond to the C-H and C-O vibrational stretching in the ethanol molecules, respectively.2*100 Selectivity for identifying ethanol can be enhanced by combining
infrared absorption at 9.5 microns and electrochemical oxidation within the same unit. The
Aicotest 7410 features this dual-sensor technique. Another examplefromthis new generation
of breath-test instruments is the Intoxiiyzer 6000, which makes use of five different IR
wavelengths for identification of ethanol. This reduces considerably the risk of interfering
substances being incorrectly reported as ethanol.
Later chapters give additional details of pre-arrest screening instruments as well as more
sophisticated units for evidential testing with microprocessor control of the entire breath-test
sequence including die volume of breath exhaled, the temperature of breath, and the actual
BrAC concentration-time profile. A 15-min observation period before conducting an evidential
breath-alcohol test is an important pan of the testing protocol to avoid problems with mouth
alcohol disturbing the results.116*117 The presence of mouth alcohol can sometimes be disclosed
by looking at the slope of the breath-alcohol concentration profile during a prolonged
exhalation.100 Otherwise, the BrAC measured after thefirstfew seconds of exhalation can be
compared with the BrAC reached after an end-exhalation as a way to disclose mouth alcohol.
If the result in thefirsttest exceeds; thefinalresult, this suggests the presence of mouth alcohol,
either caused by recent ingestion or by regurgitation of stomach contents or spontaneous
gastro-esophageal refiux. The results of the breath-alcohol test as well as demographic details
about the suspea can be printed out directly on-the-spot or stored in the computer memory
and down-loaded later to a central computer network for producing summaxy statistics and
quality control charts.
Reporting results of breath-alcohol analysis is a bit confusing and this depends on whether
these are intended for use in clinical and emergency medicine or traffic law enforcement. To
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Table 5.2.4.4 Inter-Laboratory Proficiency Test of Blood-Alcohol Analysis
Performed at Specialist Forensic Toxicology Laboratories in the
Nordic Countries*
Laboratory
1
2
3
4
5
Mean
SD
CV%

Blood-1
0.46
0.47
0.46
0.47
0.48
0.47
0.008
1.7%

Bfood-2 Blood-3
1.01
2.15
2.27
1.01
1.01
226
1.00
2.17
1.01
2.15
1.01
2.20
0.005
0.060
0.49%
2.7%

Btood-4 Btood-5
1.62
0.74
J.70
0.78
1.67
0.77
1.66
0.78
1.66
0.78
1.66
0.77
0-029
0.017
1.7%
2.2%

Biood-6
1.75
1.S3
1.81
1.81
1.79
1.80
0.030
1.7%

*7be bleed samples were obtainedfromapprehended drinking drivers and eoUetted into tubes
containingfluorideand oxalate and smaU portions removed for sending to the participating
laboratories. The between^aboratory CVs were always less than 3% and the corresponding
within-laboratory CVs were mostly less than 2% (data not shown).

test if a patient is under the influence of alcohol for clinical purposes, the BrAC is generally
converted into the presumed concentration in venous blood. This requires the use of a
calibration factor called die blood/breath ratio so that BrAC x factor » BAC. This blood/
breath factor is assumed to be a constant for all individuals and 2100:1 has traditionally been
accepted for legal purposes.13402 In many tLS. states a concentration of 0.10 g% in blood is
equated with 0.10 g/210 L breath and this 2100:1 relationship is therefore affirmed by
statute.100
However, many empirical studies have shown that calibration with a factor of2100:1 tends
to give results that underestimate the venous BAC by about 10% when near simultaneous
samples are taken 1 to 2 h after the end of drinking.108 A closer agreement between blood and
breath-alcohol is obtained when a 2300:1 factor is used for calibration.10* Analytical precision
improves considerably if BrAC is reported directly instead of estimating the coexisting venous
BAC. In experiments with an evidential breath-analyser (DataMaster), the BAC was estimated
with a 95% confidence interval of 15 mg/dl compared with 5 mg/230 L when BrAC was
reported directly.118
Note that breath-alcohol instruments are calibrated to estimate the concentrations of
alcohol in whole blood and not the concentration is plasma or serum and this is often
overlooked by many dmicians who seem to consider blood and plasma concentrations of
alcohol as being the same. To derive die concentration of alcohol in plasma or serum indirectly
by the analysis of breath, the breath-test instrument should be calibrated with a plasma/breath
factor of about 2600:1 because whole blood contains about 14% less alcohol than the same
volume of plasma or serum (Table 5.2.1). Nowadays, when breath-alcohol testing is used for
traffic law enforcement the results are almost always reported as die concentration of alcohol
in die breath without considering the persons BAC. This avoids making any assumptions about
the blood/breath ratio and hs variability between,and within individuals. Statutory limits for
driving in many countries are therefore written in terms of threshold blood and breath-alcohol
concentration depending on the specimen analyzed.
5JLA QUALITY ASSURANCE ASPECTS OF ALCOHOL ANALYSIS
Much has been written about quality assurance of clinical laboratory measurements and
concepts such as precision, accuracy, linearity, recovery, sensitivity, and limits of detection and
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quantitation have been discussed in detail elsewhere.119 In addition, when the results are used
as evidence in criminal and civil litigation, the chain of custody record of the specimens is
extremely important to document. This chain must be kept intact from the moment of
sampling to die moment the results are reported and each person involved in the handling,
transport, analysis, and storage of die specimen must be traceable from these written records.
The entire procedure including the actual chromatographic traces as well as evidence of correct
calibration on the day the specimens were analyzed and also internal and external control tests
might need to be documented several months or years later. Important details concerning preanaiytical, analytical, and post-analytical aspects of blood-alcohol analysis are presented below.
SJLAA Pre-Aaafytical Factors
Information should be given to the subject about the reason for taking a blood-sample and,
if necessary, informed written consent should be obtained. The equipment used for drawing
blood is normally an evacuated tube (5- or 10-ml Vacutainer tubes) and sterile needle
attachment. The blood sampling site is usually an antecubital vein and if necessary a tourniquet
can be used to dilate a suitable superficial vein. Sufficient blood should be taken to allow
making several determinations of die blood-alcohol concentration and any re-testing that
might be necessary as well as the assay of drugs of abuse. The specimen tubes should be gently
inverted a few times immediately after collection to facilitate mixing and dissolution of die
chemical preservatives; sodiumfluoride(10 mg/mL) to inhibit die activity ofvarious enzymes,
micro-organisms, and yeasts, and potassium oxalate (5 mg/mL) as an anticoagulant. The tubes
of blood should be labeled with the person's name, the date and time of sampling,- and the
name of the person who took the sample. The Vacutainer tubes containing blood should be
sealed in such a way as to prevent unauthorized handling or tampering and special adhesive
paper strips are available for this purpose. The blood samples and other relevant paper-work
should be secured with tape so that any deliberate manipulating or adulteration is easily
detected by laboratory personnel after shipment. After taking the samples, the tubes of blood
should be stored in a refrigerated room before being sent to die laboratory by express mail
service.
Although pre-analytical factors are more important to consider and control when endogenous substances are analyzed, such as in clinical chemistry, a standardized sampling protocol
is also important forforensicblood-alcohol analysis. Two tubes of blood should be drawn in
rapid succession and die skin cleaned with soap and water and not with an organic solvent such
as ether, isopropanol, or ethanol. Obviously, die blood samples should not be takenfromveins
into which intravenous fluids are being administered.120 This kind of emergency treatment is
often given as a first-aid to treat patients suffering from shock or trauma as a result of
involvement in traffic accidents. The blood samples should be taken only by trained personnel
such as a phlebotomise registered nurse, or physician.
SJLA2. Analytical Factors
The blood specimens must be carefully inspected when they arrive at die laboratory, making
a note wheriier or not die seals on the package as well as the individual tubes of blood are intact,
if there are any blood-dots, and if the blood seems to have been diluted with other liquids.
Details of any mishaps during transport (breakage, leakage of blood), as well as die date and
time of arrival should be recorded. The information written on the Vacutainer tubes should be
compared with other documentation to ensure die suspect's name and the date and time of
sampling are correct. The same unique identification number or barcode should be added to
all paperwork and biological specimens received and this number used to monitor passage of
the specimens through the laboratory. Ensure that the erythrocytes and plasmafractionsare
adequately mixed before removing aliquots of whole blood for analysis. Replicate determina-
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dons can be made with different chromatographic systems and preferably by different technicians working independently.26 Any unidentified peaks on the gas chromatograms should be
noted because these might indicate the presence of other vokdles in die blood sample.
SJLA3 Post-Analytical Factors
Quality assurance of individual results can be controlled by looking at critical differences
(range) between replicate determinations. The size of the difference will be larger the higher
the concentration of ethanol in the blood specimen because precision tends to decrease with
an increase in the concentration of ethanol. Control charts offer a useful way to monitor dayto-day performance in die laboratory; one chart being used to depict precision and another the
accuracy ofthe mediod by analyzing known strength standards together with unknowns. These
charts make it easy to detect the presence of outliers. 26 ' m;m The rate of loss of alcohol during
storage needs to be established under refrigerated conditions (+ 4°C) and also when specimens
are kept deeply frozen.223*224 If necessary, corrections can then be made if the blood specimens
are reanalyzed after prolonged periods of storage. The chromatographic traces and other
evidence corroborating die analytical results, such as calibration plots or response factors,
should be carefully labeled and stored safely in fire-proof cabinets. It might be worthwhile to
ensure that the laboratory is accredited for making forensic topological analyses and die
results of external proficiency trials should also be made available for scrutiny.
5JL4A Inter-laboratory Proficiency
Two papers recently looked at die results from inter-laboratory proficiency tests of bloodalcohol analysis at clinical chemistry laboratories.125*22* In one study, originating from Sweden,
all participating laboratories used gas chromatography for analysis of plasma-ethanol and the
coefficients of variation between laboratories were within die range 10 to 17%.225 In a similar
study among UK laboratories, the corresponding CVs depended in part on the kind of
methodology used for the analysis of alcohol. Immunoassays generally performed worse than
gas chromatographic methods (liquid injection and headspace technique) and die CVs ranged
from 8% to 2054.226
Table 52 AA presents results from a recent inter-laboratory comparison of blood-alcohol
analysis made at specialist forensic toxicology laboratories in the Nordic countries (Denmark,
Finland, Iceland, Norway, and Sweden). All participants used headspace gas chromatography
to analyze ethanol and the'blood samples were obtained from apprehended drinking drivers.
The coefficient of variation between laboratories was always less than 3% regardless of the
concentration of alcohol, which testifies to highly standardized analytical work. The corresponding CVs within laboratories were mostly 1% or less based on 3 to 6 determinations per
sample. If die overall mean BAC in each sample is taken as the target value, then all the
laboratories showed an accuracy to within 5% of that attributed.
SJLS FATE OF ALCOHOL IN THE BODY
Ethanol is a small polar molecule and its low molecular weight and weak charge allow it to
penetrate easily through biological membranes. After ingestion, ethanol is absorbed readily
from die stomach but absorption occurs much fester from die upper part of the small intestine
where the available surface area is much larger owing to die presence of microvilli on the
mucosal cells. Both the rate and extent of absorption is delayed if there is food in die stomach
before drinking.127 Blood draining from die gastrointestinal tract collects in the portal vein
where the alcohol is transported through die liver, and then on to the heart and the systemic
circulation. The metabolism of alcohol occurs mainly by die action of enzymes located in the
liver although recent research suggests that small amounts of alcohol might be metabolized in
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Figure 5.2.5 Mean concentration-time profiles of
ethanol in blood vs. breath (x2100), blood vs. saliva,
and blood vs. urinefromexperiments with healthy
men who ingested 0.68 g ethanol per Kg body
weight as neat whisky in the morning after an
overnight last.

Blood Alcohol

the mucosa of die stomach.128 After absorption,
ethanol distributes uniformly throughout all
bodyfluidsand tissue without binding to plasma
T o * , fe
proteins. Provided that the systemic availability
of the dose is 100%, such as when administered
a t»n
by i.v. infusion, it is possible to determine total
129
body water by the ethanol dilution method.
The peak blood-alcohol concentration after
Stfiva AleoM
drinking, as well as die time of reaching the
peak, varies widely from person to person and
depends on many factors. After 48 healthy male
volunteers drank 0.6S g ethanol/kg body weight
as neat whisky on an empty stomach, die peak
concentration in capillary (fingertip) blood was
readied at exactly 10,40,70, and 200 min after
the end of drinking for 23,14, 8, and 3 subjects, respectively.130 The quantities consumed,
the rate of drinking, the dosage form (beer,
wine, spirits, cocktails) and most importantly
the rate of gastric emptying impacts on the
speed of absorption.131 The concentrations of
ethanol in bodyfluidsandtissuesafter reaching
equilibration will depend on the water contents,
the ratio of blood-flow to tissue perfusion, as
well as various time elements.120 Kgure 5.2.5
shows tiie mean concentration- time profiles of
ethanol in blood, breath, urine, and saliva obTmm.k
tained from experiments with healthy male volunteers who drank 0.68 g/kg as neat whisky in
20 min after an overnight fast.132
The bulk of the dose of alcohol entering the bloodstream (95 to 98%) is eliminated from
the body by metabolism which takes place mainly in the liver by the action of class I enzymes
of alcohol dehydrogenase (ADH).127 Between 2 to 5% of the dose is excreted unchanged in
breath, urine, and sweat, and a very smallfractionis conjugated with glucuronic add.133 Small
amounts of alcohol might undergo pre-systemic oxidation by ADH located in the gastric
mucosa or the liver or both, but the quantitative significance offirst-passmetabolism (FPM)
is still an unsettled question.134
At moderate BAG (>60 mg/dL), the microsomal enzymes (P450IIE1), which have a
higher km (60 to 80 mg/dL) compared with ADH (km 2 to 5 mg/dL), become engaged in
the metabolism of ethanol.135'136 The P450 enzymes are also involved in the metabolism of
many other drugs and environmental chemicals which increases, die risk of drug-alcohol
interactions and this might account for the toxicity of ethanol in heavy drinkers and
alcoholics.137*13* Moreover, the activity of P4502E1 enzymes increase after a period of continu-
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ous heavy drinking owing to a fester de novo synthesis of the enzyme, and metabolic tolerance
develops as reflected in two- to threefold fester rates of elimination of alcohol from the
bloodstream in alcoholics.139*141
The effects of ethanol on performance and behavior are complex and involve an interaction
with membrane receptors in the brain associated with the inhibitory neurotransmitters giutamate
and gamma aminobutyric acid (GABA).142M3 The behavioral effects of ethanol are dosedependent and drinking small amounts initially produces feelings of euphoria followed by
depression and stupor after large doses are ingested. EthanoPs depressant effects are related to
an alteredfluxofions through the chloride channel activated by GABA.144 Thefeetthat ethanol
modifies neuro-transmission at die GABA receptor also helps to explain the cross-tolerance
observed with other classes of drugs such, as the benzodiazepines and barbiturates, which also
bind to the GABA receptor complex to produce their effects on brain functioning.143
Although ethanol-induced impairment shows a reasonably good overall correlation with
the coexisting blood-alcohol concentration, there are large variations in response for different
individuals who drink the same amount of alcohol within the same timeframe.The reasons for
this are twofold; first, larger people tend to have more body water so the dose of alcohol enters
a larger volume resulting in lower BACs compared with lighter people with less body water.
This phenomenon is known as consumption tolerance arid is caused primarily by variations in
body weights and the relative amount of adipose tissue which is influenced by age, race, and
gender. The second reason for the inter-individual differences in ethanol-induccd -effects on
performance and behavior h called concentration tolerance caused by gradual habituation of
brain cells to the presence of alcohol during exposure to die drug over long periods. Besides
the development of acute tolerance, which appears after a single exposure (see Chapter 1), a
chronic .tolerance develops, after a period of continuous heavy drinking. The mechanisms
accounting for chronic tolerance seem to depend on changes in die composition of cell
membranes, particularly die cholesterol content, the structure of die fatty acids, and also the
arrangement of the phospholipids in die membranes.142'144
In occasional drinkers, die impairment effects at specific blood-alcohol concentrations are
often classified according to various stages of intoxication as evidenced by the clinical signs and
symptoms observed. This nodon was first proposed by Bogen145 but has been subsequently
developed further and improved by others. At a BAC of 10 to 30 mg/dL slight changes in
performance and behavior can be demonstrated with highly specialized tests such as divided
attention. Between 30 to 60 mg/dL, most people experience euphoria, becoming more
talkative and sociable. At a BAC between 60 to 100 mg/dL, a marked euphoria and excitement
is often reported with partial or complete loss ofinhibitions and in some individuals judgement
and control are seriously impaired. When die BAC is between 100 and 150 mg/dL, which are
concentrations of ethanol seldom reached during moderate social drinking, psychomotor
performance deteriorates markedly and articulation and speech become obviously impaired.
Between 150 and 200 mg/di, ataxia is pronounced and drowsiness and confusion are evident'
in most people. Controlled studies at high BAC with moderate drinkers are lacking because of
die gross intoxication produced, but anecdotal information exists from die field of emergency
medicine. The relationship between BAC and clinical impairment is well documented in drunk
drivers who often attain very high BACs of 350 mg/dL or more but most of these individuals
are obviously chronic alcoholics.14*
It is important to note that the magnitude and appearance of various signs and symptoms
of inebriation depend to a great extent on the rate of drinking and whether die person starts
from zero BAC, that is after a period of abstinence or with a residual BAC from a recent
drinking spree.147*14* In the latter case, the severity of intoxication is less pronounced because
previous consumption of alcohol means that the individual has acquired some degree of
tolerance. Drinking too much too fast is dangerous and if gastric emptying occurs rapidly, the
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Figure 5.2.6.1 individual concentration-time profile of ethanol in venous Mood after an intravenous
administration of 0.8 g/kg at a constantrateever 30 min. Key pharmacokinetic parameters are defined
on this trace.
BAC increases with such a velocity that the vomit reflex in the brain is triggered. This
physiological response to acute alcohol ingestion has probably saved many lives.
5 JL6 CLINICAL PHARMACOKINETICS OF ETHANOL
The discipline known as pharmacokinetics deals with the way that drugs and their metabolites
are absorbed, distributed, and metabolized in the body and how these processes can be
described in quantitative terms.149*150
5JL6.1 WidmarkModel
The clinical pharmacokinetics of ethanol have been investigated extensively once the 1930s
thanks to the early availability of a reliable method of analysis in small volumes of blood.151
Figure 5.2.6.1 shows a typical blood-alcohol concentration-time profile after intravenous
infusion of 0.80 g ethanol/kg body weight at a constant rate for 30 min. The key pharmacokinetic parameters are defined on this trace in accordance with the model developed by
Widmark.151 The peak BAC coincides with the end of the infusion period being followed by
a diffusion plunge during which time die ethanol equilibrates between well perfused and poorly
perfused organs and tissues. At about 90 nun post-infusion, the BAC starts to decrease at a
constant rate per unit rime according to zero-order kinetics and the slope of this rectilinear
disappearance phase is commonly referred to as the alcohol bum-off rate or p-slope. However,
specialist texts in pharmacokinetics refer to the zero-order elimination slope as ko instead of
p. 152 When the BAC decreases below about 10 mg/dL, shown in Hgure 5.2.6.1, after a time
of 450 min, a curvilinear disappearance phase starts to develop and this lasts for as long as
alcohol is still measurable in die blood. The elimination of alcohol now follows first-order
kinetics and the rate constant is denoted kx and clearance from the bloodstream during this
terminal phase has a half-life of about 15 min.255
The first person to make a comprehensive mathematical analysis of BAC profiles was Erik
MP Widmark and details of his life and work were recenriy published.154 Widmark introduced
die following equation to represent the elimination kinetics of alcohol from blood:
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where
Ct m blood alcohol concentration at some time t on the post-absorptive pan of die curve.
C0 » blood alcohol concentration extrapolated to the time of starting to drink.
{$ » rate of elimination of alcohol from blood.
t = time in minutes.
The rate of elimination of alcohol from the blood in moderate drinkers falls within the range
of 10 to 20 mg/dL/h with a mean value of about 15 mg/dL/h.129-131 Higher values are seen
in drinking drivers (mean 19 mg/dL/h) 155 and in alcoholics undergoing detoxification (mean
22 mg/dL/h). 156 Thefesterbum-off rates seen in heavy drinkers are probably a consequence
of boosting the microsomal enzymes (P450IIE1) owing to prolonged exposure to high
concentrations of ethanol. The P450IIEI enzymes have a higher K,,, (60 to 80 mg/dL)
compared with ADH (2 to 5 mg/dL) and Ac slope of the elimination phase tends to be steeper
starting from a higherfaitfafBAC as in alcoholics compared with moderate social drink*
03157458 jjj a controlled study with alcoholics undergoing detoxification, the mean slope was
22 mg/dL/h with a range from 13 to 36 mg/dL/b-156 Liver disorders such as alcoholic
hepatitis and cirrhosis did not seem to influence die rate of disposal of alcohol in these
individuals.127*156
The rate of elimination of alcohol from the blood was not much influenced by die time
of day when 0.75 g/kg was administered at 9 AM, 3 PM, 9 PM, and 3 AM, according to a recent
investigation into chronopharmacokientics of ethanol.159 However, gastric emptying seems to
occurfesterin the morning as reflected in a 32% higher peak BAC and an earlier rime of its
occurrence when 1.1 g/kg alcohol was consumed between 7.15 and 7.45 AM, compared wirii
the same time in the evening.1*0 Smoking cigarettes slows gastric emptying and as a consequence delays the absorption of a moderate dose (0.50 g/kg) of ethanol resulting in a lower
peak BAC in smokers.161
By extrapolating the rectilinear elimination phase back to the time of starting to drink gives
the y- intercept (Cp), which corresponds to the theoretical BAC if the entire dose was absorbed
and distributed without any metabolism occurring (Hgure 5.2.6.1). The empirically determined value of C0 will always be greater than die ratio of dose/body weight because whole
blood is 80% w/w water compared with die body as a whole which is 60% w/w on average
for men and 50% w/w for women. The apparent volume of distribution (Vd) of alcohol is
obtainedfromthe ratio of dose (g/kg) divided by C0 and in clinical pharmacology textbooks
die Vd has units of liters/kg.152 However, because BAC in Widmark's studies was reported in
units of mg/g or g/kg, the ratio dose/C 0 known as the Widmark r factor is a ratio without
any dimensions and should be 5.5% greater than Vd reported in units of L/kg.154-162
Values of the distribution factor r differ between individuals depending on age and body
composition particularly on die proportion offer to lean tissue. Obviously, die value of r will
also depend on whether whole blood or plasma specimens were used to plot die concentrationtime profile and extrapolating to determine Q,.229 As shown in Hgure 5 J2.1, the plasma-alcohol
curves run on a higher level compared with whole blood-alcohol curves because of the different
amounts of water in these specimens. According to Widmark, die relationship between alcohol
in the body and alcohol in the blood at equilibrium can be represented by the Sallowing
equations.
A/(pxr)«C0

(2)

A * C c x (p x r)

(3)
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where
A = amount of alcohol in grams absorbed and distributed in the body.
p - body weight of the person in kg.
r = Widmarks r factor.
C0 « y-intercept (Kgure 5.2.6.1)
These equations make it easy to calculate the amount of alcohol in the body from the
concentration determined in a sample of blood provided that the value of r is known and that
absorption and distribution of alcohol are complete at the time of sampling blood.
In the fasting state, the factor r will depend on age, gender, and body composition and
Widmark reported mean values of 0.68 for 20 men (range 0.51 to 0.85) and 0.55 for 10
women (range 0.49 to 0.76).151 However, in many later studies with more volunteer subjects,
it wasfoundthat average values of r were 0.70 L/kg for men and 0.60 L/kg for women with
95% confidence limits of about ±20%.n7 Widmark's equations for JJ and r can be easily
combined by eliminating C0 to give the following equation:
A«pr(C 1 + Pt)

(4)

The above equation can be used to estimate the total amount of alcohol absorbed from tie
gastrointestinal tract since die beginning of drinking. By rearrangement, the blood alcohol
concentration (Q) expected after intake of a known amount of alcohol is calculated with the
help of the following equation.

Q-(M*)-*

(5)

When calculating BACfromdie dose administered or vice versa, it is necessary to assume that
the systemic availability is 100% and that complete absorption and distribution of alcohol in
the body water compartment has occurred at die time of sampling blood. Furthermore,
individual variations in £ and r introduce uncertainty in the calculated dose (A) or BAC (CJ
when average values are applied to a random subject from the population. The amount of
individual variation was recently estimated as ±20% for 95% confidence limits in tests with over
100 subjects.163 However, in the entire population of drinking drivers, these limits can be
expected to be much wider.
52-6JL MlcbacBs-Mcntcn Model
Because die class IADH enzymes have a low km (3 to 5 mg/dL), they become saturated with
substrate after 1 to 2 drinks and the rate of disappearance of etbano! from blood therefore
follows zero-order kinetics over a large segment of the post-absorptive elimination phase
(Kgure 5.2.6.1 ). m a 3 X When the blood-alcohol concentration decreases below about 10 m g /
dL, die ADH enzymes are no longer saturated and the curve changes to a curvilinear
disappearance phase (first-order kinetics). However, these low blood-alcohol concentrations
are not very relevant in forensic science work.
It was suggested and shown by Lundquist and Wolthers164 that the entire post-absorptive
elimination phase (zero-order andfirst-orderstages) might be rationalized by an alternative
pharmacokinetic model, namely that of saturation kinetics. Theyfittedthe Michaelis-Menten
equation to BAC-time data including die very low concentrations (<10 mg/dL) thanks to the
availability of a highly sensitive ADH method for blood-alcohol analysis. By solving the
integrated form of the M-M equation, the parameters V ^ and k* were determined. This
approach based on die Michaelis-Menten equation or saturation kinetics was later strongly
advocated by many specialists in pharmacokinetics, among others, Wagner, Wilkinson, and
their colleagues165*167 and values of 22 mg/dL/h and 5 mg/dL have been reported for V ^
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and k,,,, respectively.167 Although die use of M-M kinetics has found some support among
forensic scientists,168 others have not considered its use worthwhile when dealing with actual
casework169 because so many other variable factors and uncertainties influence the absorption,
distribution, and elimination of ethanol. Moreover, the mathematical concepts needed to
understand and apply M-M kinetics are more challenging than those necessary to derive the
"Widmark equation. Explaining the scientific principles of pharmacokinetic modeling to a judge
and jury, as is sometimes necessary in DUJ litigation, is prohibitive. Moreover, the notion of
multiple enzyme systems being involved in the metabolism of ethanol such as die various
isozymes of ADH, including generic variations and the contribution of P450HE1 to the
disposal of ethanol after chronic ingestion (metabolic tolerance), are not strictly compatible
with the use of a single enzyme system required by the Michaelis-Menten equation.170471
5*2*63 First-Pass Metabolism and Gastric Alcohol Dehydrogenase
Recent research efforts indicate that a small part of the alcohol a person consumes is metabolized before it reaches the systemic circulation and this process is known asfirst-passmetabolism (FPM).272-173 Some of the alcohol ingested is seemingly dearedfromdie blood eidier in
the stomach or during thefirst-passof the portal blood through the liver. The magnitude of
first-pass metabolism depends on many factors and seems to be greater when very small doses
of ethanol (0.15 g/kg) are administered and particularly when alcohol is taken together with
or after a meal presumably because under these conditions there is a longer time available fincontact between alcohol and die enzyme-rich mucosal surfaces in die stomach.172
Distinguishing betweenfirst-passmetabolism occurring in die stomach as opposed to die
liver has proven a difficult task and much debate has arisen about die significance of gastric
ADH in accountingforFPM.274*275 Some workers maintain that gastric metabolism of ethanol
plays a significant role in the overall disposal of ethanol especially when emptying of the
stomach is delayed and the absorption phase is more prolonged.173 Others consider that
negligible amounts of alcohol undergo presystemic oxidation in die stomach mainly because
the amount of gastric ADH is only a smallfractionof the amount of hepatic ADH available.275
Moreover, the main advocates ofgastric ADH and EPM ofethanol failed to consider the critical
importance of stomach emptying and its influence on the rate of absorption of alcohol.176 For
drugs that obey saturation kinetics, die bioavailability should become more variable as a
consequence of changes in absorption rate which modulates die fraction escaping first-pass
metabolism.277 Factors that influence the rate of absorption of alcohol from die gut (food,
•drugs, type of beverage, posture, time of day) also influence the concentration entering the
liver and die corresponding degree of saturation of the metabolizing enzymes.177
Interest in FPM escalated even further after several common medications such as aspirin
and H2-reeeptor antagonists (cimeddine and ranitidine) were shown in vitro to inhibit ADH17*"
181
extractedfromgastric biopsies.179 This observation lead to much speculation about adversedrug reactions and the role ofgastric-ADH as a protective barrier against the toxicity of ethanol
in some individuals.122 Proponents ofFPM argued that ifalcohol was taken together with these
common medications, this would result in the peak BAC being higher than expected probably
leading to a more pronounced impairment of body functions.1*0*182 Accordingly, those individuals lacking gastric ADH. or exhibiting reduced enzymatic activity such as women, oriental
populations, and alcoholics, might be more susceptible to the toxic effects of heavy drinking.273*2*3 These conclusions proved too hasty because many later studies into die efiects of
cimeddine and ranitidine on the pharmacokinetics of ethanol failed to confirm the initial
reports showing higher peak BAC and AUC and enhanced bioavailability.1*4*2*7
What did emergefromthis new wave ofinterest in clinical pharmacokinetics of ethanol was
strong and convincing information documenting die large inter- and intra-individual variations
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Figure 5.2.6.4 individual concentrationtime profile of ethanol in venous blood
from experiments with nine subjects who
drank 030 g ethanoi/kg body weight in
10 min either after an overnight rast or
after eating breakfestl h before drinking
alcohol Note the large inter-individuaJ
variations and much lower peak BAC
with smaller area under the curve and
the shortertimeto eliminate the dose of
alcohol in the fed-state. The Insert figure
shows mean ±SE for fed and fasting
conditions.
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in the pharmacokinetic profiles of
ethanol especially when small doses
(0.15 to 0.3 gAg) w « e ingested after a meal."*1*1
5JL6A food and
Pharmacokinetics of&hanol
Having food in the stomach before
drinking retards the absorption of
ethanol and the peak BAC and die
initial impairment effects are considerably diminished compared with
drinking the same dose on an empty
stomach.*51454-192'193 The bioavailability of ethanol is markedly reduced
Time* nun
whenever consumption takes place
after a meal and estimating values of
r or V d under these conditions give results that are too high, suggesting a loss of ethanol. The
composition of the meal in terms of its far, protein, or carbohydrate content was less important
in this respect.194"197 Figure 5.2.6.4 gives examples of pharmacokinetic profiles of ethanol in
venous blood for nine subjects who drank 030 g ethanol per kg either on an empty stomach
(overnight fast) or exactly 1 h after earing a protein-rich breakfast. The large inter-individual
variations in peak BAC, area under the curve (AUC) are dearly evident. The broken diagonal
lines show die slope and position of the zero-order elimination phase expected for a standard
man with a volume of distribution of0.70 liters/kg and an elimination rare constant of 15 m g /
dL/h and when the bioavailability of alcohol was 100%. The observed BAC profiles were
considerably lower than the values expected in every single case when the alcohol was
consumed after the meal, which implies that some of the alcohol escapes being absorbed into
the blood. Whether this reflects an activefirst-passmetabolism (stomach orfiveror both) or
whether an accelerated metabolism primarily takes place early after drinking during the
absorption phase is not known.134
It seems that a prerequisiteforfindingan appreciable FPM was that the subjects had eaten
food prior to drinking alcohol.198 This raised a question about the role of stomach emptying
and the speed of absorption of alcohol as a determinant of PPM.176*1*14" In Kgure 5.2.6.4
(insert), food taken 1 h before drinking not only lowers peak BAC and AUC but also seems
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to boost the rate of elimination of ethanol.193 This might be explained by a more efficient
extraction of ethanol in the liver when the absorption from the gut is slow, and more
prolonged, such as when alcohol is taken after eating a meal.376 Food increases liver blood Sow
and this might facilitate a more effective exposure of ethanol to the metabolizing enzymes in
the liver.194496 Whatever the mechanism, earing a meal before drinking is an effective way to
produce a lower and later occurring peak BAC, a fester rate of clearance of ethanol from the
body, and diminished feelings of inebriation.192.
5*2.7 CONCLUSIONS
Ethanol tops the list of drugs of abuse in most countries, and too much drinking is a wellknown cause of reckless behavior. Drunk drivers are over-represented iircrashes and deaths on
the highway and alcohol intoxication is the common denominator in many accidents within the
home and in the workplace. Alcohol abuse and alcoholism are major public health hazards with
enormous costs for the individual and society. Measuring alcohol in body fluids will continue
to be the most frequently requested procedure in analytical toxicology for a long time to come.
Few substances can be determined with such a high degree of accuracy, precision, and
selectivity as the concentration of ethanol in a person's blood.26 The analytical phase of the
procedure is hard to fault especially when methods such as headspace gas chromatography are
used at an accredited laboratory.26 Making duplicate determinations is an effective safeguard
against various mishaps occurring during the analysis and the aliquots ofblood analyzed should
be taken from two separate tubes.26 Moreover, to enhance selectivity, at least, two different
chromatographic systems can be used thus providing different retention times for ethanol*200
Alternatively, an independent assay method such as ADH or chemical oxidation can be run in
parallel with GC.73
More attention needs to be given to die pre-analytical factors including the condition of
the subject, the way the blood sample was taken, and the circumstances surrounding the
sampling procedure. This becomes significant whenever blood samples are taken from victims
of traffic accidents who require emergency hospital treatment, such as administration of drugs
or intravenous fluids, to counteract shock. It is important to remember that the result of a
chemical or biochemical testis only as good as die sample received. When the analytical results
make the difference between punishment or acquittal, as in trials concerning driving under the
influence of alcohol, pre-analytical factors are as important to control and document as
analytical factors.
Widmark's method continues to dominate die way thatforensicscientists and others deal
with the pharmacokinetics of alcohol when requested to calculate the amount ingested from
a single measurement of BAC.131 Making back extrapolations of BAC is not recommended
because of the wide variations in absorption, distribution, and elimination patterns of ethanol
both within and between different individuals.****192*01 This becomes especially important
when small doses of alcohol (03 g/kg) are taken after a meal because under these condidons
the bioavailability ofalcohol might be reduced by as much as 60% (Hgure 5.2.6.4).1*9 Warnings
about adverse drug* alcohol interactions, e.g., after taking medication such as aspirin and H 2 reccptor antagonists, before drinking alcohol and the risk of obtaining higher peak BAC and
larger performance decrements seem to have been much exaggerated.1*4*1*7
Other ways of studying die pharmacokinetics of alcohol have been proposed including the
use of Michaeiis-Menren kinetics202 and other saturarion-type models.205"205 Recently a threecompartment model206 as well as a non-compartment model207 were used to explore the
disposition and fete of alcohol in the body in quantitative terms.
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The Effect of Food on Alcohol Absorption and
Elimination Patterns

REFERENCE: Watkins, R L and Adler, E V , "The Effect of Food on Alcohol \bsorption
and Elimination Patterns," Journal of Forensic Sciences, JFSCA, Vol 38, No 2, March 1993,
pp 285-291
ABSTRACT: The same nine subjects (six male, three female) were given near bolus doses
of alcohol (0 69 g/kg) on two occasions separated by one week They were instructed to
consume the alcohol as rapidly as possible (12 1 min average) The alcohol was consumed
after dilution to 15% with fruit punch mix Both phases of the expenment were conducted
in a similar manner with the exception of stomach condition In Phase I the alcohol was
consumed immediately after a large meal In Phase II, the alcohol was consumed after an
approximate 6 h fast An Intoxilyzer 4011A was used to measure Breath Alcohol Concentration (BrAC), beginning immediately after the alcohol was consumed and ending approximately 4 h after the end of drinking The BrACs were measured in grams per 210 L of
breath, at approximate 8 min intervals over the course of the expenment The alcohol
absorption and elimination curves were plotted and evaluated for each subject in both experiments The average time required to reach maximum BrAC was 41 mm for both empty
and full stomach conditions The average elimination rate of ethanol was found to be significantly lower after a meal (0 017 BrAC/h compared to 0 020 BrAC/h) but the time required
to reach zero BrAC was not significantly different (5 01 h full stomach, 5 05 h empty stomach)
KEYWORDS: toxicology, breath alcohol, ethanol, alcohol concentration, alcohol absorption,
alcohol elimination, time to maximum, maximum reached, dnving under the influence

Alcohol absorption and elimination patterns are frequently key elements in the medicolegal evaluation of driving under the influence (DUIs) and alcohol involved accidents
Cnminahsts are frequently called upon to estimate alcohol concentrations at the time of
driving or accident These estimates are generally based upon a breath test taken at a
later time This operation is known as retrograde extrapolation (also back calculation,
or relation back)
At least two state courts have decided that breath test results are inadmissible unless
there is evidence relating the measured result to the time of driving [1,2] Consequently,
alcohol absorption and elimination patterns have become vital elements in DUI litigation
The literature makes a number of references to the variability of alcohol absorption
and elimination [3-5], however there are few quantitative studies of absorption and
elimination patterns under different stomach conditions (empty or full stomach) Sedman
et al [6] evaluated the effect of vanous types of liquid food upon alcohol absorption and
metabolism Under those experimental conditions they found the presence of food in the
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>tomach prolongs the absorption of alcohol and delays the time of occurrence of peak
Mood alcohol concentration
The present experiment was designed to compare the effect of empty and full stomach
:onditions on the following factors
1
dose
2
3
4
5

Time required to reach maximum breath alcohol concentration (BrAC) after a bolus
of alcohol
Maximum BrAC attained
Alcohol elimination rate from breath
Time required to reach zero BrAC
Theoretical maximum BrAC (C0) [7]

Methods
Subjects and Conditions
The experiment was conducted in two phases scheduled one week apart using the same
nine volunteers (six male, three female) The phases consisted of
I Consumption of alcohol after a meal consisting of pepperom and sausage pizza
II Consumption of alcohol under fasting conditions
Except for the food variable, similar conditions were maintained in both phases The
volunteers were social drinkers with no history of alcohol abuse and were instructed not
to eat after noon on the day of the experiment The experimental trials were then
conducted at approximately 6 30 p m after approximately 6 h of fasting The volunteers
were weighed and dosed at 0 69 g/kg The alcohol solutions were 15% v/v (m fruit punch
mix) and were consumed as rapidly as possible (Avg 12 1 mm, range 25 min) In phase
I all subjects consumed the same kind of pizza immediately prior to the ingestion of the
alcohol solution
Breath Testing and Equipment Used
Breath testing began after the consumption of the alcohol solutions Immediately after
the consumption of the solution each subject was instructed to rinse the mouth with tap
water The BrACs were then measured at approximate 8 min intervals over a period of
approximately 4 h
An Intoxilyzer model 4011A was used for all BrAC measurements The analytical
capabilities of this instrumentation have been evaluated by Emerson et al [8] Poor to
testing, the Intoxilyzer calibration was checked at the 0 10 BrAC level using a wet bath
Simulator All BrACs are reported as grams of alcohol per 210 L of breath

Results
The breath alcohol concentrations were plotted against time (Figs 1 and 2), and from
these plots the time to maximum BrAC, the maximum BrAC attained, the alcohol
elimination rate, the time required to reach zero BrAC, and theoretical maximum BrAC
(C0) were noted These values, their averages and standard deviations appear in Table
1 Time zero for each plot was considered to be the midpoint of the drinking time for
each volunteer
The time required to reach maximum BrAC was considered to be the time at which
the BrAC reached within 0 003 BrAC of the highest value attained This averaged 41
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Time after drinking, h
FIG 1—Breath ethanol concentration time plots for six different subjects after they drank 0 69 g
of ethanol per kg of body weight as 15% ethanol/punch mix The subjects consumed the ethanol as
rapidly as possible on an empty stomach and after a large meal

mm for both full and empty stomach conditions, with a range of 43 8 for the full condition
and 75 mm for the empty condition
The theoretical maximum (C0) for each individual was determined by projecting the
negatively sloped, relatively linear portion of the curve (after approximately 1 5 h absorption time) backward to time zero The alcohol elimination rates were determined by
dividing the Y intercepts of these lines by the X intercepts yielding the change in BrAC
per unit time
The average time required to return to zero BrAC was similar in both conditions
(Full—5 01 h, empty—5 05 h)
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FIG 2—Breath ethanol concentration time plots for three different subjects after they drank 0 69
g of ethanol per kg of body weight as 15% ethanoll punch mix The subjects consumed the ethanol
as rapidly as possible on an empty stomach and after a large meal

Discussion
As expected, the presence of food in the stomach reduced the peak BrACs (averaging
21 5% lower) However, regardless of stomach condition the time required to reach
maximum BrAC was relatively short, on average being 41 min The most important
finding of this study was the short time required to reach the maximum BrACs, and the
failure of food to prolong the rising phase (upward sloped leg of the BrAC curve)
It appears that a large portion of alcohol ingested is rapidly absorbed directly through
the stomach In a review article, [9] Holt noted that up to 43% of an administered dose
of alcohol may rapidly diffuse through the stomach wall within the first 20 mm after
ingestion Cortot et al [10] found 73% of the alcohol ingested was absorbed from the
stomach They found 39 4% of the ingested alcohol was absorbed through the stomach
withm the first hour after a meal McFariane et al [11] found that infusion of lipids into
the ileum and duodenum significantly delayed gastric emptying and depressed the maximum blood alcohol concentrations (BACs) reached However, even under these conditions, maximum BAC was reached within 0 5 h, while 100% of the nonabsorbable
radioactive marker remained in the stomach
We found that the alcohol elimination rate was lower in the full stomach condition
compared with the empty stomach condition (0 017 BrAC/h vs 0 020 BrAC/h) The
difference was statistically significant according to the paired-sample t test However the
time required to eliminate all of the alcohol in the system was not significantly different

TABLE 1—BMC (g/210L) results after near bolus dose of alcohol (0.69 g/kg).
Subject
#/age/wt/sex
kg

1/39/79.3/f
2121165 Mi
3/29/89.1/m
4/32/96.3/m
5/23/78.2/m
6/36/87.2/m
7/25/68.2/m
8/43/101/m
9/41/64.6/f
Mean
SD
Range

Time to Max BrAC, h
From end
From mid pt
of drinking
of drinking

0.48
0.20
0.53
0.35
0.65
1.45
0.53
0.83
1.20
0.689

0.36
0.14
0.51
0.29
0.64
1.39
0.46
0.75
1.11
0.628

1.25

1.25

Max BrAC
Empty stomach
0.095
0.068
0.079
0.096
0.080
0.065
0.069
0.075
0.080
0.079
0.010

Theoretical
Max BrAC,
C0

Time to
0 BrAC,
h

0.116
0.097
0.106
0.095
0.100
0.098
0.088
0.097
0.105
0.100
0.008

5.55
5.05
4.90
4.80
5.35
4.20
4.45
5.05
6.15
5.056
0.549

Elimination
Rate,
BrAC/h

0.021
0.019
0.022
0.020
0.019
0.023
0.020
0.019
0.017
0.0200
0.0017

>
H

z
C/)

>
2
O

>

1
2
3
4
5
6
7
8
9
Mean
SD
Range

0.80
0.67
0.73
0.32
0.93
0.46
0.58
0.65
1.05
0.687

0.58
0.52
0.64
0.19
0.84
0.36
0.43
0.48
0.89
0.548

0.73

0.70

Full stomach
0.069
0.062
0.064
0.074
0.054
0.047
0.051
0.060
0.075
0.062
0.009

0.106
0.083
0.082
0.080
0.077
0.066
0.078
0.086
0.100
0.084
0.011

6.20
6.10
4.45
4.10
5.40
4.20
4.10
4.20
6.35
5.011"
0.933

0.017
0.014
0.018
0.020
0.014
0.016
0.019
0.020
0.016
0.0171"
0.0023

o
rrn
33

rn

O

O
O
O
O

>
O

o
o

fl

No significant difference from empty stomach, t = 0.2146 P = 0.83.
^Significantly different from empty stomach, t = 3.194 P < 0.05.
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Tiese observations may be explained by two different mechanisms. One possibility is
hat the rate of alcohol metabolism is actually slower in the full stomach condition but
he first pass metabolism in the stomach reduced the amount of alcohol by just the right
.mount to require precisely the same amount of time to reach zero BrAC. The other
>ossibility is that the metabolic rate remained the same in the full stomach condition and
hat the alcohol absorption continued at a relatively low linear rate from the time of peak
ilcohol concentration until reaching zero BrAC. The most likely explanation would
ippear to be the latter because it does not require the precisely balanced action of two
mrelated mechanisms.
All of the elimination rates measured in this study were within the range commonly
ised by forensic scientists in connection with retrograde extrapolations [12-14].
The rapid fluctuations of BrAC with time noted by Dubowski [3] were seen in this
tudy during the empty stomach condition. They appeared primarily within the first 1.5
I after drinking and were generally absent afterwards. The maximum fluctuations were
Lround 0.02 BrAC in magnitude and were short-lived, lasting 0.5 h or less. We would
.peculate that they reflect the opening and closing of the pyloric valve, thus dumping
ilcohol into the intestine in a series of waves.
All five of the factors studied appear to be reasonably predictable and sufficiently
•eliable to make estimates of BrACs at some time removed from the time of a breath
est. However useful such estimates may be in DUI cases, it should be remembered that
.he process of alcohol absorption is highly variable. The limitations and pitfalls associated
with retrograde extrapolations are often not appreciated by laymen and the courts. Any
attempt at retrograde extrapolation should be made with caution, and performed by
persons able to assess and discuss the applicability of a retrograde estimate to a particular
situation.
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Addendum F

BLOOD ALCOHOL TESTING USING THE INTOXILYZER 5000 SERIES,
INTOXILYZER 8000 AND GAS CHROMATOGRAPHY
AND
BLOOD ALCOHOL ABSORPTION AND METABOLISM
STUDY

UTAH HIGHWAY PATROL
UTAH PUBLIC HEALTH LABORATORY
SEPTEMBER 2003

OBJECTIVES
The Utah Highway Patrol and the Utah Public Health Laboratory conducted a joint study
with the following objectives:

1.

Determine how measurement of breath alcohol from various models of the Intoxilyzer 5000
compares with direct blood alcohol results. An important part of this study was to compare
the performance of the Intoxilyzer 8000 instrument with Intoxilyzer 5000 models.
Statistical analysis wil 1 be used to help compare the instruments. This comparison wil 1 be
instructive to the breath alcohol-testing program and to legal proceedings in Utah involving
DUI cases tested with Intoxilyzer 5000 and 8000 instruments.

2.

Conduct a pharmacokinetic study of volunteer subjects. Study the correlation between
alcohol dose and blood alcohol levels, and the absorption and burnoff rates of alcohol from
blood. This firsthand study of alcohol absorption and metabolism in human subjects will
better qualify both Utah Highway Patrol technicians and State Health Laboratory
toxicologists who interpret alcohol levels as expert witnesses in Utah.

INTRODUCTION

The Utah Highway Patrol has oversight responsibility in the state for the breath alcoholtesting program for violation of state laws pertaining to the operation of a motor vehicle
while under the influence of alcohol (DUI). The Utah Highway Patrol, which uses
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Intoxilyzer CMI breath instruments, may add the Intoxilyzer 8000 to the Utah approved list
of breath alcohol testing instruments. The Intoxilyzer 8000 was recently released. This
instrument, not intended to replace the 5000 series, was designed to be more portable and
rugged for use in the field. This instrument, like its predecessors, has been tested and
approved by the federal government. See Appendix 1 for more details on Intoxilyzer 8000
and the currently Utah approved breath alcohol testing instruments.

Technical studies comparing blood alcohol concentrations, as calculated from breath alcohol
measurements and direct blood alcohol tests, have been made on several occasions in the
United States and in Utah. These studies have generally indicated close agreement between
blood and breath alcohol tests.

METHODS AND MATERIALS:
The Utah Highway Patrol provided one each of the following breath alcohol instruments: An
Intoxilyzer 5000 66 series, an Intoxilyzer 5000 68 series, an Intoxilyzer 5000 68 EN series and an
Intoxilyzer 8000. In addition two preliminary breath testers (PBTs) were used. Trained UHP
technicians operated the breath testing instruments. The technicians, prior to the beginning of the
testing, checked calibration of the instruments. The toxicologists from the Utah Public Health
Laboratory standardized the gas chromatograph according to the laboratory procedural manual.
Six volunteer subjects, (3 male and 3 female) were used in the study.
Each subject self-administered a specific volume of 70 proof Gin, 80 proof Vodka, or 80 proof
whiskey. Orange juice, Coca-Cola and Sprite were used as mixers. See Appendix 2 for the volume
of alcohol each subject drank. The amount consumed by each subject was pre calculated using
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body weight and the Widmark Factor (r) to achieve a maximum blood alcohol concentration
between 0.10% and 0.13%. The subjects took 35 to 60 minutes each to complete the ingestion of
all the alcohol.
After the drinking was completed, breath tests were taken beginning 15 minutes after the last drink
and continuing approximately every 15 minutes until the blood concentration was less than 0.05
percent. Blood specimens were drawn from each subject 10 minutes after drinking ended, then
after the breath test indicated the subject had reached a peak and then hourly until the breath test
concentration fell to 0.07 percent or less. The blood specimens were labeled with the first name of
the subject and time the blood collected and then delivered to the toxicologists for blood alcohol
testing. The blood samples were analyzed by gas liquid chromatography using a Hewlett Packard
5890 series II gas chromatograph (GC). The blood alcohol measurements with corresponding time
after drinking stopped are shown in Appendix 3.
The subjects were generally confined to the study area and supervised closely for personal safety.
A meal was served at noon, which was after the ingested alcohol was essentially absorbed from the
stomach and intestinal tract. The subjects were delivered to their homes by the Highway Patrol
after the study was completed.

RESULTS AND DISCUSSION
Graphs of blood alcohol concentration versus time (in minutes) from the completion of drinking
were plotted. Graphs for each subject showing alcohol concentration with time as measured by five
instruments are shown in Appendix 4. The direct blood GC analyses were generally higher than the
results produced by four breath testing instruments. It is a frequently encountered observation that
near simultaneous breath and blood measurements produce blood alcohol higher (in the elimination
phase) by direct measurement of blood than by breath measurement. Under these conditions, the

4

use of the breath test instead of the blood test is a bias in favor of a defendant when his alcohol
level is near the per se limit.

Objective 1 - Comparison Of The Intoxilyzer 8000 with Other Instruments
The Intoxilyzer 8000 produced breath alcohol results that were generally closer to the direct blood
alcohol results than the Intoxilyzer 5000 models. In Female C the Intoxilyzer results were slightly
above the direct blood alcohol results. However, on average no gender difference in magnitude
between breath testing results and direct blood alcohol was observed. The individual variation in
measurements between the instruments on the same subject is almost always within 0.02% at any
given time.
An attempt was made to measure and compare reproducibility of the blood alcohol measurements
with each of the instruments. Except at the beginning and end of the elimination phase, blood
alcohol decreases essentially linearly with time. A statistically calculated measurement called
coefficient of correlation (R) was used to measure the degree of linearity observed for each of the
five elimination curves for each of the six subjects. See Appendix 5 for a detailed discussion of
coefficient of correlation and linear regression. When R is 1.000, there is a perfect correlation
(linear relationship between two variables). When R is "0", there is no correlation between two
variables. The average R for each instrument is shown below:

Average R

Intoxilyzer

Intoxilyzer

Intoxilyzer

Intoxilyzer

5000 66

5000 68

5000 68 EN

8000

GC

0.9844

0.9891

0.9814

0.9861

0.9941

The measurements of blood alcohol by GC were the most linear. The R for the
Intoxilyzer 8000 was comparable to the other breath instruments. We can conclude that direct
blood alcohol measurement by GC gives the most reproducible results. The Intoxilyzer 8000 is
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comparable to the other breath instruments in reproducibility or precision of blood alcohol
measurements.

Objective 2 - Study Of Alcohol Absorption And Metabolism
A. The time for alcohol to reach its peak level in blood after drinking stops.
The time at which the blood alcohol peaks after alcohol consumption depends on a number of
variables. Probably the most important factor is the amount of food consumed and length of time
since food consumption. Food in the GI tract delays alcohol absorption. It has been shown that
peak blood alcohol levels can occur anywhere from less than 30 minutes to several hours after the
last ingestion of alcohol.
The blood alcohol of each of the 6 subjects peaked within one hour after drinking stopped. See
Appendix 3.
R

To calculate the alcohol removal rate from the blood of the six subjects.

By measuring the slope of the best-fit linear curve for the elimination portion of the blood alcohol
graph, one can calculate the rate for which a person metabolizes alcohol as reflected in the rate of
decrease of blood alcohol levels. The slope of each elimination curve was calculated and then
averaged for each subject. (See Appendix 6)

Female A
Average rate of
elimination of 0.021
alcohol from
blood in %/hour

Female B

Female C

Male A

Male B

Male C

0.018

0.021

0.029

0.021

0.029

The average elimination rate for different individuals is 0.018% w/v, ranging from 0.01% w/v to
0.04% w/v. Two of six subjects (Male A and Male C) eliminate alcohol above the average rate.

C

To calculate the Widmark factor, for each of the six subjects.
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The Widmark factor (r) is the effective volume of distribution of the body for a given absorbed
dose of alcohol. Average r-values are used to estimate the amount of alcohol consumed at a
previous time to the measurement of a blood alcohol level. The Widmark factor (r) can be
calculated from the following relationship:
r = A_ ,
pa

A=

total amount of alcohol administered

p=

subject's weight

a=

the extrapolated concentration of alcohol that would
have occurred if the ethanol had been instantaneously
mixed through the body compartment in which it is
equilibrated after absorption and distribution is
complete.

The r-values for each of the subjects have been calculated. See Appendix 7. The mean "b" from
all the instruments was used for the extrapolated blood alcohol of time zero for each subject. We
were unable to calculate Widmark factor for Male A because he had a positive alcohol before the
drinking study began. The calculated r-values are as follows:

Calculated
Widmark
factor (r)

Female A

Female B

Female C

Male A

MaleB

Male C

0.75

0.49

0.59

NA

0.69

0.66

The average Widmark factor for women is 0.55 and 0.68 for men.
Researchers have found Widmark factors for different individuals to range from 0.46 to 0.90. The
Widmark factors for the above subjects were fairly close to average except for Female A. She was
very slender. People with low body fat have a higher Widmark factor than those with higher body
fat.
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CONCLUSIONS
Agreement among the breath testing instruments was very good. The Intoxilyzer 5000 66 tended to
measure a little lower breath alcohol results than the other breath testing instruments. The
Intoxilyzer 8000 tended to measure slightly higher results than the other breath instruments.
As reported elsewhere, this study showed that breath-testing results are lower than direct blood
alcohol results during the elimination phase. This can be a bias in favor of the defendant. There
was no observed gender difference in the magnitude of the low bias for breath testing results
compared to direct blood alcohol results. The variation in reproducibility of breath testing results,
while greater than for direct blood alcohol results, is within acceptable limits.

The subjects studied were normal in the time for blood alcohol levels to peak. Blood alcohol
elimination rates for two of the subjects were significantly higher than average but well within the
observed range of large groups of individuals. While four of the subjects have a normal Widmark
factor (r), one of the female subjects had a significantly higher value than the average female.
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APPENDIX 1

Breath Test Instruments
The Utah Highway Patrol provided four evidentiary breath test instruments. They also provided
two models of PBT's or non-evidentiary, preliminary breath testers. The latter were used to check
their accuracy and precision against the evidentiary instruments without intent of them being used
as a part of the formal study.
Intoxilyzer 5000
Three of the instruments were varying models of the Intoxilyzer 5000. In the state of Utah
administrative rules there is a list of approved instruments. They are the Intoxilyzer 5000, 66 series,
68 series and 68 Enhanced or EN series. They provided one of each for this evaluation.
They all use infrared spectrometry and utilize three filters in the 3 micron range. They look almost
identical, operate exactly the same, but the later models employ some improvements over the
earlier models.
66 Series
This model replaced the previous models of Intoxilyzers that had been used here in this state in the
mid to late 1980's. (4011 series) It employs an external heated breath tube with lA inch tubing. It
employed a pressure switch and a slope detector to verify deep lung breath samples. Some people
found it difficult to satisfy the minimum requirements for an adequate breath test.
68 Series
This model was introduced in the late 1990's. The breath tube used larger diameter tubing, 3/8 inch
as opposed to lA inch. This made it easier for the test subject to provide the volume of breath
needed. This model used a flow meter as opposed to a pressure switch. This requirement facilitated
the test subject in supplying a deep lung breath sample and allowed the breath sample volume to be
measured.
This series also employed a cooled detector that was more accurate at lower levels of alcohol. A
stand by mode was also utilized to avoid lengthy warm up times.
68 EN Series
The latest of the Intoxilyzer 5000 series was introduced around the turn of the century. This model
is much like the 68 series. Wiring was re-routed to the mother board; the sample chamber end
blocks were re-designed. These improvements were targeted to facilitate maintenance and repairs.
A newer, more reliable printer was also used.
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Intoxilyzer 8000
The Intoxilyzer 8000 was recently released. It is not intended to replace the 5000 series. It was
designed to be more portable and rugged for use out in the field. It can operate on 12 volts or 110
volts. It is encased in high impact ABS plastic and has no moving parts inside. It also uses a less
fragile light source. It uses infrared spectrometry in the 3 and 9 micron range.
Preliminary Breath Testers
As previously mentioned, these devices were not intended to be part of the formal study. They were
only used to verify that the fuel cell technology that they employ could also be reliable when used
properly. Both of these instruments utilize a fuel cell to detect and quantify alcohol.
Neither of these devices is considered as evidence. They do not employ safeguards against possible
interferences as the 5000 or 8000 series Intoxilyzer. They are also sensitive to fluctuations in
temperature.
These are hand-held testers. They are intended to be used at road side, as a sobriety test or to show
the presence of alcohol.
S-D2
This is the predecessor of the S-D5. This particular instrument has recently been used for training
purposes only. The accuracy of the calibration had not been recently checked. Subsequent to this
study it was checked and found to be reading low, by approximately 0.015 grams/210L.
S-D5
This instrument is smaller, and more automated than the S-D2. It has a larger digital display and is
easier to operate.
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APPENDIX 2
Amount of Alcohol Consumed By Each Subject
A = Amount of pure alcohol consumed
A = (Volume of alcoholic beverage) (proof-200) (density of alcohol)
Female A
Volume of alcoholic beverage consumed = 4 ounces of Vodka
Proof of alcoholic beverage = 80
A = (4) (80-200) (0.79) = 1.3 ounces
Female B
Volume of alcoholic beverage consumed = 7 ounces of Rum
Proof of alcoholic beverage consumed = 70
A = (7) (70-200) (0.79) = 1.9 ounces
Female C
Volume of alcoholic beverage consumed = 7 ounces of Rum
Proof of alcoholic beverage consumed = 70
A = (7) (70-200) (0.79) = 1.9 ounces
Male A
Volume of alcoholic beverage consumed = 6.5 ounces of Vodka

Proof of alcoholic beverage consumed = 80
A = (6.5) (80-200) (0.79) = 2.1 ounces
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MaleB
Volume of pure alcohol consumed - 9 ounces of whiskey
Proof of alcoholic beverage = 80
A = (9) (80+200) (0.79) = 2.8 ounces

MaleC
Volume of alcoholic beverage consumed = 6.5 ounces of whiskey
Proof of alcoholic beverage consumed = 80
A = (6.5) (80-200) (0.79) - 2.1 ounces
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APPENDIX 3
Data from subject Male A 1 80 lbs
;
Drinking began at:
9:40
Completed drinking at:

Time 9:40
10:28
10:38
10:40
~10:41
10:43
10:45
10:48
11:07
11:08
11:10

J 1 -11
11:13
11:22'
11:24
U :25
11:28
11:31
11:33
11-38
11-40
11:41
11:43
11:44
11:52
11:53
11:55
11:58
" 12:00
12:06
12:07
12:08
12:09
12:10
12:22
12:23
12:24
12:25
12:27
12:30
12:37
12:38
12:39
12:40
12:41
12:53
12:54
12:55
12:56
12:57
13:08
13:10
13:11
13:12
13:13
13:22
13:23
13:23
13:26
13:27
13:33
13:38
13:40
13:43
13:44
13:44

-a
CO

3*
o

Q.

d

-4

LU

i

Ela

!

3

CD
O

CD

000
:48
58
00
01
03
05
08
27
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30
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33
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:48
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53
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2:03
2:04
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2:15
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3:42
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4:00
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10:18 =

0
0 80
0.97
1.00
1.02
1.05
1.08
1 13
1.45
1.47
1.50
1.52
1.55
1.70
1.73
1.75
1.80
1.85
1.88
1 97
2.00
2 02
2.05
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2.47
2.48"
2.50
2.70
2.72
2.73
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2.78
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2.97
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3.02
3.21
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3.47
3.50
3.52
3.53
3.55
3.70
3.72
3.72
3.77
3.78
3.88
3.93
4.00
4.05
4.07
4.07

66 Series

68 EN

68 Series

0 025

SD2

8000

SD5

I

0 085

0 092

0 093J

,__ _]

0 092
0 095,
0 089
0 097
0 109
0 111
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_ .
' 0.104
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0.091 -

0 108'
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1

j
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!
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APPENDIX 3
115
lb.;
;
9 35
J . ^5P m P' e * : _ e d drinking at 1 0:30 [

Data from subject Female A
Drinking began at:
o
c

52
o
o

31
Q.

Time

3

3
3"
CD

:6 Series 68 Series

68 EN

SD2

8000

SD5

CD

10:11
10:23
10:24
10:26

10:29
10:32
10:32|
10:40;
10:42'
" 10:43*
10:45~
10:55
10:56
10:57
10:58
J 1:02
11:10
11:11
11:12
11:13
J 1:25!
1T:26~
11:27'
11:30
11:30
11:40
11:41
11:42
11:43
11:44
11:55
11:56
11:57
11:59
12:00
12:10
12:11
12:12
12:13
12:25

" 12:26
J 2:27
12:29
12:40
12:41
12:42
12:44
12:55
12:56!
12:57
12:59!
13:00*
13:10
13:11:
13:12
13:14
13:13
13:14

0:36
0:48
0:49
0:51
0:54
0:57
0:57
1:05

J:07l
1:08:
1:10:
1:20*
1:21
1:22*
1:23
1:27 :
1:35
1:36
1:37;
1:38j

T:50l
1:51'
1:52;
1:55*
1:55*
2:05
2:06,
2:07 ;
2:08^
2:09i
2:20 r
2:21!
2:22^
2:24 !
2:25i
2:35.
2.36
2:37
2:38
2:50
2:51
2:52
2:54^
3:05'
3:06*
3:07'
3:09
3:20~
3:21."
3:22
3:24
3:25
3:35
3:36
3:37*
3:39
3:38
3.39

0.60
0.80|
0.82 :
0.85!
0.88;
0~95J
0.95!
1.081.
1.12J.
1.13 0.068:
"1.17J
1.33;
1.35
1.37 0.065
1.38 !
1.45'
1.58f

0.061

l 0.075I
| 0.074
I

T

2.37;
2.40!
2.42:
2.58i
2.60
2.62
2.63
2.83*
2.85
2.87
2.90J
3.08*
3.10
3.12
3.15;
3.33*
3.35,
3.37
3.40'

0.083;

[~

0.077 !
0.071 i

I

i

j

!

''• 0.075 :
0.082

I

!

'

1"
1 "
:

y
r

0.075.

0.073 T

0.074
J

0,075]
0.077

0.069!

1.601
1.62 T 0.065^
1.63;
1.83 1
1^85f
1.87J 0.057
1.92!
1.93J
2.08 j
2.1 0:,
2.12: 0.05
2.131
2.151
2.33!
2.35 1

]
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1
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APPENDI X 3
Data from subject Female C
Drinking began at:

180
9:34

}
lb!
Co mpleted drinking at: 10:201
j

\

i

X
0

c

m

a

•o
CO
Q.
•H

Time

3'
CD

9:34! 0:00
10:35! 1:01
1:06
10:40
10:42
1-08
10:44
1:10
10:45
1:11
10:57
123
1:24
10:58
1:26!
11:00
11:02
1:28!
11:14
1:40!
11:16
1:42:
1:43
11:17
11:18
1:44
11:27 " 1:53
11:33
1:59
11:34
2:00
11:35
2:01
2:03
11:37
2:14!
11:48
2:16
11:50
2:18
11:52
11:53
2:19
2:30 "'"*
12:04
2.32
12:06
2:33
12:07
2:35
12:09
2:48
12:22
2:50
12:24
12:25 "2:51
2:531
12:27
12:28
2:54^
3:06
12:40
3:08
12:42
3:09
12:43
12:45
3:11;
12:58
3:24
3:25
12:59
3:26 ; "
~ 13:00
3:27
13:01
13:17! 3:43
13:18
3:44^
13:19
3:45
3:47 1
13:21
3:59!
13:33
4:01
' 13:35
13:36
4:02
4:03
13:37
'> 13:38 4:04|

•

!

0

;

j

3
3
0

-|

|

66 Series

0.00:
1.02!
1.10!
1.13
1.17
1.181
1.38|
1.401
1.43i
1471
1.67!
1.70!
1.72!
1.731
1.88:
1.98
2.00!
2.02
2.05i
2.23!
2.27:
2.30!
2.32
2.50!
2.53'
2.55
2.58'
2.80:
2.83i
2.85;
2.881
2.90I
3.10!
3.13;
3.15
3.18
3.40!
3.42!
" 3.43!
3.45
3.72
3.73
3.75!
3.78!
3.98;
4.02i
4.031
4.051
4.07!

68 Series
i
i
0

0

8000

68 EN
0

SD5

SD2

CD
O
O
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>

O
O
3"
O

0
0.072

l_0

|
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|
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1
1

j
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i
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1 0.088

j

\

1
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,

|
I

i
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-j
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! 6.089
i

0.08

;

! 0.084
j

0.08^

—[••-
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-

!

6.077

i
I
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i
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!
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•
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~p -
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I

i
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• • •
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j
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|
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i

0.048
I
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|
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•
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!
j
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i
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APPENDX 4

Female A

0.00

1.00

3.00

2.00
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-•— 66 Series

68 Series —*— 68 E N — i — 8000

Blood

Female B
0.12

0.00
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0.14
0.12

BAC

0.1
0.08
0.06
0.04
0.02
0
0.00

1.00

2.00

3.00

4.00

5.00

H ours
- • — 6 6 Series

68 Series —-*—68 EN — I — 8 0 0 0

Blood

MaleC
l

0
1
VJ. I
N^fe*^

0.08 -

o
<

I

0.06

I

0.04

\

0.02
0 *
0.00

,)

1.00

2.00

3.00

4.00

5.00

Hours
-•—66 Series

68 Series —*— 68 EN —4—8000

21

Blood

APPENDIX 5
Linear Regression Analysis and Coefficient of Correlation
As An Indicator of Precision or Reproducibility
If one plots data points from two related variables, and obtains a straight line, then there is a linear
relationship between the two variables. From many studies it is known that during the elimination
curve of alcohol from blood that alcohol level decreases almost perfectly linearly with time. This
relationship can be predicted with an equation:
Y = mx + b
Y = alcohol level
x = time (in hours since drinking stopped)
b = the theoretical blood alcohol level at the time drinking stopped assuming that
all of the alcohol had been absorbed from the GI tract
m = the slope or elimination rate of alcohol in %/hr
In actual measurements (see Appendix 4) the plot of points of alcohol level and time do not quite
lie in a straight line. The average difference from the best-fit line and actual observation can be
assumed to be mostly due to error in measurement. The regression (analysis which is a complex
formula that is calculated on a computer or special calculator) finds the equation of the best-fit line
between the points, Y = m x + b, as described above.
The coefficient of correlation, R, is then calculated which tells how well the measured points fit the
calculated straight line. When R = 1.00, the points fall on the line. When R = 0, the points are
random and there is no linear relationship between them. The linear regression calculations (shown
in Appendix 5A) were made for the six subjects using five different instruments to measure the
linearity of the elimination phase. The calculated constants, m (elimination rate), b (theoretical
time zero blood alcohol level) and R (the coefficient of correlation).

22

All five of the instruments show an average R close to 1.00. The direct blood alcohol by GC shows
the highest R value indicating the best overall reproducibility of measurements. The
reproducibility of the Intoxilyzer 8000 is comparable to the other breath instruments.
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APPENDIX 5A

t
UBJECT Statistic

em A

em B

m
b
R
m
b
R

!
i

I

i

INSTRUMENTATION !
i
INTOXILYZER INTOXILYZER INTOXILYZER
INTOXILYZER GAS CHROMATOGRAPH
5000 68
5000 66
5000 68EN_
HP 5890 II
8000
|
Mean
0.019
0.023
0.023;
0.02
0.021
0.02
0.084
0.097
0.097
""0:693
0.093^
!
6.094
-0;gg42
0.9872
0.9973
0.9997
6.989!
i. 0.9978
!
i
0.019!
0.02
0.016!
0.017
6.017
0.018
0.114
0.111!
0.102!
0.112
0.116
0.111!
0.9517
0.9637!
0.9579
0.9701
0.9998
0.9687'

I
i

i

!

i.

m
em C

|b

R

0.023
0.116
0.9924

0.022
0.115
0.9897

0.022
0.112
0.9862!

|

o.6ieT

0.019
0.114
0.9702

6.106
0.9851

0.021
~0'.Tl3
0.9847!

0.03

0.024

0.029

0.994

6.984

0.9882

0.021
0.123
0.9917!

6.018
0.125H
0.9972

0.021
0.119
0.9914

0.028
6.127
6.9928

0.024
6.118
0.9986

0.029
0.126
0.9947

0.9861

0.9941

!
m
b
R

0.9833

lale B

m
b
R

0.021
0.112
0.9991

0.026
6.125
0.9961

0.02
6.112
•6.9732

dale C

m
b
R

0.031
0.127
0.9925!

6.032!
0.131 i
0.99621

6.031
6.125!
6.9936

0.9844

0.9891 j

laleA

0.033

0.029

!

0.028

i

0.9916

I
0.9883

I

h

!
i

I
yayerag e

0.9814

j

ly instrunlent)
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APPENDIX 6
Determination Of Alcohol Elimination Rates From The Blood
In Appendix 5 the formula Y = mx + b is the equation for the plot of blood alcohol levels with
time (in hours) for the elimination phase of the blood alcohol curves. In this equation "m" is the
slope or disappearance rate (%/hour) of alcohol in blood.
These rates were calculated in Appendix 5 and shown below with an average for each subject:
Rate of Blood Alcohol Elimination In % Hour

Instrument:

5000 66

5000 68

5000 68EN

8000

GC

Average Rate

Female A

0.019

0.023

0.023

0.020

0.020

0.021

Female B

0.020

0.019

0.016

0.017

0.017

0.018

Female C

0.023

0.022

0.022

0.019

0.018

0.021

Male A

0.033

0.029

0.028

0.030

0.024

0.029

MaleB

0.021

0.026

0.020

0.021

0.018

0.021

MaleC

0.031

0.032

0.031

0.028

0.024

0.029
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APPENDIX 7

Pa
See Appendix 2 for "A" the amount of alcohol each subject drank and for "p" the body weight of
each subject.
"a", the theoretical blood alcohol of time zero (time when drinking stops, and assuming that the
alcohol was all absorbed and distributed throughout the body), is the "b" constant calculated in
Appendix 5 in the equation Y=mx+b
The calculation for the Widmark factor

are shown below for each of the subjects:

Female A:

r=

1.3 oz
= 0.75
(115 lbs) (16 oz./l lbs) (0.093 gm/100 ml)

Female B:

r=

1.9 oz
(214 lbs) (16 oz/1 lb) (0.118 gm/100 ml)

=0.49

Female C:

r=

1.9 oz
(1801bs)(16oz/l lb) (0.113 gm/100 ml)

=0.58

Male A:

Unable to calculate r because this subject had a positive blood alcohol level prior to
beginning the drinking study.

Male B:

r=

2.8 oz
(213 lbs) (16 oz/1 lb) (0.119 gm/100 ml)

= 0.69

Male C

r=

2.1 oz
(156 lbs) (16 oz/1 lb) (0.126 gm/100 ml)

= 0.66
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ABSTRACT: The rate of disappearance of alcohol from the blood
O-slope) was determined in drinking drivers by taking two blood
samples about 60 min apart (mean 68 min, span 30 to 120 min).
The results were compared for men and women as a function of
their age and the prevailing Wood-alcohol conccmrarion (BAQ.
The material consisted of 1090 double blood samples from 976
men and 114 women with mean age 36.6 ± 12.9 y (± SD) and
38.0 ± 123 y ( i SD),respectively.The mean BAC for the male
DUI suspects was 1.88 ± 0.748 xng/mL (± SD) compared with
1.86 ± 0.702 (± SD) fot the females. Therelationshipbetween
p-slope (y) and BAC (x) was y = 0.175 + 0.009.x with a small
positive correlation (r = 0.13) and standard error estimate (SyJ of
0.049rag/rnL.The mean f^-slope for female DUI suspects was
0.214 ± 0.053 mgfmUh (± SD), compared with 0.189 ± 0.048
mg/mL/h in the male suspects, and this small difference was
statistically highly significant (r - 5.21, p < 0.001). The overall
mean rate of alcohol elimination from blood in drinking drivers
was 0.191 ± 0.049 mg/mL/h (± SD), and the 95% limits of
agreement (LOA) spannedfrom0.09 to 0J29 mg/mL/h. The value
of the £-slope was slightly steeper starting from a high initial
BAC but was not much influenced by the person's age.
KEYWORDS: forensic science, forensic toxicology, alcoholics,
analysis, Mood-ethanol, (Aslope, ethanol metabolism, elimination,
drunk drivers, pharrnacokinetics
The rate of disappearance of alcohol from the blood O-slope)
is an important parameter with special significance whenever the
pharniacokinetics of ethanol are considered (1). The p-slope, which
is sometimes referred to as the alcohol bum-off rate, has been
much discussed and debated in litigation concerning driving under
the influence of alcohol (DUI), particularly when forward or backward extrapolations of a person's BAC are required by law (2-4).
The customary way to determine the £-slope involves making
controlled drinking experiments with healthy volunteers who consume a known moderate amount of alcohol on an empty stomach
(5-7). From the BAC measurements made every 30 to 60 min
,
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during the postabsorptive phase, the rate of disappearance of alcohol from the bloodstream is easily calculated (7). Many studies
have shown that the mean P-slope for moderate drintes is between
0.10 and 0 2 0 mg/mL/h (mean 0.13 to 0.15 mg/mLVh) when the
dose of alcohol is consnmed in the morning after an overnight
fast (5,7,8). Women tend to have a slightly steeper p-slope compared with men according to several controlled studies (5,6,9,10).
It is widely known that heavy drinkers and alcoholics develop
metabolic tolerance during a drinking binge and alcohol is eliminated faster compared with those who only drink occasionally
(10-14). One recent study in chronic alcoholics undergoing detoxification reported a mean P-slope of 022 mg/mL/h with a range
from 0.13 to 0 3 6 mg/mL/h (11). This faster rate of ethanol disposal
in recently drinking alcoholics stems from microsomal enzymes
(P4502E1) being engaged in the oxidation processes in addition to
hepatic class I alcohol dehydrogenase (ADH) (3,15). The P4502E1
system has a higher kn for oxidation of ethanol (0.60 to 80 mg/
mL) compared with ADH (0.05 to 0.10 mg/mL) and, more
importantly, the microsomal enzymes become more effective after
a period of heavy drinking as a result of an increased synthesis
of the enzyme (16,17). However, after a few days of abstinence,
it seems that alcoholics lose their ability to bum off alcohol faster
than moderate drinkers (18-20).
The P-slope in drinking drivers has never been determined in
an unequivocal way, that is, by evaluating BAC profiles for a large
segment of the postabsorptive period. Instead, {^-slopes in drinking
drivers have been estimated by taking two blood samples about
60 min apart ( 2 1 ^ ) . The results obtained in this way reflect the
disappearance rate of alcohol from the blood over the time period
studied, and the existence of 2Kro-ordef or saturated MichaelisMenten kinetics means that the P-slopes should
the same
for most of the postabsorptive period (3,7,21,22). However, not
all DUI suspects will have reached the postpeak phase at the time
of taking blood samples, and relatively shallow P-slope, or no
change in BAC at all, might be observed (3). Others might find
themselves on a BAC diffusion plunge when the first sample of
blood was taken leading to an abnormally high value for the
p-slope (3,21). Nevertheless, by examining a sufficiendy large
material of double blood samples, a reliable estimate of the mean
velocity of alcohol elimination from the bloodstream can be
obtained in DUI suspects.
In this paper, we have determined ibe rate of alcohol elimination
from blood O-slope) in over 1000 individuals apprehended for
DUI in Sweden. The results were evaluated as a function of the
person's age, gender, and the prevailing blood-alcohol concentration.
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irial and Methods

kiope = (BAC, - BAQO/fe - t{)
Jl original BAC values were converted from milligram/gram
centration units to milHgram/iiullilitre units by multiplying
h result by 1.055, which is the average density of whole blood,
i statutory alcohol limits for driving in the Scandinavian couns and in Germany are defined in terms of weight of alcohol
weight of whole blood (mg/g or g/kg). The average time
ween taking thefirstand second sample of blood was 68 min
nning from 30 to 120 min. The vast majority of double blood
aples (75%) were obtained between 47 and 84 min apart
suits
rhe mean age of the 976 men was 36.6 ± 12.9 y, and this was
: significantly different from die 114 women 38.0 ± 123 y (r
0.73, p > 0.05). The age distributions are shown in Fig. 1 in
ich it can be seen that the age of the men tended to peak between
: ages 20-29 years (29%) and then tail off towards die age of
years. By contrast, women showed no marked peak in their
5 distribution but were more inclined to be middle aged when
prehended for DUL The proportion of female suspects aged
-50 years was 29% compared with 21% in the male DUL
spects.
The frequency distribution of ^-slopes is shown in Fig. 2. The
san was 0.191 mg/mL/h, standard deviation 0.049, coefficient
variation 25%, skewness 0.647, and kurtosis 2.17 indicating a
trfy good overall fit to the normal distribution. Tlie mean {Jjpe in men was 0.189 ± 0.048 mg/mUh (N = 976) compared
ith 0.214 ± 0.053 {N = 114) for the women, and this small
Oder-related difference was statistically highly significant (r =

1 5 - U 20-2* 25-29 SO-M 3 S - » 4©-<U 45-49 SO-S4 SS-59 GO-W tS-*9

Age group, yr
FIG. 1—Frequency distribution ofagefor male andfemale DUI suspects
apprehended in Sweden.
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le police authorities in Sweden frequently take two separate
>Ies of venous blood from drinking drivers, particularly if the
ir is not arrested at the wheel and therefore has the opportunity
aim drinking alcohol after driving. Alleged drinking after the
ise, the hip-flask ploy, is a common defense tactic in Sweden
tell as in other countries (23). The allegation of drinking
the offense might be confirmed or challenged depending on
her the BAC increases or decreases between the times of
5ling blood. However, interpreting the position of the BAC
e based on only two randomly timed specimens of blood is
gilt with difficulties and is not a recommended practice (3).
atheless, the police persisted with submitting double blood
imens for quantitative determination of alcohol. The first sam>f blood is normally taken about 60 to 90 min after the person
rested for DUL
J
t collected together the resultsfromanalyzing a large number
ouble blood samples at the National Laboratory of Forensic
mistry in Linkoping, Sweden. When the BAC in the first
pie was below 020 mg/mL or above 3.5 mg/ml., these specis were eliminated leaving a total of 1090 double blood samples
l 976 men and 114 women. The concentration of alcohol in
>d samples was determined by headspace gas chromatography
described elsewhere, and the coefficient of variation of the
bod of analysis was less than 1% (24). This high analytical
dsion means that the changes in BAC over time are not conlded by inherent analytical sources of variation (25). The mean
riplicaxe determinations on each blood specimen was used to
ulate the {Aslope as follows:

5 0 -J

0 -

I 0r , ,.,0.05
f PI0.20
T - r l0.10
| l P0.15

0.25

030

035

0.40

B-slope mg/ml/h
FIG. 2—Frequency distribution of the raze of disappearance of alcohol
from blood ($-slope) in drinking drivers as derived from analysis of two
blood samples taken approximately 1 h apart

521 p < 0.001). There were 24 individuals with ^-slopes less
than 0.10 mg/mL/h (mean 0.074), and BAC in the first sample of
hlood was 221 mg/mL on average, being significantly higher than
the mean of 1.87 mg/mL for the material as a whole.
Figure 3 shows the p-slopes plotted as a function of age for
male and female DUI suspects separately. The women maintained
a faster rate of disappearance of alcohol from blood in all age
groups studied. Table 1 gives a more detailed breakdown of £slopes as a function of age. The 95% limits of agreement gives a
good indication of the magnitude of variation within each age
group. However, for some age groups, there were not enough
women to allow making this calculation.
Figure 4 shows a scatter plot of p-slope plotted against BAC
in the first blood sample. A very weak correlation was found
(r = 0.13) which speaks against any strong association between
burn-off rate and BAC. The regression equation was y (p-slope)
= 0.175 + 0.009x (BAC). Table 2 presents a more detailed breakdown of ^-slopes according to BAC subdivided at intervals of 0 J
mg/mL. The mean £-slope was slightly steeper when the mean
BAC was above 1.0 mg/mL compared with below 1.0 mg/mL.
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Relationship Between Age and B-slope
for Male and Female Drinking Drivers
0.3a

y = 0.175 + 0.009x
0.5
•0.30
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FIG. 3—Rate of disappearance of alcohol from blood in male and
female drinking drivers plotted as a function of their age.

TABLE 1—Disappearance rate of alcohol from blood ($-slope)
arranged according to the blood-alcohol concentration for men
and women drinking drivers. Values for eight male subjects with BAC
> 3J mg/mL were omitted.
Span of
BAC
mg/mL

Subjects

Men
Women
Total
03-0.99 Men
Women
Total
1.0-1.49 Men
Women
Total
13-1.99 Men
Women
Total
2.00-2.49 Men
Women
Total
230-2.99 Men
Women
Total
3.00-3.49 Men
Women
Total
0.O-0.49

Number of
Specimens
27
5
32
81
8
89
147
10
157
224
31
255
252
31
283
146
24
170
91
5
96

95% Limits
£-slope mgfmUh
of
Mean 2. SD Agreement
0.165
0.159
0.163
0.172
0.185
0.173
0.183
0.211
0.185
0.191
0.223
0.195
0.189
0.217
0.192
0.194
0222
0.198
0207
0206
0207

± 0.030
± 0.030
a: 0.029
± 0.035
£ 0.028
± 0.035
± 0.042
± 0.038
± 0.043
± 0.050
± 0.050
± 0.051
± 0.043
± 0.055
± 0.045
± 0.049
± 0.059
* 0.052
± 0.062
± 0.064
± 0.064

0.105-0225
0.099-0219
0.105-0221
0.102-0242
0.129-0241
0.103-0243
0.099-0267
0.135-O287
0.099-0271
0.091-0291
0.123-0303
0.093-0297
0.103-0275
0.107-0327
0.102-0282
0.096-0292
0.104-0340
0.094-0302
0.083-0331
0.078-0334
0.079-0335

Discussion
• The very high mean BAC in both the male (1.88 ± 0.748 mg/
mL) and the female DUI subjects (1.86 ± 0.702 mg/mL) indicates
that these individuals have problems with their drinking, and many
are chronic alcoholics. This suggests that the ^-slopes in DUI
suspects should agree more closely with values seen in alcoholics
during detoxification rather man in healthy volunteers who participate in controlled drinking studies in the laboratory (3,11).
In the present work, we have assumed that all individuals have
reached the postpeak stage of alcohol metabolism at the time of
lairing the first blood sample. This assumption is not unreasonable
considering that about 94 min had elapsed after they were apprehended for DUL This is also supported by hundreds of bolus
dose drinking experiments and a few controlled studies involving

0.1 H

. :%

* * ^m \

1.0

*•!

2.0

• • :•

3.0

4.0

Blood Alcohol, mg/ml
FIG. A—Scatter plot of the rate of disappearance of alcoholfrom blood
($-slope) as a function of the mean blood alcohol concentration. The
regression line (solid) and 95% limitsfor a single new observation (broken
lines) are shown.

prolonged heavy drinking (26,27). The {S-slope was less than 0.10
mg/mL/h for 24 individuals (22%), and this might indicate a slow
absorption phase or reaching a BAC plateau during the sampling
interval. Accordingly, these shallow ^-slopes are not accurate estimates of the rate of disappearance of alcohol from blood because
absorption and distribution of alcohol are probably incomplete (3).
The position of the blood-alcohol curve when drinking drivers
are apprehended has never been determined in an unequivocal
way, that is, by taking a long series of consecutive samples of
blood or breath. However, Zink and Bernhardt (27) conducted an
interesting study in which people drank huge amounts of alcohol
for 6 to 10 h and venous blood was sampled during and after
drinking at 15 mm intervals. This kind of prolonged ingestion of
alcohol should resemble the drinking habits of many DUI suspects
who eventually reach very high BAC. The results of the study
showed that most subjects had already reached their peak BAC
before finishing the last drink, and all of them had peaked within
50 min after end of drinking. Unless a DUI suspect consumes
alcohol when stiH driving, it is safe to assume that the peak BAC
has been reached by the time samples of blood are taken for
forensic purposes. The {J-slopes reported here are therefore reliable
estimates of alcohol bum-off rate in this population of heavy
drinking men and women.
The small gender-related differences in ^-slopes for DUI suspects support earlier results from several controlled drinking experiments in men and women as was first reported by Widmark (5)
and later confirmed by Osteriind et aL (6). It is important to realize
that the magnimrie of the £-slope not only reflects the activity of
alcohol-metabolizing enzymes, but also depends to some extent on
the volume of distribution of alcohol and therefore the proportion of
body water (14). Those people with a relatively small volume of
distribution, e.g., women compared with men or elder men compared with younger men tend to have slightly steeper ^-slopes
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kBLE 2—Rate of disappearance of alcohol from blood (fi-slope)
ranged according to the age of male and female drinking drivers.
Values for eight men aged over 70 years were omitted

rs

Subjects

Number
of
Specimens

19

Men
Women
Total
Men
Women
Total
Men
Women
Total
Men
Women
Total
Men
Women
Total
Men
Women
Total
Men
Women
Total
Men
Women
Total
Men
Women
Total
Men
Women
Total
Men
Women
Total

60
7
67
158
14
172
126
11
137
129
16
145
120
' 11
131
108
17
125
103
16
119
81
11
92
40
8
48
25
1
26
16
2
18

1

24
29
34
•39
44
-49
-54
-59
-64
-69

{Aslope mg/mUh
Mean ± SD
0.172 ± 0.039
0.181 ± 0.031
0.173 ± 0.038
0.179 ± 0.037
0.196 ± 0.041
0.181 ± 0.037
0.177 ± 0.044
0.222 ± 0.051
0.181 ± 0.046
0.193 ± 0.054
0.214 ± 0.053
0.195 ± 0.055
0.199 ± 0.051
0.213 ± 0.034
0.201 ± 0.050
0.193 ± 0.043
0.209 ± 0.074
0.195 ± 0.048
0.195 ± 0.052
0.237 ± 0.059
0.201 ± 0.055
0.196 ± 0.053
0J210 ± 0.032
0.198 ± 0,051
0.194 ± 0.050
0.233 ± 0.061
0.201 ± 0.054
0.195 ± 0.053
0.275 + + + + +
0.198 ± 0.054
0.193 ± 0.071
0.178 + + + + +
0.191 ± 0.074

95% Limits
of
Agreement
0.133-0211
0.119-0.243
0.097-0249
0.105-0.253
0.114-0278
0.107-0.255
0.089-0.265
0.120-0324
0.089-0273
0.085-0301
0.108-0320
0.085-0305
0.097-0301
0.145-0.281
0.101-0301
0.107-0.279
0.061-0357
0.099-0.291
0.091-0.299
0.119-0355
0.091-0311
0.090-0302
0.146-0^74
0.096-0300
0.094-0294
0.111-0355
0.093-0309
0.089-0301

+++++
0.090-0306
0.051-0335
+++++
0.043-0339

4,28). A given concentration of alcohol in blood can seemingly
s cleared fester from a smaller volume than from a larger volume,
bis suggests mat the product of £-slope and volume of distribution
Vidmark's *Y*) should be approximately the same regardless of
JX and age (2&-30).
The finding of steeper £-slopes in drinking drivers (0.19 mg/
iL/h) compared with moderate drinkers (0.13 to 0.15 mg/mL/h)
» easily explained by overrepresentation of heavy drinkers and
Icoholics among the DUI suspects. These individuals have
cquiied an enhanced capacity to dispose of ethanol because micrownal enzymes (P4502E1) are activated as a consequence of reguir heavy drinking. When the initial BAC was below 1.0 mg/mL,
ae average £-slope was 0.175 ± 0.0364 (N = 155) compared
with 0.194 ± 0.0257 (N = 935) when the BAC exceeded 1.0 mg/
aL; tins difference was statistically highly significant (t = 7.9,
> < 0.001). Those apprehended" DUI suspects with BAC less than
.0 mg/mL might have been engaged in moderate acute intake of
ilcohol without the P4502E1 en2ymes becoming boosted. This
»uld explain the smaller ^slopes at relatively low BAC compared
vith those having very high initial BAC because of prolonged
aeavy drinking.
The rate of disappearance of alcohol in DUI suspects based on
double blood samples has been investigated in several earlier studies (31-33). The overall results from evaluating several thousand
DUI suspects agree well with the average £-slope of 0.19 mg/mL/
h reported here. In conclusion a mean p-slope of 0.19 mg/mL/h
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can be considered a reliable average value for the disappearance
rate of alcohol in this population of drinkers (DUI suspects). However, because of individual variations in activity of alcohol metabolizing enzymes, the 95% limits of agreement could span from
0.09 to 0.29 mg/mUh. These limits should be used when expert
witnesses are asked to speculate about a person's BAC some time
before sampling blood. Reports of very low ^-slopes ( < 0.08 mg/
mL/h) probably reflects some weakness in tbe experimental design
such as giving a very low dose of alcohol, insufficient number
of blood samples, existence of a prolonged absorption phase, or
distribution plateau.
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INFLUENCE OF SEVERAL FACTORS ON BLOOD ALCOHOL
CONCENTRATIONS AFTER DRINKING ALCOHOL
N. A. PIKAAR, M. WEDEL and R. J. J. HERMUS
TNO-CIVO Toxicology and Nutrition Institute, Department of Nutrition, P.O. Box 360, Zeist, Netherlands
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Abstract — The influence of several factors on the blood alcohol course after drinking diluted
ethanol was studied in young, healthy volunteers under strictly standardized conditions. These
factors were sex, dose and concentration of the alcohol, physical exercise immediately after
drinking, meal consumption before drinking and energy content and composition of the meal. In
18 blood samples, taken within 6 hr after alcohol ingestion, blood alcohol concentration (BAC)
was determined enzymatically. Concomitantly breath analyses were performed. In general, both
methods gave similar results. Peak concentration and area under the blood alcohol curve increased with increasing dose. With the same amount of ethanol, peak concentration and area
under the curve tended to be greater in women than in men. Consumption of a meal had an
attenuating effect. The area under the curve was smaller after a high-energy meal than after a
low-energy meal. Peak concentration depended on meal composition, increasing in the order
high protein < high sucrose = high complex carbohydrate < high fat. A similar trend was
observed for the area under the blood alcohol curve.

INTRODUCTION
Drinking alcoholic beverages results in a rapid
increase of the blood alcohol concentration
(BAC). After having reached a maximum
value the BAC returns slowly to the basic
level. The course of the alcohol concentration
in time (the alcohol curve) depends on drinking conditions. Insight into the factors influencing the alcohol curve is important because of its
potential consequences for metabolism and the
implications for health.
Several studies revealed as relevant factors
the dose (Haggard et al., 1938, 1941; Wagner et
al, 1976; O'Neill et al, 1983) and the concentration (Haggard et al, 1938; O'Neill et al,
1983) of the alcohol ingested, the consumption
of a meal (Haggard et al., 1938, 1941; Lin et al.,
1976; Sedman et al., 1976; Welling et al., 1911;
Wilkinson et al., 1977), the composition of the
meal (Lin et al., 1976; Sedman et al., 1976;
Welling et al, 1911 \ Wilkinson et al, 1977),
and the time of drinking relative to the consumption of a meal (Lin et al., 1976; Wilkinson
et al., 1977). The elimination of ethanol from

the blood is probably enhanced by fructose
(Sprandel et al, 1980; Meyer et al, 1982).
Other factors that could influence the BAC are
sex or body composition (Marshall et al, 1983;
Goist and Sutker, 1985) and physical exercise
(Barnes etal, 1965; Krebs et al, 1969; Schiirch
et al, 1982; Sautier etal, 1982). The variables
frequently used for characterizing the alcohol
curve are the peak concentration (c p e a k ), the
peak time (/peak)* the area under the blood
alcohol curve (AUC) and the time it takes until
the alcohol concentration has returned to a
pre-selected value (tx). The variables are elucidated schematically in Fig. 1.
In the studies cited above experimental conditions varied widely or were marginally
defined. Moreover, the meals used were sometimes very different from current dietary habits
and the type of alcoholic beverages varied considerably between the studies. There is still uncertainty, therefore, as to the exact influence
of the factors.
The main purpose of this study was to investigate the influence of various factors on the
course of the blood alcohol concentration
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under strictly standardized but nevertheless
practical conditions The factors studied are
sex, dose, concentration, physical exercise and
several aspects of meal consumption In addition, breath analyses were performed to compare the results with blood alcohol data under
a large number of conditions
MATERIALS AND METHODS
Subjects
Ten male and ten female, apparently healthy
students (age 19-26 years) participated in the
study Body weight ranged from 55 to 71 kg in
females and from 65 to 83 kg in males Selection was based on moderate drinking habits
(regularly drinking a maximum average of 2
glasses of alcoholic beverage per day), abstinence from drugs and trustworthiness with
regard to instructions Written informed consent from all participants was obtained The
experiments were approved by the Medical
Ethical Committee of the Institute All subjects arrived after an overnight fast at the Insti-

The test solution used consisted of pure
ethanol diluted with water to the volume percentage required To avoid interference of (unknown) congeners in natural beverages we
only used pure ethanol instead of common
alcoholic beverages The amount of alcohol
per glass was 9 5 g To mimic the practical
situation of drinking, we applied equal doses
irrespective of the body weights of the subjects
The study consisted of two experiments in
which the effects of sets of explanatory variables (factors) on the course of blood alcohol
concentration were investigated We used a socalled factorial experimentation (Cox, 1958,
Cochran and Cox, 1957) to investigate the
effects of a set of factors simultaneously in one
study The treatments given to subjects were a
combination of levels of the different factors,
whereas the number of observations was equal
for each treatment Factorial experiments
have, compared to a s,eY\es ot cxpewments on
the separate factors, the advantage of greater
precision and enable dependencies of the
effects of factors (interaction) to be investigated, thus allowing a broader range of validity
(Cox, 1958) The variation between subjects
and between experimental days were controlled with Latin squares (Cochran and Cox,
1958)
Experiment 1
In the first experiment the effects of five factors were studied sex (male/female), dose (3/5
glasses), concentration (6/12/36 %, v/v) consumption of a meal before alcohol ingestion
(yes/no) and exercise performed immediately
after drinking (yes/no) The meal was standardized and consisted of bread, margarine,
cheese, marmalade and orange juice (1 9 MJ,
fat 28 en %, carbohydrate 59 en %, protein 12
en %) It was to be consumed within 20 mm
Exercise was performed on a bicycle ergometer
(men at 125 W, women at 100 W) for 1 hr,
immediately after drinking of the alcohol To
reduce the number of observations needed for
the experiment a fractional factorial design was
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applied in which only a suitable selection of all
possible treatments was used. Six men and six
women each received a treatment four times,
so that a total of 48 observations were made.
Experiment 2
In the second experiment the influence of a
meal on the course of the alcohol level in the
blood was further explored: the influence of
energy content (high/low), the composition of
the meal (high fat/high carbohydrate/high
protein/high sucrose), time of drinking (during
the meal/one hour after the meal) and sex
(male/female) on the alcohol curve were
studied. The alcohol dose was fixed at four
glasses. A low-energy meal consisted of 20%
and a high-energy meal of 30% of the recommended daily intake for healthy young men
and women with slight to moderate physical
activity (11.6 and 8.8 MJ respectively) according to the Nederlandse Voedingsmiddelentabel
(1983)- The proportions of fat, protein and
carbohydrate were the same for the meals with
a high and low energy content and for those
given to men and women. The proportions in
percentages of energy are shown in Table 1.
The total amount of fructose — free and as a
constituent of sucrose — expressed as a percentage of total carbohydrate intake varied
from 10 to 14 in the high-carbohydrate meals
and from 33 to 37 in the high-sucrose meals.
Each of four male and four female volunteers
received four different treatments, so that a
total of 32 observations were made.
Analytical methods
Venous blood samples were drawn by means

of a venacatheter at t = - 1 , 1, 10, 20, 30, 40,
50, 60, 75, 90, 105, 120, 150, 180, 210, 240, 270
and 300 min (t = 0 denotes the moment of alcohol ingestion). A protein-free filtrate was prepared by mixing 1 volume of blood with 1
volume of 7% (w/v) of perchloric acid, followed by centrifugation. The filtrates were
stored at 4°C and analysed for BAC the next
day, using an enzymatic method (Test Combination Boehringer Mannheim Nr. 123960).
In addition, the BAC was estimated indirectly
by analysing a breath sample with an Intoxilyser apparatus (CMI Inc., Minturn Colorado
U.S.A., Model 4011 AS), immediately after
drawing the blood. The first sample was
omitted because of presence of alcohol
in the mouth. The accuracy was checked by
using the accessory absorption filter. In addition, testing of air samples, equilibrated at
37°C with ethanolic standard solutions proved
to be satisfactory. The 18 BAC results describe
the change in time of the alcohol concentration
in the blood for each person on a single day. To
characterize this alcohol curve the following
variables were chosen: the highest alcohol concentration observed (c p e a k ), the time corresponding with c peak (f peak ), the area under the
time-alcohol curve estimated by the trapezoidal rule (AUC) and the time required for
the alcohol level to return to 0.3 g/1. (t0 3 ).
Statistical methods
The effects of the factors on the four variables in each of the two experiments were
evaluated by analysis of variance (ANOVA),
according to the designs described above
(Cochran and Cox, 1957). In the ANOVA, the

Table 1 Energy percentages of fat, protein and carbohydrate of
the meals in experiment 2

High
fat
Fat
Protein
Carbohydrate

52-54
20-22
26
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Type of meal
High
High
protein
carbohydrate
20
43-44
35-36

11
9-10
79-80*

High
sucrose
10
10
80f

*Free + bound fructose 10-14% of total carbohydrate
fFree 4- bound fructose 33-37% of total carbohydrate.
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main effects and interactions of the factors
were tested with F-tests. Interactions between
three or more factors were assumed to be
absent. Differences between the means of the
levels of factors were subsequently tested with
Mests, using the standard error of the difference between means (S.E.D.). The calculations were performed with the statistical
package GENSTAT (Alvers, 1977). One variable, the AUC for breath analysis in the first
experiment, was skewed and transformed by
logarithms whereby the means presented in the
table are geometrical means. Differences were
considered to be significant at P < 0.05.
RESULTS
The main results of experiment 1 are presented in Table 2 and those of experiment 2 in
Table 3. Tabulated are c peak , fpeak, A U C and
r0.3, obtained by blood and breath analysis. Significant interactions between the factors of
experiment 1 (regarding r 03 ) are presented
in Table 4, those of experiment 2 (regarding
Seak) in Table 5.
In experiment 1 alcohol dose and meal consumption show main effects for both blood and
breath analysis. A dose of three glasses
obviously results in lower values for c p e a k ,
A U C and t0 3 than does a dose of five glasses.
Having a meal before drinking the alcohol also
results in a lower c p e a k , a later / peak and a smaller AUC than when no meal is used. Also, in
breath analysis a later t03 was observed when
no meal was consumed. Alcohol dose and sex
show an interaction in the results for f0.3>
(Table 4). The f0 3 value, measured in blood is
significantly longer in women than in men, but
only after drinking of three glasses of alcoholIn breath analysis this holds true for both three
and five glasses.
In experiment 2 the main effects of energy
level and meal composition were observed in
both blood and breath analysis data (Table 2).
Values of c peak in women are higher than in
men, although there is an interaction with time
of drinking as will be discussed below. The
AUC and c peak are smaller after consumption
of a high-energy meal than after a low-energy
meal. Meal composition had a significant effect
on c peak and AUC in both blood and breath

analysis. The c peak value is lower after a highprotein meal than after one of the other three
types. High-carbohydrate and high-sucrose
meals do not differ significantly in their effect
on c peak but the peaks are clearly lower than
after a high-fat meal. The results for A U C
parallel this trend. The results for r0>3 in breath
are similar except for a significantly longer f0 3
after a high-carbohydrate meal then after a
high-sucrose meal. The c peak is affected by two
interactions: sex/time of drinking in both blood
and breath analysis and energy level/time of
drinking in blood analysis only (Table 5). The
difference in c peak between men and women is
greater for alcohol ingestion after a meal than
for ingestion during a meal (Table 5a); or, the
difference between drinking during and after a
meal observed in women was not found in
men. After a low-energy meal c p e a k is higher
than after a high-energy meal except in blood
analysis in the case of drinking during the meal
(Table 5b).

DISCUSSION
In two experiments the effects of a number
of factors on BAC were investigated as
measured by blood and breath analysis. In
general, the results obtained in blood and
breath analysis showed similar trends.
However, c peak as measured by breath analysis
was invariably higher and AUC was smaller
than in blood. This effect can be explained by
assuming that breath analysis results reflect
alcohol levels in arterial blood in the lung
whereas the blood analysis results are obtained
from venous blood samples. The effect of distribution on arterial blood alcohol levels is
probably less substantial than for venous blood
levels. In our study c peak as measured by breath
analysis was significantly higher when exercise
had been performed than without exercise.
These results are not supported by the blood
analysis data and are probably unreliable
because of the lack of equilibration between
arterial blood and breath alcohol due to rapid
respiration.
In conclusion, although systematic differences exist between blood and breath analysis
values, both can be used to evaluate the effect
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Table 2 Means of c peak , tpCdk, AUC and /0 3* per factor level, averaging the levels of the other
factors (experiment 1)
Breath analysis

Blood analysis
Dose
N = 24
Cpea\(g/1.)
'peak (hr)

AUC(g/l.hr)
'o 3 (hr)

3 glasses

5 glasses

0.44 d t
0.66
1 00d
2.08 a

0.73 b
0.91
2.43 b
4.09b§

Yes

No

0 51 a
0.96d
1.47a
3 02

0.66b
0.62 b
1.96b
3.15

Meal consumption

(0 04)$
(0.09)
(0.17)
(0 04)

3 glasses

5 glasses

0.49a
0.71
0.94d
1.92a

0.78 b
0.90
2.31 b
4.13 b

Yes

No

0.55a
1 05 a
1.41a
2.82a

0.73 b
0.56 b
1.85b
3.23 b

(0.05)
(0.08)

- II

(0 05)

N=24
Cpeak (g/L)
'peak (hr)

AUC(g/l.hr)
/o 3 (hr)
Concentration
N= 18

6%

12%

36%

Cpeak (g/L)
'peak ( h O

0.56
0.77
1.62
3.01

0.64
0.80
1.83
3.17

0.56
0.79
1.69
3.08

AUC(g/l.hr)
'o 3 (hr)
Sex
/V = 24
Cpeak (g/l-)
'peak (hr)

AUC (g/l hr)
'o 3 (hr)
Exercise
N = 24
Cpeak (gA.)
'peak (hr)

AUC (g/l.hr)
'n 3 (hr)

Men

Women

0.53
0.79
1.48
2.94a

0.65
0.79
1.95
3.23 b

Yes

No

0.58
0.84
1.68
3 15

0.59
0.74
1.75
3.02

(0.02)
(0 09)
(0 05)
(0.19)

(0
(0
(0
(0

05)
11)
22)
30)

(0.04)
(0.09)
(0.17)
(0 04)

(0.02)
(0.09)
(0.05)
(0.19)

6%

12%

36%

0.62
0.75
1.57
2.98

0 66
0.77
1.68
3.08

0.63
0.89
1.63
3.02

Men

Women

0.58
0.72
1.40
2.66a

0.69
0.89
1.85
3.39 b

Yes

No

0.58a
0.95
1.53a
2.96

0.70 b
0.66
1.72b
3.09

(0.02)
(0.10)

—

(0 12)

(0.07)
(0.08)

—

(0.24)

(0.05)
(0.08)

—

(0.05)

(0.02)
(0.10)

—

(0.17)

*For abbreviations, see text.
fMeans on one row for blood and breath analysis separately, not sharing a superscript are
significantly different at P < 0.05.
^Standard error of the difference between means.
interaction, see Table 4.
||No S.E.D. due to log transformation.

of the different factors on blood alcohol levels
except in situations of physical exercise.
After ingestion of the same amount of alcohol cpeak w a s mostly higher, AUC was larger
and t03 was longer in women than in men.
These parameters cohere in a logical manner.
However, in experiment 1 the differences in
c peak and AUC were not significant. Sex dif-

ferences did also emerge from experiment 2 in
which four glasses of alcohol were consumed.
This difference in response is probably due to
differences in fat-free mass and therefore in
distribution volume, women on the average
being lighter and having a higher percentage of
body fat. Both Marshall et al. (1983) and Goist
and Sutker (1985) observed a higher c p e a k and
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Table 3a. Means of cn ak, 'Peak> A U C and /o 3* per factor level, averaging the levels of
the other factors (experiment 2)
Blood analy sis
Sex
N= 16

Men

Women

0.43af
1.68
1.30
2.76

0.63 b §
1.83
2.01
4.43

Energy level
N= 16

High

Low

cpCak(g/l-)

0.48*
1.69
1.47d
3.36

0.57b§
1.82
1.84b
3.84

Time of drinking
/V= 16

During

After

Cpeak(g/l.)
'peak (hr)

0.51
1.68
1.61
3.42

0.54
1.83
1.70
3.77

Cpeak(g/1)
'peak (hr)

AUC(g/l.hr)
'o 3 (hr)

'peak ( h r )

AUC(g/i.hr)
'0.3 ( h r )

AUC(g/l.hr)
'0.3 ( h r )

(0.04)t
(0.14)
(0.27)
(0.66)

(0.02)
(0.17)
(0.08)
(0.21)

(0.02)
(0.17)
(0.08)
(0.21)

Breath analysis
Men

Women

0.48a
1.43
1.18
2.80

0.68b§
1.73
1.91
• 3.97

High

Low

0.52a
1.59
1.37a
3.30

0.64 b
1.57
1.71b
3.47

During

After

0.56
1.60
1.46
3.10a

0.60
1.55
1.62
3.66 b

(0.05)
(0.24)
(0.29)
(0.46)

(0.03)
(0.15)
(0.08)
(0.17)

(0.03)
(0.15)
(0.08)
(0.17)

§Interaction, see Table 5.
For other footnotes see Table 2.

Table 3b. Means of c pedk , fpcak, A U C and /o 3* per factor level, averaging the levels of
the other factors (experiment 2)

Meal composition

High
fat

High
carbohydrate

High
protein

High
sucrose

0.65 c t
1.54
2.06 c
4.00

0.54b
1.76
1.72bc
3.90

0.42a
1.84
1.33a
3.12

0.50 b
1.88
1 50 ab
3.37

(0.03)1:
(0.24)
(0.11)
(0.29)

0.72 c
1.28
1.89°
3.72 c

0.59b
1.47
1.58bc
3.67a

0.47a
1.73
1.28a
3.19a

0.52 ab
1.82
1.41ab
2.96 b

(0.04)
(0.21)
(0.11)
(0.25)

Blood analysis (N = 8)
Cpe-k (g/1.)
'peak ( h O

A U C (g/1.hr)
'0 3 (hr)

Breath analysis (N = 8)
Cpcak(g/l.)
'peak (hr)

AUC(g/l.hr)
'0 3 (hr)

For footnotes see Table 2.
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Table 4. Interaction effects on t03 (hr)* (experiment 1)

Sex:

N= 12
Dose
3 glasses
5 glasses
S.E.D.

Men

Blood analyslis
Women S.E.D.

1.76at
4.12b
(0.06)

2.41 b
4.06 b
(0.06)

(0.06)t
(0.06)

Bireath analysis

Men

Women

S.E.D.

1.54a
3.77b
(0.08)

2.29 c
4.49 d
(0.08)

(0.08)
(0.08)

For footnotes see Table 2.

Table 5. Interaction effects on cpcak (g/1.)* (experiment 2)

N--= 8 T i m e iof drinking:

During
meal

Blood analysis
After
S.E.D.
meal

During
meal

Breath analysis
After
S.E.D.
meal

(a) Sex
Men
Women
S.E.D.

0.44 a t
0.58b
(0.04)

0.42a
0.67c
(0.04)

(0.03)$
(0.03)

0.49a
0.63 b
(0.06)

0.46a
0.74c
(0.06)

(0.04)
(0.04)

(b) Energy 1level
High
Low
S.E.D.

0.49a
0.53a
(0.03)

0.47a
0.62 b
(0.03)

(0.03)
(0.03)

0.52a
0.59 b
(0.04)

0.51 a
0.68 b
(0.04)

(0.04)
(0.04)

For footnotes see Table 2.

a larger A U C in women than in men when
alcohol was administered on the basis of body
weight, but in both instances the sex difference
could be explained by differences in amount of
body water.
The alcohol dose proved to exert the greatest
effect on the course of the alcohol concentration. After drinking five glasses of alcohol,
compared to three glasses, the cpealc value increased almost proportionally, fpeak was about
one third longer, AUC was about 2.5 times
larger and t03 was about twice as long.
In contrast to dose, concentration had hardly
any effect on the alcohol curve.
In our experiments, exercise did not have
any effect on the alcohol curve as determined
by blood analysis. The breath analysis data
were unreliable for reasons stated above. Our

results are in agreement with those of Barnes et
al. (1965) and Sautier et al. (1982). Two other
studies arrived at conflicting conclusions.
Krebs et al. (1969) reported a lower BAC and a
lower rate of removal of the alcohol due to
short severe exercise. Schurch et al. (1982)
observed an increased ethanol elimination during exercise, the degree depending on the type
of diet.
The effect of a meal on the alcohol curve was
also substantial. Drinking immediately after a
meal compared to drinking without a preceding meal resulted in our experiments in a reduction of about 25% in c peak and AUC. The
strongest effect was observed in tpciik which was
twice as long. Haggard et al. (1938) also
studied the effect of dose, meal consumption
and alcohol concentration on the alcohol
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curve They obtained similar results although
they used gin whisky or beer instead of diluted
alcohol After doubling the dose c pcak was
nearly twice as high, whether a meal was taken
or not Strong dilution of the beverage had
little effect irrespective of meal consumption,
the greatest effect being a decrease in t0 5
Meal consumption reduced c p e l k by more than
50%, compared with drinking on any empty
stomach
The effect of time of drinking in relation to
meal consumption was rather small
The energy level and the composition of the
meal had a major influence on the alcohol
curve The AUC was 25% larger for a low
energy meal than for a high energy meal, and
the same trend was observed for c p c a k Meal
composition influenced the values of c p e a k and
A U C , both decreased in the direction high
fat-high carbohydrate-high sucrose-high protein The differences between high carbohydrate and high sucrose meals were slight
After a high fat meal c pe lk and AUC were 50%
greater than after a high protein meal The
absence of differences in the alcohol curves
between a high carbohydrate and a high
sucrose meal suggests that the supposed inter
ference of the fructose component (12% and
35% of total carbohydrates respectively) in the
ethanol metabolism under the conditions of
this test is negligible in contrast to the findings
of Sprandel et al (1980) and Meyer et al
(1982) who used higher doses under other test
conditions Lin et al (1976) studied the influence of meal size and time of drinking on the
alcohol curve A comparison with our results is
hampered by the differences in treatment, in
particular because meals in our study had a
higher energy content than meals in theirs
They observed a similar but relatively greater
effect of the energy level on c pcak and AUC
Sedman et al (1976) found no differences in
AUC after meals of different composition
(high fat, high protein, high carbohydrate)
There were some differences in c peak and fpelk,
depending on the composition of the meal, but
since these meals were in liquid form no valid
comparison with our results is possible Well
ing et al (1977) applied solid rather conven
tional meals high in fat, protein or carbo
hydrate The energy level was not specified

Relative to drinking without a meal, c p e a k and
AUC decreased strongly after a meal, the
values depending on the composition in the
order carbohydrate < fat < protein This
shows remarkable discrepancy with our expen
ment particularly for protein However, com
pared with the studies of Lin et al (1976),
Sedman et al (1976) and ours the dose applied
by Welling and the resulting BAC were very
low even when no meal was taken In con
formity with the findings of Burns and Mosko
witch (1981) we observed that protein and
carbohydrate suppressed the alcohol concen
tration more strongly than fat and that a high
energy meal was more effective than a
low energy meal This effect was greatest when
the beverage was taken 30 mm after the meal
(since the data of Burns and Moskowitch are
only available as an abstract, no extensive com
panson is possible) Haggard et al (1941)
stated that fat appears to hasten alcohol
absorption from the stomach
The major difference between our study and
others is that in our study the effects were
investigated under strictly standardized conditions In particular the effects of varying levels
of fat protein and carbohydrate were evaluated at constant energy content of the meal
Under these conditions it was clearly demonstrated that alcohol dose, meal consumption
and meal composition are the mam determinants of the blood alcohol concentration
Acknowledgements — This study was supported by a grant
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The Hague Netherlands Thanks are due to Dr W van
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Alcohol Metabolism
Metabolism is the body's process of converting Ingested substances to other compounds
Metabolism results in some substances becoming more, and some less,toxicthan those
originally ingested. Metabolism Involves a number of processes, one of which is referred to
as oxidation. Through oxidation, alcohol is detoxified and removed from the blood,
preventing the alcohol from accumulating and destroying cells and organs A minute amount
of alcohol escapes metabolism and is excreted unchanged in the breath and in urine. Until
all the alcohol consumed has been metabolized, it is distributed throughout the body,
affecting the brain and other tissues (1.2). As this Alcohol Alert explains, by understanding
alcohol metabolism, we can learn how the body can dispose of alcohol and discern some of
the factors that Influence this process. Studying alcohol metabolism also can help us to
understand how this process influences the metabolism of food, hormones, and medications.
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Blood alcohol concentration (BAC) after the rapid consumption of different
amounts of alcohol by eight adult fasting male subjects/ (Adapted from
Wilkinson et alM Journal of Pharmacokinetics and Biopharmaceutlcs 5(3):207224,1977.)
100 mg% is the legal level of intoxication In most States. 50 mg% is the level at
which deterioration of driving skills begins, (JAMA 255:522-527,1986.)

*// the same number of drinks are consumed over a longer period of time,
BAC's will be lower.

The Metabolic Process
When alcohol Is consumed, it passes from the stomach and Intestines into the blood, a
process referred to as absorption. Alcohol is then metabolized by enzymes, which are body
chemicals that break down other chemicals. In the liver, an enzyme called alcohol
dehydrogenase (ADH) mediates the conversion of alcohol to acetaldehyde, Acetaldehyde is
rapidly converted to acetate by other enzymes and is eventually metabolized to carbon
dioxide and water, Alcohol also is metabolized in the liver by the enzyme cytochrome
P450IIE1 (CYP2E1), which may be increased after chronic drinking (3). Most of the alcohol
consumed Is metabolized in the liver, but the small quantity that remains unmetabolized
permits alcohol concentration to be measured in breath and urine.
The liver can metabolize only a certain amount of alcohol per hour, regardless of the amount
that has been consumed. The rate of alcohol metabolism depends, In part, on the amount of
metabolizing enzymes in the liver, which varies among individuals and appears to have
genetic determinants (1,4). In general, after the consumption of one standard drink, the
amount of alcohol in the drinker's blood (blood alcohol concentration, or BAC) peaks within
30 to 45 minutes, (A standard drink is defined as 12 ounces of beer, 5 ounces of wine, or 1.5
ounces of 80-proof distilled spirits, all of which contain the same amount of alcohol.) The
BAC curve, shown on the previous page, provides an estimate of the time needed to absorb
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and metabolize different amounts of alcohol (5). Alcohol is metabolized more slowly than it is
absorbed. Since the metabolism of alcohol Is slow, consumption needs to be controlled to
prevent accumulation in the body and intoxication.
Factors Influencing Alcohol Absorption and Metabolism
Food. A number of factors influence the absorption process, including the presence of food
and the type of food in the gastrointestinal tract when alcohol is consumed (2,6). The rate at
which alcohol is absorbed depends on how quickly the stomach empties its contents into the
intestine. The higher the dietary fat content, the more time this emptying will require and the
longer the process of absorption will take, One study found that subjects who drank alcohol
after a meal that included fat, protein, and carbohydrates absorbed the alcohol about three
times more slowly than when they consumed alcohol on an empty stomach (7).
Gender. Women absorb and metabolize alcohol differently from men. They have higher
BAC's after consuming the same amount of alcohol as men and are more susceptible to
alcoholic liver disease, heart muscle damage (8), and brain damage (9). The difference In
BAC's between women and men has been attributed to women's smaller amount of body
water, likened to dropping the same amount of alcohol into a smaller pall of water (10). An
additional factor contributing to the difference in BAC's may be that women have lower
activity of the alcohol metabolizing enzyme ADH In the stomach, causing a larger proportion
of the ingested alcohol to reach the blood. The combination of these factors may render
women more vulnerable than men to alcohol-induced liver and heart damage (11-16),
Effects of Alcohol Metabolism
Body Weight Although alcohol has a relatively high caloric value, 7.1 Calories per gram (as
a point of reference, 1 gram of carbohydrate contains 4.5 Calories, and 1 gram of fat
contains 9 Calories), alcohol consumption does not necessarily result in increased body
weight. An analysis of data collected from the first National Health and Nutrition Examination
Survey (NHANES I) found that although drinkers had significantly higher intakes of total
calories than nondrinkers, drinkers were not more obese than nondrlnkers. In fact, women
drinkers had significantly lower body weight than nondrlnkers. As alcohol intake among men
increased, their body weight decreased (17), An analysis of data from the second National
Health and Nutrition Examination Survey (NHANES II) and other large national studies found
similar results for women (18)r although the relationship between drinking and body weight
for men is inconsistent. Although moderate doses of alcohol added to the diets of lean men
and women do not seem to lead to weight gain, some studies have reported weight gain
when alcohol is added to the diets of overweight persons (19.20).
When chronic heavy drinkers substitute alcohol for carbohydrates in their diets, they lose
weight and weigh less than their nondrlnklng counterparts (21,22). Furthermore, when
chronic heavy drinkers add alcohol to an otherwise normal diet, they do not gain weight (21).
Sex Hormones. Alcohol metabolism alters the balance of reproductive hormones in men
and women (23-28). In men, alcohol metabolism contributes to testicular Injury and impairs
testosterone synthesis and sperm production (24,29). In a study of normal healthy men who
received 220 grams of alcohol daily for 4 weeks, testosterone levels declined after only 5
days and continued to fall throughout the study period (30,31). Prolonged testosterone
deficiency may contribute to feminization in males, for example, breast enlargement (32). In
addition, alcohol may interfere with normal sperm structure and movement by inhibiting the
metabolism of vitamin A, which is essential for sperm development (30,33). In women,
alcohol metabolism may contribute to Increased production of a form of estrogen called
estradiol (which contributes to increased bone density and reduced risk of coronary artery
disease) and to decreased estradiol metabolism, resulting in elevated estradiol levels (28).
One research review indicates that estradiol levels Increased In premenopausal women who
consumed slightly more than enough alcohol to reach the legal limit of alcohol (BAC of 0.10
percent) acutely (28). A study of the effect of alcohol on estradiol levels In postmenopausal
women found that in women wearing estradiol skin patches, acute alcohol consumption
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significantly elevated estradiol levels over the short term (34).
Medications, Chronic heavy drinking appears to activate the enzyme CYP2E1, which may
be responsible for transforming the over-the-counter pain reliever acetaminophen
(Tylenol™) and many others) into chemicals that can cause liver damage, even when
acetaminophen is taken in standard therapeutic doses (3,35,36). A review of studies of liver
damage resulting from acetamlnophen-alcohol Interaction reported that in alcoholics, these
effects may occur with as little as 2.6 grams of acetaminophen (four to five "extra-strength*
pills) taken over the course of the day In persons consuming varying amounts of alcohol
(35,37). The damage caused by alcohol-acetaminophen interaction is more likely to occur
when acetaminophen is taken after, rather than before, the alcohol has been metabolized.
Alcohol consumption affects the metabolism of a wide variety of other medications,
increasing the activity of some and diminishing the activity, thereby decreasing the
effectiveness, of others (35).
Alcohol Metabolism-A Commentary by
NIAAA Director Enoch Qordls, M.0.
The study of metabolism has both practical and broader scientific implications. On the
practical side, information on how the body metabolizes alcohol permits us to calculate, for
example, what our blood alcohol concentration (BAC) is likely to be after drinking, including
the impact of food and gender differences in the rate of alcohol metabolism on BAC. This
information, of course, is Important when participating in activities for which concentration is
needed, such as driving or operating dangerous machinery.
With respect to its broader scientific application, metabolism, which has long been studied, is
emerging with new implications for the study of alcoholism and its medical consequences,
For instance, how is metabolism related to the resistance of some individuals to alcoholism?
We know that some inherited abnormalities In metabolism (e.g.,flushingreaction among
some persons of Asian descent) promote resistance to alcoholism. Recent data from two
large-scale NIAAA-supported genetics studies suggest that alcohol dehydrogenase genes
may be associated with differential resistance and vulnerability to alcohol. These findings are
important to the study of why some people develop alcoholism and others do not. Studies of
metabolism also can identify alternate paths of alcohol metabolism, which may help explain
how alcohol speeds up the elimination of some substances (e.g., barbiturates) and Increases
the toxicity of others (e.g., acetaminophen). This Information will help health care providers
in advising patients on alcohol-drug interactions that may decrease the effectiveness of
some therapeutic medications or render others harmful.
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13.2 DIH DEFENSES
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After prohibition was abolished in the United States in 1933, consumption of alcohol escalated
as did many of the negative consequences associated with too much drinking. Among other
things, the number of alcohol-related accidents within the home, at work, and on die roads
increased alarmingly.1*2 Alcohol and transportation made a poor mix, and in efforts to curb this
new wave of road-traffic accidents and deaths on the highways, more effective legislative
measures were urgently needed.3*4
The first laws prohibiting driving under the influence of alcohol (DUI) appeared in the
1920s, but the criteria used to demonstrate impairment and unfitness to drive were not very
sophisticated. These included the smell of alcohol on the breathy the ability of a person to walk
a chalk line, and various behavioral signs and symptoms of inebriation.3 Gaining a conviction
for drunk driving was by no means certain, unless the suspect showed obvious signs and
symptoms of gross intosdearion.6 It was strikingly obvious that more sensitive and more
objective methods were needed to decide whether a person was under the influence of alcohol.
Following the lead of some European countries, efforts in the U.S. were directed towards
measuring the concentration of alcohol in blood and other body fluids as evidence of intoxication.7 However, quantitative studies of the relationship between blood-alcohol and impairment were virtually non-existent at this time.
These efforts led to the first statutory limits of blood alcohol concentration (BAC) for
driving being set at 150 mg/dL (0.15 g/dL), a conservatively high level.8*9 Subsequently, this
threshold BAC for driving has progressively been lowered, first to 100 mg/dL (0.10 g/dL)
and in some U.S. states the limit is now set at 80 mg/dL (0.08 g/dL) 1 0 For young (< 21 y)
drivers an even lower BAC, so called zero tolerance limits, has been sanctioned (0.00 to 0.02
g/dL). n Legal limits of blood alcohol concentration differ from country to country and also
within regions of the same country, e.g. the various states in America and Australia.12 Lowering
the legal alcohol limits for driving even further is supported by many national and international
medical societies including the American Medical Association.13 Judging by recent trends in
Europe, it seems that most countries are aiming for a threshold BAC limit of 50 mg/dL (0.05
g/dL); France approved a 0.05 g/dL limit in 1995, whereas Sweden adopted 0.02 g/dL in
1990. *
Punishment and sanctions for those found guilty of drunk driving have become increasingly severe and include suspension of the drivers license, heavy fines, and sometimes a
mandatory term of imprisonment.14*16 ThefirstDUI statutes stipulated that the concentration
of alcohol present in body fluids (blood, breath, or urine) was admissible as presumptive
evidence of unfitness to drive, but that this was a rebuttable presumption.4'6 In contrast, most
of the DUI statutes in operation today are the so called per se laws, under which the person's
BAC or breath alcohol concentration (BrAC) is the sole deciding factor necessary as proof of
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unfitness to drive,15*16 In short, a person can be found guilty of drunk driving without
exhibiting visible signs of intoxication when alcohol concentration per se statutes are in
operation.16 This legal framework, whereby the concentration of alcohol in a specimen of blood
or breath determines guilt or innocence, places high demands on the analytical methods used
for forensic purposes. Moreover, pre-analytical factors such as sampling, transportation, storage
and handling of specimens needs to be carefully regulated and controlled. The combined
influences of per se legislation, the compelling objective standard provided to juries in the
numerical value of the BAC or BiAC result, and the increasingly harsh penalties imposed on
those found guilty of DUI explain, at least in part, the vigorous defense attacks against
prosecution evidence based on results of BAC or BrAC determinations.
Soon after chemical tests for intoxication were introduced and used on a large scale, the
reliability of the approved methods and the results obtained were increasingly being questioned.4 The practice of running duplicate determinations on the same specimen or obtaining
two or more specimens of the same or different bodyfluids(e.g. blood and urine) and testing
these by different analytical methods has much to recommend it.14*15 Defending drinking
drivers has become a lucrative business and many lawyers specialize in this area of jurisprudence. A plethora of textbooks and newsletters are available that provide detailed information
about the science and law of DUI litigation.17"21 These typically present recent examples of
DUI case law, reviews and opinion of articles published in scientific peer-review journals, and
hints and tips for developing more effective strategies for defending and also for prosecuting
drunk drivers.22
This review artide discusses the strengths and weaknesses of common DUI defense
challenges. The work is subdivided into four main sections. Thefirstdeals with general attacks
on potentially incriminating evidence, the second focuses on challenging results of urine
alcohol analysis, the third deals with scrutiny of blood sampling and analysis, and the fourth
section is concerned with the use of evidential breath-alcohol instruments. Procedural aspects
of the DUI offense, such as whether the arresting police officer followed the correct protocol
when the driver was apprehended, had reasonable suspicion or probable cause for making the
arrest, performed thefieldsobriety tests properly, or gave the appropriate warnings demanded
by the local rules and regulations prior to administering the chemical test, are not considered.
The chemistry and physiology offorensicalcohol testing are the main focus of this review and
much of the perpetual nit-picking and procedural issues often raised in DUI litigation are
omitted.
An extensive list of references is provided, and most citations refer to articles published in
peer-review US. and European English language journals. However a bimonthly journal from
Germany called Blutalkohol (blood-alcohol), is worthy of note. Biutalkohol is published by
Stcintor-Verlag, Hamburg and thefirstvolume appeared in 1962/63. This periodical contains
a wealth of information about forensic aspects of alcohol with direct relevance to the defense
and prosecution of DUI suspects. Although most of the articles are written in German, English
summaries are provided.
13*2.1 GENERAL CHALLANGES
13JL1.1 Drinking After the Offense
A frequent-defense tactic is one in which the suspect claims to have consumed alcohol after
driving or being involved in an accident such as a single-vehicle crash; this approach is
sometimes called the hip-flask ploy.23*24 Prosecution for DUI must necessarily relate driving
with consumption of alcohol at a time before or during the driving. In these cases however it
is alleged that the drinking took place after the driving, but prior t;o obtaining a specimen of
blood or breath for forensic analysis. For example, hit-and-run drivers often manage to drive
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home. When eventually apprehended by the police, they might claim to have been sober during
the driving but thereafter needed alcohol to "calm their nerves'7 or alleviate the condition of
shock caused by "hitting a bird", and the resulting damage to the car. Subjects will often insist
they drank alcohol after chiving, even when they cannot produce any empty or opened bottle
of liquor or any other credible evidence such as eye-witnesses to support their story. Some of
the more experienced DUI offenders, especially repeat offenders, may carry a bottle of alcohol
in their coat pocket or glove compartment, for the express purpose of being able to drink after
driving; hence the origin of the term hip-flask defense. In some jurisdictions the prosecutor
must prove beyond a reasonable doubt that the allegation of drinking after die offense was
untrue, or that in spite of the alcohol consumed after driving the suspect's BAC or BrAC at
the time of driving still exceeded the legal limit. This is often a difficult task.
To deal with alleged drinking after the offense, the prosecutor has several options available
and should seek help from qualified forensic experts when preparing the case. First, it is
important to document the testimony of the police or other witnesses who might have
observed the actual driving, or the behavior and general appearance of the suspect when
arrested. Such observations as the smell of alcohol on the breath, slurred speech, or unsteady
gait are important to document before the driver has had the opportunity to drink any more
alcohol, should be noted. In cases where the subject has allegedly consumed a large quantity
of alcohol immediately before being apprehended by the police, one would also expect to see
a dramatic and progressive onset of symptoms of intoxication. Second, information regarding
the quantity of alcohol allegedly consumed after driving, the time of intake and the sex, age,
height, and body weight of the suspect can be used to calculate the expected BAC.22 If this
approach is used, the suspect should be given the "benefit of any doubt* by assuming that at
the time of sampling blood and breath, absorption and distribution from the post incident
ethanol consumption was complete.
The Widmark equation (see Chapter 5) is commonly used to calculate the expected BAC
on the basis of the person's body weight and drinking pattern.25'26 Making an adjustment for
elimination of alcohol through metabolism between the time of starting to drink and the time
of sampling blood is usually warranted, especially when several hours have elapsed between the
time of the driving and the time of obtaining a blood-sample. In this way, a theoretical mean
BAC and its 95% confidence interval, can be compared with the analytical report from the
forensic laboratory. The resulting difference in BAC, if any, should reflect the BAC that existed
prior to the post-incident drinking, and therefore the BAC before or during driving. The use
of a 95% confidence interval is a safeguard to allow for inter-individual variations in absorption,
distribution and elimination patterns of alcohol (see Chapter 5 for details). Grossly exaggerated
claims of the amount of alcohol consumed after the offense, such as drinking a whole bottle
of liquor in a relatively short time span, are dearly unrealistic and should be given litde
credibility.
The limitations of urine alcohol concentration (UAC) testing are dealt with in the next
section, however, if the police manage to obtain samples of urine and blood shordy after
driving, the magnitude of the UAC/BAC ratio can help to resolve whether alcohol was
ingested within approximately 1 h of taking the samples. This approach was tested empirically
by Iffiand et aL27 who found that UAC/BAC ratios between 1.0 to 1.15 indicated fairly recent
drinking whereas ratios larger than 1.2:1 indicate that the drinking began much earlier. This
fits with the observation that dining the absorption phase of alcohol kinetics, before equilibration has been reached, UAC is generally less than or equal to BAC. In the post-absorptive phase
of alcohol metabolism, UAC is usually 1.3 to 1.5 times higher than BAC.28*29 The concentration of alcohol in pooled bladder urine mirrors the average concentration prevailing in the
blood during the formation of urine in the kidneys and storage in the bladder.28 Because urine
has about 20% more water than an equal volume of whole blood, the concentration of alcohol
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in newiy secreted urine is about 20% higher than BAC and a urine/blood ratio of 1.2:1 should
be expected. Dividing the measured UAC by 1.2, gives an estimate of the-lowest BAC at the
time of voiding or since the bladder was last emptied. Moreover, a UAC/BAC ratio exceeding
1.3 suggests that the bulk of the alcohol was already absorbed into the blood and distributed
throughout total body water. Whenever the police suspect that a person will assert consumption of alcohol after driving, efforts should be made to obtain two specimens of urine about
30 to 60 min apart. If the UAC of the second void is higher than thefirstvoid then it seems
reasonable to assume that absorption of alcoholfromthe stomach is not complete at the time
of sampling. Such afindingwould support the claim of recent consumption of alcohol. If the
UAC decreases between thefirstand second void 30 to 60 min later, this suggests that the
post-absorptive phase has become well established and the main part of the alcohol was
imbibed at least 1 to 2 h earlier. **&
If the ratio of UAC/BAC is less than or close to unity, this supports the contention of
recent consumption of alcohol and the BAC curve was probably soH'rising, or near the peak.
If an alcohol-free pool of urine existed in the bladder before drinking started, this would tend
to dilute the concentration ofalcohol secreted into the bladder and might suggest a rising UAC
between the two successive voids, even though in reality the BAC curve was in the post-peak
phase. Alternatively, evaluating the change in BAC between the times of taking two blood
samples 30 to 60 min apart gives a good indication of whether a rising orfallingBAC existed
at the time of sampling.30
Forensic toxicologists in Germany have developed another way to deal with allegations of
drinking after the ofense and this method has become known as congener analysis.31'34 In brief,
this method entails analyzing the alcoholic beverage the suspect claims to have consumed after
driving with the aim of identifying other volatile constituents besides ethanol. Pure ethanol
does have a distinctive odor, although these other congeners (non-ethanol volatiles) produced
during the fermentation process help impart the distinctive smell andflavorto the drink.31 The
results of the congener analysis are then compared with the volatiles present in a sample of
blood or urine takenfromthe suspect in an attempt to match the components. Methanol, 1propanol, 2-buranol and 2-methyl-l-propanol are typical examples of congener alcohols that
can be identified in bodyfluidsdepending on the particular kind of beverage consumed.32 The
results of congener analysis, together with other information, has been accepted by the courts
in Germany when dealing with hit-and-run drivers who frequently claim drinking after the
offense.31*34 The usefulness of analyzing methanol as a congener in forensic casework is limited
by the fact that this alcohol is produced naturally in die body and its concentration in body
fluids increases after ingestion of ethanol because of competition for the metabolizing enzyme
alcohol dehydrogenase.35*57 Furthermore, if the beverage consumed before the incident is the
same as that allegedly consumed afterwards, the congeners will be the same and this approach
would not work.
Claims of drinking after the ofense can be counteracted by appropriate legislation. For
example, in Norway it is a separate offense for a motorist to consume alcohol within 6 hours
of driving if there is good reason to believe that the police will want to investigate some event
related to the driving. Thus, drinking within 6 h of an accident to reach a BAC in excess of
the legal limit carries the same penalty as being found guilty of drunk driving (Norwegian traffic
law, paragraph 22). Without this kind oflegislation, die magnitude of the UAC/BAC ratio and
the change in BAC between successive samples, or UAC between two successive voids,
provides useful information to evaluate whether or not a person has consumed alcohol within
an hour or so before taking the samples. Knowledge of the stage ofalcohol kinetics is important
not only in alleged drinking after the offense but also when asked to engage in retrograde
extrapolation of BAC to an earlier time. Accurate back-tracking of BAC to the time of driving
isfraughtwith difficulties, and only an approximate result, and likely range ofvalues is possible,
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based on known population averages for alcohol elimination. Again, the need to back extrapolate can be avoided by statutory definition of the relevant BAC for prosecution as that existing
at the time of sampling or within 2 to 3 h of the driving.
13JL13. Laced Drinks
The "laced drinks" defense is another challenge that arises during prosecution of drunk drivers
in their attempts to avoid punishment for DDL17*1*'20'21 The usual story is that a friend or
associate has added liquor (usually vodka) to a non-alcoholic drink or to beer when the person
concerned was otherwise engaged or distracted. Another spin on this scenario is where the
suspect has been invited to consume some kind of homemade beverage which was not
recognized as containing a high alcohol content because the taste was masked by strong
flavoring. Unintentional intoxication through the over-consumption of alcohol containing
chocolates or alcohol soakedfruithave also been alleged. Only later, after being apprehended
for DUI, was it apparent to the subjects in these cases that die drink must have contained an
unusually high concentration of alcohol which was not obvious from the taste. The subjective
intoxication effects of alcohol differ widely among different individuals and this allows the
defendant to argue that he or she was driving with a BAC above the limit but without intent,
which although not a complete defense, may have some mitigating value.
Widmark calculations (see Chapter 5) are commonly used to estimate the BAC expected
from the amount of alcohol inadvertently consumed in-the laced drink.24'25 However, relating
a given BAC to a precise degree of intoxication is difficult because of the wide variations in
consumption and concentration tolerance between different individuals. Dram-shop laws in
the U.S. place responsibility on the host at the party, or the owner of the bar for damages
caused by a drunk driver if that person was served alcohol while he or she was visibly
intoxicated.17"22 In a well-documented laced drinks case, a woman was acquitted after driving
with a BAC of 0.17 g/dL. She admitted drinkingfroma ""punch bowP when visiting the home
of some friends, although she denied knowledge of the fact that the drink was laced with 96%
v/v cthanol, and did not feel any definite impairment effects of alcohol despite the high BAC.
The medicolegal experts called by the court refused to state with certainty that the women must
have felt under the influence of alcohol at a BAC of 0.17 g/dL. On appeal to the high court,
the woman was acquitted of willfully driving under the influence. The prosecutor approached
the supreme court but permission to review the case was refused.38 The trend toward introducing lower legal limits and zero tolerance laws for young people should make the laced drinks
defense, and driving over the limit without intent, a much more common defense tactic. This
follows because of the great difficulty in recognizing symptoms ofintoxication at very low levels
such as 0.02 g/dL where impairment may be minimal. The same applies to driving in the
morning following an evening of heavy drinking, when low per se illegal concentrations of
alcohol in the blood are enforced.
13JL13 Rising Blood-Alcohol

Concentration

Some DUI suspects argue that their BAC or BrAC was below the legal limit at the time of
driving, but that the concentration of alcohol had risen to exceed the legal alcohol limit at the
time of obtaining samples for analysis. In short, if the prosecution BAC was 0.12 g/dL at the
time of the test, it might be suggested that it was below 0.10 g/dL at the time of driving some
time earlier.39*40 The key question here is by how much can the BAC or BrACriseafter the last
drink? To answer this question, details of the subject's drinking pattern before or during the
driving, as well as the various time elements and intake of food should be carefully investigated.
The pharmacokinetics of alcohol show large inter-individual variations especially when small
doses are taken after a meal.41'42 This challenge is known as therisingBAC defense and the usual
scenario according to the defendant is that he or she was engaged in moderate social drinking
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for several hours after work, perhaps with a meal'or eating bar snacks. For some unexplained,
and physiologically improbable reason, the alcohol ingested during the evening remained
unabsorbed in the stomach until the person decided to leave for home or drive to the next bar.
Shortly after driving the person is either involved in an accident or pulled over by the police
because of a moving traffic offense, and in this connection is arrested for DUI. The defendant
then claims that between the time of being apprehended and the time of taking the blood or
breath-alcohol test, the alcohol in the stomach has become absorbed into the blood bringing
the person over die legal limit.
Obviously, this scenario is unreasonable because alcohol, unlike many other drugs, starts
to become absorbed from the stomach immediately following ingestion. Gastric emptying
accelerates this process and leads to a rapid onset of the effects of alcohol on the brain. Indeed,
people indulge in drinking primarily to experience alcohol's enjoyable pharmacological effects
such as euphoria, relaxation and diminished social inhibitions. In order for tins to happen, the
alcohol must become absorbed into the blood and transported to the brain. The intoxicating
effects of alcohol are more pronounced during the rising limb of the BAC profile, and people
would surely be surprised if they had been consuming drinks for several hours without
experiencing any effect! Unfortunately, only a handful of studies have looked at the pharmacokinetics of alcohol under real world drinking conditions to establish,, for a large number of
subjects, the degree of rise in BAC and the time needed to reach the peak after the last drink.
Gullberg ** reported a study in which 39 subjects-drank various quantities of alcohol under
real world drinking conditions. The mean timerequiredto reach the peak BAC after end of
drinking was 19 min (span 0 to 80 min) and 81% of subjects reached a peak within 30 min.
A study reported by Shajani and Dinn44 also gives a clue to therimeneeded to reach peak BAC
under social drinking conditions. In 8 men and 8 women who consumed known amounts of
alcohol according to choice, the maximum BAC was reached 35 min (span 17 to 68 min) after
end of intake. Taken together these studies and a few others suggest the low probability that
the result of a blood or breath-alcohol test made some time after driving will be higher than
at the time of driving which is often 1 to 2 h earlier, Zink and Bernhardt45 made an important
contribution when they allowed heavy drinkers to consume very large amounts of alcohol over
periods of 6 to 10 h, resulting in peak BAC's in the range 0.10 to 0.38 g/dL, and taking
samples ofvenous bloodforanalysis of alcohol at 15 min intervals during and after the drinking
spree. In this way accurate information was obtained about the shape of the concentration-time
profile and the time of reaching the peak as well asrisein BAC after the last drink. Importantly,
they found that half the individuals had reached their peak BAC even before the last drink was
taken (i.e.-, the rate of elimination exceeds the rate of consumption). The longestrimenecessary
to reach a peak was 50 min after end of drinking (mean± SD, 7.7 ± 22.9 minutes), and when
a rise in BAC occurred between the end of drinking and the peak BAC it was invariably less
than 0.02 g/dL. This study has important ramifications because many DUI suspects have
blood-alcohol concentrations in this high range when they are apprehended.
Drinking alcohol together with a large meal was studied by Jones and Ncri42 who found
that under these conditions, although the peak BAC was attained soon after the end of drinking
for most subjects, a BAC plateau developed where for some, the BAC remained fairly constant
for 2 to 3 h. Interestingly, in 10 of these subjects, 70% of the peak BAC had been attained
within 15 min after the end of drinking. More studies are needed delineating the absorption
kinetics of alcohol for different drinking conditions, with different beverages and formulations
and with fast and slow ingestion of alcohol, on an empty stomach and after a meal.
Although the person's BAC or BrAC at the time of driving or when a road-traffic accident
occurred might be considered the most relevant result for prosecution, it is fairly obvious that
estimating this value can involve some uncertainty. This follows because the blood or breathtest is often made 1 to 2 h after the driving and there is a wide variation in absorption,
distribution, and elimination patterns of alcohol in individual DUI suspects. Much can be
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gained by statutory definition of the relevant BAC or BiAC as that prevailing at the time of
the chemical test and not at the time of driving. Unfortunately, many jurisdictions persist with
using the BAC or BrAC at the time of driving as the figure needed for prosecution of DUI
suspects. Other jurisdictions accept the chemical test result, provided it was obtained within
two hours of the driving, as being equivalent to the BAC at the time of driving- Samples of
blood or breath taken outside this time frame require the prosecution to estimate the BAC or
BrAC prevailing at the time of driving. This entails making a back extrapolation of BAC from
time of sampling to the time of driving which is always subject to some uncertainty. In cases
where the statutory period of two or three hours between the driving and the time of the test
is exceeded, error in back extrapolation can be minimized (in the defendant's favor),- by only
extrapolating back to the end of the two or three hour period.
Provided the subject was in the post-peak phase of alcohol absorption-distribution at the
time of driving and at the time of sampling blood, extrapolating back with a conservative
alcohol bum-off rate, such as 0.008 to 0.010 g/dL per hour, can be defended. Other
safeguards against over-estimation include an adjustment for absorption of alcohol contained
in the last drink, and allowing for the possibility of a BAC concentration plateau existing where
BAC remains more or less constant for several hours, as sometimes happens if alcohol is
ingested together with a large meal. Other reasonable approaches include the use ofpopulation
mean elimination rates, with 95% confidence intervals to establish the most likely upper and
lower limits of BAC.
A recent study of double blood samples from 1090 DUI suspects arrived at a mean alcohol
bum-off rate of 0.019 g/dL per hour with 95% limits of agreement, spanning from 0.009 to
0.029 g/dL/h. * These results suggest that making a back estimation of a person's BAC over
long periods, of time and assuming a relatively low and constant bum-off rate such as 0.008
to 0.01 g/dL/h will lead to a large underestimate of the BAC at the time in question, but
always in the defendant's favor. While this approach gives a definite advantage to the suspect,
the practice of making a back estimation of a person's BAC is inevitably a controversial issue
in DUI litigation and should be avoided whenever possible, 47"50
13JL1A Pathological States and Ethanol Pharmacokinetics
The pharmacokinetics of many prescription drugs have been carefully investigated in patients
suffering from various diseases.51'53 Much less work has been done concerning the influence of
disease states on absorption, distribution, and metabolism of the social drug ethanol. DUI
suspects sometimes claim however that they suffer from certain medical conditions or pathological states which they hope might explain their BAC being above the legal limit for driving.
Many daims of this kind have been documented such as liver cirrhosis, kidneyfidlxireor absence
of a kidney or one lobe of the lung. Because only 2 to 5% of the total quantity of alcohol
consumed is excreted in urine and breath, reduced efficiency of the lungs or kidney has
marginal effects on the total amount of alcohol eliminated from the body. The rate of alcohol
elimination from blood in patients with kidney failure scheduled for hemodialysis was no
different from the burn-off rate in healthy control subjects.54
Major surgery to the gastro-intestinal tract, such as gastrectomy, is known to cause a more
rapid absorption of alcohol leading to an overshoot peak which tends to be somewhat higher
than the maximum BAC expected.55*57 A similar phenomenon is often observed when drinking
neat liquor on an empty stomach. 41 However, 1 to 2 h after drinking ends, the BAC should
approach the value expected for the dose of alcohol ingested and the person's gender and body
weight because alcohol has now had sufficient time to equilibrate in the total body water. The
rate of absorption of alcohol shows wide inter-individual variations even in apparently healthy
individuals, and estimating the peak BAC from amount consumed is subject to considerable
uncertainty.41 Jokipii58 devoted his thesis work to comparing blood-alcohol profiles under
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controlled conditions in healthy subjects and in those with various diseases (livier cirrhosis,
acute hepatitis, hyperthyreosis, diabetes mellitus, and neurocirculatory asthenia or dystonia).
This publication is unfortunately not widely available, although its salient features were
reviewed with the conclusion that these particular pathological states did not cause distorted
alcohol burn-off rates or abnormal distribution volumes of ethanol compared with healthy
control subjects. 59
Drunk drivers with de facto diseased liver, such as alcohol hepatitis or cirrhosis, insist that
this renders them slow metabolizers of ethanol compared with individuals having normal liver
function. Controlled studies of the effect of various liver diseases on the rate of disappearance
of alcohol from blood are rather sparse. Ethical issues preclude embarking on detailed investigations of this topic. Thosefewstudies available do not support the notion of a slower rate
of metabolism outside the limits of 0.009 to 0.025 g/dL/h seen in healthy individuals.60*63
Moreover, results of alcohol drinking experiments in patients with .cirrhosis are often confounded by the problem of malnutrition in these test subjects. This also leads to a slower
elimination rate of alcoholfromblood.52*63 In patients with cirrhosis and severe portal hypertension, where some blood isforcedto bypass the liver, there is some evidence to suggest a
slower rate of ethanol disappearance (0.007 g/dL/h). The reason for thisfindingis probably
diminished flow of blood to the alcohol metabolizing enzymes, and not so much necrosis of
the liver tissue.64
People sufferingfromchronic liver disease often accumulate afluidin the peritoneal cavity
called ascites.63'66 Indeed, ascites is one consequence oflong-term abuse of alcohol and alcoholinduced cirrhosis. Because the ascitesfluidis mainly water, this furnishes a body fluid reservoir
for ethanol increasing the person's volume of distribution. The volume of ascites fluid can vary
widely between different individuals, and up to 5 liters is not uncommon. An increased total
body water in patients with ascites raises the volume of distributionforother hydrophilic drugs
besides ethanol. The concentration of alcohol in ascites will be closer to the concentration in
plasma and serum than in whole blood. When alcohol has been cleared from the blood
circulation the pool of alcohol in the ascitesfluidcan redistribute back into the bloodstream.
However, alcohol cannot concentrate in this fluid space and ascites fluid should therefore
contain approximately 10 to 20% more alcohol than an equal volume of whole blood. like die
situation with urine (see Chapter 5), there should also be atime-lagin the clearance of the
alcohol from ascites fluid compared with blood.
Most of the scientific evidence indicates that alcoholics generally tend to metabolize
alcoholfesterthan moderate drinkers owing to induction of the microsomal enzyme denoted
P4502E1, one of the consequences of long-term heavy drinking. 67 In a recent study in
alcoholics undergoing detoxification with initial BACs of 0.20 to 0.45 g/dL, the burn-offrate
(fi-slopes) rangedfrom0.013 to 0.036 g/dL/h with an average of 0.022 g/dL/h. ** A similar
mean value was reported when the work of several research groups based in Germany were
compiled together; average elimination rate 0.022 ± 0.005 g/dL/h (mean ± SD). * Many
DUI suspects arc clearly alcoholics, and in a study of 1090 apprehended drunk drivers from
whom two blood samples were taken 60 min apart, the mean £-slope was 0.019 g/dL/h with
95% limits of agreement of 0.009 to 0.029 g/dL/h, being in dose agreement with values for
alcoholics during detoxification.46
Individuals sufferingfromdiabetes mellitus with impaired glucose metabolism might have
elevated concentrations of ketone bodies, including acetone, circulating in their blood. Note
that the acetone produced can also become reduced to isopropanol in the liver through the
alcohol dehydrogenase pathway.70 However, when modern gas chromatographic (GC) methods are used for blood alcohol analysis, acetone and isopropanol are easily distinguished, so
defense challenges directed at die lack of specificity of GC methods of alcohol analysis are
therefore pointless if two or more different stationary phases are used for the chromatography.71 There is no evidence to suasest that the rate of ethanol metabolism should be any
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different in people suffering from diabetes compared with healthy control subjects.72'75 The
metabolic disturbances associated with insulin-dependent diabetes arc. not related to the
enzymes involved in the disposal of ethanol.74 Total body water and activity of alcohol
dehydrogenase enzymes decreases in states of malnutrition and protein deficiency, and this is
reflected in slower burn-off rates of alcohol-73*76 However, moderate losses of body water after
prolonged sauna bathing did not result in any marked differences in the shape of blood-alcohol
profiles.77 A low relative TBW/kg body weight is associated with a smaller volume of distribution for ethanol and this explains the well known male-female difference in peak BAC and
area under the curve for the same dose of alcohol per kg body weight. 78 The distribution
volume of ethanol was shown to decrease in male subjects between the ages of 20 to 60 years
along with a decrease in total body water in the elderly.79
People involved in traffic accidents might be badly injured and suffer from shock and
hemorrhage owing to massive losses of blood. This raises the question about the influence of
trauma and shock on the hepatic metabolism of alcohol and the resulting blood-alcohol
profiles.*0-*2 In a recent study with 10 subjects involved in accidents when under the influence
of alcohol, and suffering from poly-traumatic shock, a scries of venous and arterial blood
samples were obtained for determination of ethanol.83 The rate of alcohol disappearance from
blood ranged from 0.017 to 0.021 g / d L / h (mean 0.018 g/dL/h) and these values were the
same regardless of whether arterial or venous blood sampling sites were used. THe results of
this study confirm many other anecdotes and case reports regarding alcohol pharmacokinetics
in people injured when drunk.80**2 Hypovolemic shock following massive loss of blood will
result in a redistribution of bodyfluidsand higher proportions ofplasma enter the intravascular
space to maintain an effective circulation and tissue perfusion.84 This might alter the relative
distribution of some protein-bound drugs and endogenous substances between body compartments, but the concentration of alcohol in the blood is not markedly influenced.85'86 Nevertheless, some people continue to speculate about the impact of trauma on blood-alcohol concentrations and alcohol bum-off rates, even though a careful review of the literature shows that
there is no substance to these opinions.87
13JL13 Drug-AIcobol Inteiactions
The use of various tonics (elixirs), cough syrups, over-the-counter medications, or even
foodstuffs that might contain alcohol, will obviously result in alcohol appearing in the blood.88
Some cough medicines, vitamin mixtures, pick-me-ups, and other health-store products may
contain considerable quantities of alcohol (>10% v/v), and overdosing with these products will
obviously elevate a person's BAC. By how much the BAC rises will depend on die quantities
consumed and the timeframein relation to driving. Medication taken in tablet form or drugs
applied externally can hardly be expected to lead to alcohol appearing in the blood. Psychopharmacological agents such as benzodiazepine derivatives may cause increased impairment
when taken together with alcohol because of interaction at the GABA receptor complex in the
brain.89 However, there is no evidence to suggest that the resulting BAC will be any different
from that expected if the same dose of alcohol had been taken without the drug-90
Intake of alcohol can modify die pharmacokinetics and behavioral effects of drugs that are
oxidized by P4502E1 enzymes or which interact with the GABA receptor to elicit their effects
on the central nervous system.91 However, these changes do not result in altered alcohol
pharmacokinetics or a raised BAC above that obtained in control experiments when the same
dose ofalcohol was consumed on an empty stomach. One drug that does block the metabolism
of alcohol is 4-methyi pyrazoie which competes with ethanol for binding sites on the primary
metabolizing enzyme AJDH.92 However 4-MP is not currently manufactured by any drug
companies even though it may have legitimate therapeutic uses in the treatment of patients
poisoned with methanol or ethylene glycol.93*94
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13JLU6 Gastric Alcohol Dehydrogenase
The enzyme mainly responsible for the metabolism of alcohol is called alcohol dehydrogenase
(ADH) and this is located in the liver and to a minor extent also in other organs and tissue such
as the kidney and the mucosa of the stomach.95 Recent studies have shown that gastric ADH
is seemingly less active in women compared with men and also in alcoholics compared with
moderate drinkers, and the overall activity decreases with advancing age.9* About 10 years ago
the suspicion arose that part of the dose of alcohol consumed was metabolized in the stomach
by gastric ADH. This process was known as pre-systemic metabolism orfirst-passeffect. This
meant that the effective dose of alcohol reaching the systemic circulation depended on the
efficacy of gastric ADH enzymes. Sex-related differences in gastric ADH offered another
mechanism to explain why women reach a higher peak BAC than men for the same dose of
alcohol.97 If a part of the dose of ethanol is metabolized by gastric ADH, this would explain
the observation of a smaller area under the BAC-time profile after oral intake compared with
intravenous administration of the same dose. Prolonged retention of alcohol in the stomach,
such as after drinking together with or after a meal, allows more opportunity for pre-systemic
oxidation by gastric ADH to occur.98*99
Interest in the role played by gastric ADH in the overall metabolism of ethanol received
a boost when in-vitro studies showed that the enzyme extracted from gastric biopsies was
inhibited by certain commonly prescribed drugs. Among others, aspirin and the H2-receptor
antagonists, ranitidine and cimetidine, used in the treatment of gastric ulcers and inhibition of
secretion ofexcess stomach acid, were capable of blocking the action of gastric ADH according
to in-vitro enzyme inhibition assays.100*101 This led to the suggestion that people taking this
medication, which is widely used in society, and now available without prescription in the ILS.,
run the risk of obtaining higher Than expected BACs and, therefore, a potentially more'
pronounced impairmentfromthe alcohol they consume.102*103 The drugs seemingly promote
the bioavailability of ethanol by removing the potential for oxidation of some of the alcohol
already in the stomach.102"104 Media coverage of this much publicized research triggered a large
number of defense challenges from individuals who claimed to combine their H2-receptor
blocking drugs with intake of alcohol.105 Studies purporting to show an enhanced bioavailability
of ethanol, and a higher peak BACfromthis drug-alcohol interaction were not very convincing. The number of volunteer subjects was often limited (N = 6) and very low doses of alcohol
(0.15 to 0.3 g/kg) were ingested 1 h after afet-richmeal. Moreover, die methods of alcohol
analysis were not appropriate considering that the maximum BACs reached were only 0.015
to 0.025 g/dL, being far removed from the statutory limits for driving in most US states,
namely 0.08 or 0.10 g/dL. 106Many subsequent studies involving larger numbers of subjects
and a better experimental design failed to confirm the enhanced bioavailability of alcohol when
H2-receptor antagonist drugs were taken together with a moderate doses of ethanol 0.15, 0.30,
or 0.60 g/kg.106-111 Accordingly, this defense challenge holds litde merit to explain a person's
BAC being above the legal limit for driving without intent. Many factors influence the,rate of
absorption of alcoholfromthe gut and the bioavailability of the dose particularly the amount
of food in the stomach before drinking. n& It is always good advice not to drink alcohol on
an empty stomach.
13.2.1.7 Endogenous Ethanol and the Autobrewery Syndrome
With the help of sensitive and specific methods of analysis, very low concentrations of ethanol
(0.5 to 1.5 mg/L) can be determined in bodyfluidsfrompeople who have not consumed any
alcoholic beverages.112'114 It seems that endogenous ethanol (EE) is produced in the gut by
microbes, bacteria and/or yeasts acting on dietary carbohydrates, but other biochemical
pathways also exist according to a comprehensive review of this subject.115 Indeed, the
existence of other metabolic precursors of EE was confirmed when ethanol was identified in
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blood and tissue samples from germ-free rats, because in these animals fermentation of
carbohydrates by microflora inhabiting the gut cannot be invoked as an explanation.116 Because
the portal blood draining the stomach and intestine must pass through the liver before reaching
the heart,, lungs, and systemic circulation, any EE formed'in the gut is probably eliminated
through the action of alcohol metabolizing enzymes located in the liver.117
Abnormally high (0.05 g/dL) concentrations of EE were measured in blood and cerebrospinalfluidfromhospitalized patients who had abstained from drinking alcohol.118*119 The
reports of this work were published in peer-reviewed journals, so these unusualfindingsgives
some cause for concern and warrant a carefully scrutiny. It seems that die methodology used
for measuring ethanol in biological specimens was rather primitive involving wet-chemistry
oxidation, which is not a specific means of identifying ethanol. Whether dietary factors or even
the medication prescribed to the patients were oxidized by the chemical reagents used in the
assay, producing falsely elevated concentrations of EE needs to be explored.120
If for some reason large quantities of ethanol are synthesized in die gastro-intestinal tract
and overwhelm the capacity of the alcohol-metabolizing enzymes in the fiver, then much
higher concentrations of EE should appear in the peripheral venous blood. This is exactly what
was described in a group of Japanese subjects who were suffering from various disorders of the
gut. Some had previously complained of experiencing feelings of drunkenness even without
consumption of alcohol.221"122 This condition seemed to appear after the subjects had eaten a
carbohydrate-rich meal, such as rice. This study from Japan was difficult to fault because
ethanol was identified in blood, urine, and breath with the aid of a reliable gas chromatographic
method for quantitative analysis.121 The term used to describe this abnormal production of EE
was "autobrewery syndrome7' and to our knowledge this has only been observed in Japanese
subjects.123 It is widely known that the activity of alcohol metabolizing enzymes, especially
aldehyde dehydrogenase, is different in Oriental populations compared with Caucasians, which
might render Japanese and other Asians less able to dear ethanol from the portal blood.59
Other requirements before "autobrewery syndrome* should be seriously considered as contributing to a person's BAG include genetic predisposition (Oriental origin), a past history of
gastrointestinal ailments, documented medical treatment for the problem, low tolerance to
alcohol, and reports of fatigue and drunkenness after eating meals.
The occurrence of EE has also attracted interest in clinical and diagnostic medicine as an
indirect way to furnish evidence of yeast infections in the gut.123 After obtaining a control pretreatment blood sample, the fasted patient receives a 5 g glucose load orally and a second blood
sample is taken again after 1 h. If the concentration of EE in the second blood sample is
significantly higher than in the first, this indicates the possibility of a bacteria or yeast
overgrowth in the stomach or small intestine causing a gut-fermentation reaction. Many studies
from various countries have confirmed the existence of EE in blood and other biological media
from healthy human subjects, but the concentrations rarely exceed 1.0 mg/L, which is about
1000 times less than the statutory BAC for unfitness to drive in most US states (0.10 g/dL
• 1.0 g/L * 1000 mg/L). These vanishingly small concentrations lack any forensic significance
except in exceptional circumstances such as that described for Japanese subjects suffering from
gastrointestinal disorders (autobrewery syndrome).121 Concentrations of EE in blood samples
from people with diabetes meilitus as well as other metabolic disorders, were not much
different from values in healthy control subjects.115
13.2.2 URINE SAMPLES
It has been known for more than a century that only a small fraction (about 1 to 2%) of the
quantity of alcohol a person consumes is excreted unchanged in the urine.124^25 Indeed,
collection and analysis of urine was recommended by Widmark as a chemical test to prove that

Drug Law /1017
a person had been drinking and as an aid in the clinical diagnosis ofdrunkenness.125 When urine
is used as a bodyfluidfor analysis of alcohol in traffic law enibrcement, great care is needed
with the sampling protocol to ensure valid interpretation of results.2*'29'126'127 This follows
because the concentration of alcohol in urine does not relate to the concentration in the blood
at the time of emptying the bladder.29 Instead, the UAC reflects the average BAC during the
time period in which the urine is being produced and stored in the bladder after the previous
void.128 During this storage time, the BAC might have changed appreciably and even reached
a zero concentration. In the morning after an evenings drinking it is not uncommon to find
that thefirsturinary void contains a relatively high concentrations of alcohol, whereas blood
or breath-alcohol content are below the limits of detection with conventional analytical
methods.129 The morning UAC reflects the person's average BAC during the night after the
last void before bedtime.
In Great Britain urine specimens were approved for evidential purposes after the Eoad
Traffic Act of 1967, when an alcohol concentration of 80 mg/dl blood or 107 mg/dL urine
were accepted as per se evidence of unfitness to drive safely.14 However the rules and regulations required the collection of two samples ofurine about 30-60 nun apart.14 Thefirstvoid
empties the bladder of old urine, and the concentration of alcohol measured in the second void
reflects the person's blood-alcohol concentration at the mid-point of the collection period.
Because mine contains about 20% more water than an equal volume of whole blood, the
concentration of alcohol in the urine produced, at the ureter will always be higher than the
concentration in bloodflowingto the kidney.2**29 The urine/blood ratio in the post-peak phase
of alcohol metabolism is about 1.33:1 on the average, although large inter- and intra-individual
variations exist.128 Studies have shown that the urine/blood ratio of alcohol as well as its
variability increases as the blood-alcohol concentration decreases.28*29 The mean ratio of 1.33:1
is higher than expected on the basis ofwater content differences (1-2:1), in part because of the
time-lag between formation ofurine in the ureter and storage in the bladder before voiding
(see Chapter 5). With relatively short storage times the UAC/BAC ratio might be dose to tie
value expected theoretically of 1.2:1. Note that in UK traffic-law enforcement, the DUI
suspect's BAC is not estimated indirectlyfromthe measured UAC. Instead, the legislature has
adopted an alcohol concentration of 107 mg/dL in urine as being equivalent to 80 mg/dL
in blood (107/80 = 1.33 ). This approach is similar to the way that the threshold limits of BrAC
have been derivedfromthe existing BAC, by dividing by the blood/breath conversion factor
adopted by the legislature in the respective countries (see Table 13^2.1). Indeed, because of
individual variations in the urine/blood and breath/blood ratios of alcohol, it is strongly
recommended that UAC or BrAC not be converted into a presumed BAC as a measure of guilt
in DUI prosecution. Instead, the threshold concentration of alcohol should be defined in terms
of the substance analyzed whether this is breath or urine. IS»i6
Not many jurisdictions allow the concentrations of alcohol determined in urine specimens
as binding evidence for prosecution in DUI, especially when per se statutes operate. This
caution is well founded if the measured UAC has to be translated into the presumed BAC
because the urine/blood ratio is highly variable between and within individuals and also
changes as a function of the BAC. However, unlike most other drugs, the UAC/BAC ratio is
not influenced by diuresis because alcohol is handled by the kidneys exactly like water in a
passive diffusion process.126 Increasing the volume ofurine exacted by drinking large volumes
of water may dilute the urine as reflected by its osmolality and creatinine content but the
concentration of alcohol in the specimen will remain unchanged.130 One objection often raised
against the use of urine-alcohol evidence in prosecution of DUI suspects is that some people
cannot completely empty their bladders on demand. The retention of old urine with a higher
content of alcohol than expected for the prevailing BAC at the time of voiding introduces
uncertainty.131 The prevalence ofurine retention in the population at large is hard to estimate
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Table 13.2.1 Evidential Breath-Alcohol Instruments Currently UsedforForensic Puiposes in Europe and
North America. The Statutory Limits of Blood-Alcohol (BAQ and Breath-Alcohol (BrAQ
Concentration are Also Reported
Breath analyzer
Country
Sweden*
Intoxilyzer 5000S
Finland*
Alcotcst 7110
Intoxilyzer 5000N
Norway
Great Britain Intoximeter 3000
Camic Breath Analyzer
Not yet decided
Ireland
Holland
DataMaster
Aicomat
Austria
Ethylometcr 679T
France
U.S.*
Breathalyzer 900
Intoxilyzer 5000
DataMasrer
Intoximeter 3000
Breathalyzer 900
Canada
Intoxilyzer 5000
Germany
Not yet decided
Not yet decided
Denmark

Br AC limit
0.10 mg/L and 0.50 mg/L
0.25 mg/L and 0.60 mg/L
0.25 mg/L
35 }ig/100 mL

BAC Limit
0.20 and 1.00 mg/g
0.50 and 1.20 mg/g
0.50 mg/g
80mg/dL

35 Jig/100 mL
220jig/L
0.40 mg/L
0.25 mg/L
0.10 and 0.08 g/210 L

80mg/dL
0.50 mg/mL
0.80 mg/mL
0.50 mg/mL
0.10 and 0.08 g/dL

0.08 g/210 L

80mg/dL
0.80 g/kg
0.80 mg/g

—
—

* Sweden and Roland have a two tier legal limit with more severe penaltiesfar a DUIsuspectwith a high BAC.
In some CLS. states several different breath-alcoholt7Utru7nentsareapprovedforfvreTisic purposes OT^the^e^oU limits
of blood and breath alcohol concentration vary from state to state.
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although this problem is seemingly more common in older men, and some studies have
detected as much as 25 mL of residual urine.151 However, tie impact of urine retention on the
concentration of alcohol determined in successive voids and the magnitude of error incurred
if the UAC is converted into presumed BAC has not been demonstrated experimentally.
Because some people might excrete glucose in their urine,132 especially those suflering from
diabetes mellitus,133 there is always a risk that ethanol can be produced in-vitro through the
fermentation of sugar by micro-organisms or yeasts infecting the bladder or urinary tract.134*133
Some reports daim that ethanol can be produced in the bladder itself, so called bladder beer.136
This makes it important to include chemical preservatives such as sodium or potassium fluoride
at a concentration of at least 1% w / v or sodium azide in the collecting tubes to inhibit microbial
synthesis of ethanol.136'137 Storage of urine specimens in a refrigerator immediately after
collection will also help to hinder the synthesis of alcohol through the action of Candida
albicans acting on glucose as substrate.157
Some new research findings have demonstrated that production of alcohol directly in the
bladder or in the collecting tubes in vitro after sampling can be detected by measuring in the
urine the concentration of 5-hydroxytryptophol (5HTOL), a minor metabolite of serotonin.138
The concentration of 5HTOL increases in blood and urine during hepatic oxidation of
ethanol, so a normal concentration of 5HTOL in urine and an elevated concentration of
ethanol suggest that the alcohol was synthesized after voiding from the action of bacteria or
yeasts on carbohydrate or other substrates.139
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13JL3 BLOOD SAMPLES
13JL3.1 Use of Alcohol Swabs for Skin Disinfection
Blood specimens collected for alcohol analysis in traffic law enforcement are generally taken
from an antecubital vein with the aid of sterile equipment such as evacuated tubes (Vacutainer)
or disposable plastic syringe and needle. Preparation of the skin at the site of blood sampling
with disinfectants such as ethanol (70% v/v) or isopropanol (70% v/v) should obviously be
avoided if specimens are intended for clinical or forensic alcohol testing. Because sterile
equipment is used, disinfection of the skin at the site of sampling is not really necessary and,
instead, cleaning the skin with saline or soap and water is sufficient. Nevertheless, alleged
contamination by ethanol or isopropanol in the swabs used to disinfect the skin is sometimes
raised as a defense challenge in attempts to invalidate results of blood-alcohol analysis.140*141
Note however that any method used for forensic alcohol analysis should be able to distinguish
between ethanol and isopropanol.
Many studies have been done to evaluate the risk of carry-over of alcohol from the
antiseptic used to swab the skin before the specimen of venous blood was taken for
analysis.142*143
A classic example of giving the benefit of the doubt was demonstrated when several
hundred convictions for DUI in Great Britain were deemed invalid and the sentences overturned. This was felt necessary because the swabs normally issued with kits for blood-sampling
from DUI suspects had been inadvertently switched to another brand which contained
isopropanol.144 The legal alcohol limit in UK is 35 jig/100 mL breath and if the result is
between 40 and 50 (ig/100 mL the suspect can opt to provide a blood sample instead and the
BAC is then used as evidence for prosecution (threshold BAC » 80 mg/100 mL). Because of
reported large discrepancies between BAC and BrAC in this kind of paired test, die swabs used
to clean the skin before drawing blood became suspect. This suspicion was strengthened when
the swabs were shown to contain alcohol (isopropanol). This led to an official investigation.
The convictions of several hundred individuals who had pleaded guilty to DUI and had
received their sentences were considered unsound and quashed. It appears that this decision
was reached by the court of appeals because the integrity of the blood specimen was cast in
doubt, and the defendants were not aware of this when they were asked to plead guilt or not
guilty to I)UI. This led to several controlled studies into the risk of carry-over of alcohol from
the swabs used to disinfect the skin. The results however showed that contamination of the
blood sample with various alcohols during venipuncture was highly unlikely and in most
studies, only traces or no alcohol at all could be detected in the specimens.145*149
If evacuated tubes are used for sampling blood, then two tubes should befilledwith blood
in rapid succession and gently inverted several times to mix with the chemical preservatives. If
some coagulation does occur, the sample should be homogenized prior to sampling to prevent
inadvertent aliquoting of the serum fraction which would contain more alcohol than a
specimen of whole blood. The chemical preservatives are typically sodium fluoride (NaF),
which prevents glycolysis and inhibits certain enzymes and micro-organisms that might be
present in the blood, and potassium oxalate which serves as an anticoagulant. These substances
are already in the tabes as supplied by the manufacturer, although the necessity of having
sodium fluoride in sterile Vacutainer tubes is open to discussion because contamination with
bacteria can in reality only arisefromthe skin at the point of inserting the needle. Nevertheless,
NaF should be included if only to prevent this defense challengefrombeing raised; the amount
of NaF recommended for blood specimens taken from living subjects is 100 mg/10 mL blood
(1% w/v). If the amount actually present is challenged then methods are available to assay
blood samples forfluorideions such as by using ion-sensitive electrodes or by other means.150
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In the event that alcohol-containing swabs are used, the practice of always taking two tubes
of blood for analysis has the advantage that any unusually large discrepancies in the results of
BAC between the two tubes can be detected. If present, this might suggest carryover or some
other problem. However, the studies from the UK cited above confirm several earlier reports
which demonstrated that the risk of carryover of alcohol, even when 70% ethanol was used as
an antiseptic is virtually non-existent.149*151 Another safeguard when filling evacuated tubes
with blood is to remove each tube from the collecting needle and holder before withdrawing
the needle from the puncture site.151
The concentration of alcohol in stored blood samples decreases on storage at 4°C despite
the inclusion of 1% w / v NaF as preservative.152 The rate of loss of alcohol is only about 0.003
g/dL per month, and evidently occurs by a non-enzymatic oxidation reaction that involves
oxyhemoglobin.132453 If blood specimens become contaminated with micro-organisms when
the Vacutainer tubes are opened to remove aliquots for analysis, this can lead to a much more
rapid disappearance of alcohol during storage compared with unopened tubes. It seems that
various species of micro-organism utilize alcohol as a food.140 Other considerations regarding
specimen collection include filling the tube with as much blood as possible, to avoid having
a large airspace. Volatiles including ethanol will accumulate in the headspace and will be lost
when die tube is opened. In the event that a tube is opened and closed repeatedly, this could
result in appreciable losses of alcohol.
The question of uptake of alcohol through the skin as a mode of entry into the body to
produce elevated BAC has been raised as a defense challenge by people working with large
volumes of solvents. In fact, the absorption of ethanol through the skin was investigated many
years ago by Bowers et al.154in controlled experiments with several children and one adult. The
legs of the test subjects were wrapped in cotton soaked in 200 mL of 95% ethanol and secured
with rubber sheeting and sealed with adhesive tapes. Blood samples were taken before and at
various times after this treatment but neither clinical signs of intoxication nor raised BAC were
noted. It seems safe to conclude that no appreciable amounts of ethanol can accumulate in the
body. BAC is not increased by absorption through intact skin.
13JL3JL Trauma and Intravenous fluids
Drunk drivers are often involved in serious road-traffic accidents causing injury and sometimes
death. Trauma resulting in massive losses of blood precipitate a hypovolemic shock and this
requires swift emergency treatment. This might involve administering medication at the site of
the accident such as pain killers and intravenousfluidsto counteract shock and replace depleted
bodyfluids.More intensive treatment can be given on arrival at a surgical emergency unit and
it is usually at this point that a blood sample is taken for clinical and/or medicolegal puiposes.
The sampling of blood for analysis of alcohol in a critically injured patient requires considerable
deliberation to safeguard the integrity of the patient and the specimen. Errors incurred in
sampling blood from trauma patients are not uncommon, and they are beyond the control of
the forensic laboratory.155 Care is needed if intravenous fluids are administered as afirstaid for
treatment of shock, and it is important that the blood sample for alcohol analysis is not taken
downstream firom the same vein used for infusion. Otherwise, this can result in a marked
dilution of the specimen and a decrease in the concentration of alcohol. If dilution of the
specimen is suspected, this can sometimes be verified by determination of hemoglobin.155
Routinely analyzing aliquots of blood from two Vacutainer tubes that are filled in rapid
succession fcraishes a useful way to reveal discrepant results and problems associated with
blood sampling. If the tube-to- tube difference in BAC exceeds that expected from knowledge
of random analytical errors and past experiences, this points to other influences such as preanalyrical factors. Abnormally large differences in BAC between the two tubes can often be
traced to dilution or coagulation of one or both of the samples because of inadequate mixing
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after collection. Note that the concentration of alcohol measured in plasma or serum will be
higher than in whole blood by about 10 to 15% as discussed in detail elsewhere.156
13JL33 Blood-Water Content and Hematocrit
The water content of whole blood is easily determined by weighing an aliquot and heating
overnight at 105 to 110°C to reach a constant weight.156 The change in weight after desiccation can be used to calculate the water content of the blood specimen. According to the
scientific literature whole blood contains 85 g water per 100 mL (95% range 83.0 to 86.5 g /
100 mL).157 The specific gravity of blood is 1.055 so the water content is 5.5% less when
expressed in mass/mass units; 85.0% w/v corresponds to 80.6 % w/w. 157 Women tend to have
approximately 1 to 2% more water than men for the same volume of whole blood owing to
loss of red cells during periods of menstruation.158
Whole blood is composed of a plasmafraction,red blood cells (erythrocytes), white blood
cells (leukocytes), and platelets. Blood hematocrit is defined as the volume of packed cells per
100 mL of whole blood when expressed as a percentage. Normal values for hematocrit in men
are 42 to 50% compared with 37 to 47% in women.159 The red cells (erythrocytes) carry the
hemoglobin and contain about 73 mL of water/100 mL cells whereas plasma contains 93 mL
of water/100 mL plasma. Assuming a hematocrit of 40%, the water content of whole blood
should be (0.40 x 73) + (0.60 x 93) or 85 mL water/100 mL of whole blood. This value
agrees well with gravimetric determinations of blood-water by desiccation when a mean 85.6%
w/v was reported.156 Because the red-cells contain so much water and the feet that alcohol
distributes in blood according to the water content of the various components, it must be
obvious that even fairly wide variations in hematocrit will not make much difference to the
concentration of alcohol per unit volume of whole blood.
This was confirmed empirically when blood was prepared in-vitro with hematocrit values
of 18, 31,39, and 60.160Thc specimens were spiked with the same amount of ethanol to give
a BAC of 0.212 g/dL and the actual concentration in each blood sample was determined by
gas chromatography to be 0.211, 0.211, 0.207, and 0-208 g/dL respectively. Thus, no
influence of varying hematocrit from 18 to 60 on the alcohol concentration in the whole
blood.160 However, if equilibrated headspace vapor above the same blood specimens had been
analyzed, the specimen with lowest hematocrit (large plasma portion and more water per unit
volume) would have had a lower headspace concentration of ethanol compared with the
specimens with higher hematocrit (low plasma portion and therefore less water content per unit
volume).138 This follows because the concentration of alcohol in the vapor phase will be higher
for the blood specimen with least water and therefore containing a higher concentration of
alcohol per mL blood-water.15S
A blood sample with abnormally low hematocrit means a low number of blood cells and
also a low hemoglobin content, which might be associated with a patient suffering from
anemia. The other extreme is polycythemia which is an over abundance of red cells per unit
volume of blood and therefore an abnormally high hematocrit in this condition. The question
of whether variations in hematocrit influence the maximum BAC reached from intake of a
known amount of alcohol is difficult to answer because large changes in hematocrit arc often
associated with changes in the distribution of body water in general and therefore with an
altered volume of distribution for ethanol.161
13.2.4 BREATH-ALCOHOL ANALYSIS
Historical developments in testing for alcohol intoxication by use of chemical analysis of blood
or breath were recently reviewed.162. Breath-tests for alcohol are currently used in forensic
science practice and traffic law enforcement for two main purposes. The first and least
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Table 13.22 Examples of the Most Commonly Used Hand-Held Breath-Alcohol Devices
for Roadside Breath-Alcohol Screening Purposes and for Estimating the
Coexisting Mood-Alcohol Concentration*
Breath-test instrument Method of alcohol analysis
Alcolmetcr SD-2
Electrochemical oxidation
Alcolmetcr SD-400
"
Alcotcst 7410
Hecrrochemical oxidation
Alcosensor III and IV
Electrochemical oxidation
Alcodoose IE
Infrared Absorption (9.5 Jim)

Manufacturer and country
Lion Laboratories, UK
DrSger, Germany
Intoximctcrs Inc., U.S.
Seres, France

*To estimate BACfrom BrAC, the breath analyzers mzestheprc-calibratedwith a bloodzbreath
factor such as 2100:1 or 230(hL

controversial application involves roadside pre-arrest screening to furnish an objective indication of alcohol involvement and whether or not the driver might be above the critical legal limit
for driving. In many situations, the police require probable cause before a chemical test for
alcohol can be administered. This requires observations about the way the person was driving,
and evidence of impairment from use of field-sobriety tests, which are important concerns
before making an arrest and administering the chemical test for alcohol. Various hand-held
devices are currently available for measuring breath-alcohol concentration at the roadside
(Table 1322). The most popular method of roadside breath testing involves die principle of
electrochemical oxidation of alcohol with a fuel cell sensor and this technology is fairly selective
because endogenous volatilcs such as acetone and methane do not react with tills land of
detector. However, if acetone is reduced in the body to isopropanol, this secondary alcohol is
oxidized widi the fuel cell sensor and can give a response which cannot be distinguished from
ethanol.16S
The results of roadside breath-testing might be displayed as colored lights such as pass
(green), warn (yellow) or fail (red) or as a digital display of breatfi-alcohol concentration in
units such as mg/L or g/210L depending on the particular jurisdiction (Table 13.2.1). If the
screening test gives a positive response this indicates the driver has been drinking and may be
over the legal limit which is sufficient probable cause to demand a specimen of blood or breath
for evidentialforensicanalysis. The suspect is then taken to apolice station where an evidential
breath-alcohol test is conducted; examples of instruments used in various countries are given
in Table 13.2.1. When properly calibrated and operated, the hand-held screening devices can
be as accurate as any other breath test instrument. Some of die limitations of screening devices
when used for quantitative evidential purposes include, the lack of protection they provide
against interference from mouth alcohol, the lack of blank tests or calibration control tests, the
feet that they can generate low results at low temperatures, and also that for some older devices
(Alcosensor m , Alcolmeter SD-2) the results are operator dependent; releasing the button
before the reading has stabilized will generate a low result. Breath-alcohol instruments used for
quantitative evidential purposes arc generally more sophisticated than the hand-held screening
devices and provide a printed record of results with date, time, location of the test as well as
computer-storage of results for generating statistical reports. Moreover, these devices ensure
that end-expired breath is being sampled and that residual alcohol in the mouth from recently
drinking or regurgitation has dissipated.
A critical element in performing an evidential breath-alcohol test is always to observe the
suspect for at least 15 min before making the breath test. During this time he or she should
not be allowed to drink, eat, smoke, or place anything in the mouth prior to completing the
test. Moreover, a duplicate test should be made not less than 2 min and not more than 5 min
after completion of thefirsttest. The instrument calibration must be controlled in conjunction
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with testing the subject and this is accomplished, with a breath-alcohol simulator device ox
alcohol in compressed gas tanks. Analysis of the room-air provides a blank test result before
and between making the duplicate tests with the subject. All these requirements have been
described in detail elsewhere and are important for ensuring a successful evidential breath
testing program, that will withstand scrutiny.164 Regardless of these many new developments
and improvements in the technology of breath-alcohol testing, challenges against the reliability
of the results are fer more common than against the results of blood-alcohol analysis. This
probably stemsfromthefeetthat breath-testing is performed by police officers whereas bloodalcohol analysis is done at government laboratories by chemists some of whom have research
experience or a Ph.D. degree. Furthermore, the blood sample is usually retained and can be
re-tested if there is any doubt about the results, whereas breath samples are generally not
preserved and therefore cannot be re-tested.
13JL4.1 Month Alcohol and Use of Mouthwash Preparations
Even during the first studies of breath-alcohol analysis as a test for intoxication, it was
emphasized that testing should not be conducted too soon after the last drink.16S Thus, Emil
Bogen in his landmark article, which was published in 1927, made the following statement;
As soon as the disturbing factor of alcoholic liquor still in die. mouth is removed, which occurs
usually withinfifteenminutes after imbibition, in the absence of hiccuping or belching, the
alcoholic content of 2 liters of expired air was a little greater than 1 cc of urine
A multitude of studies have been done since the 1930s to confirm the importance of a 15min deprivation period after the last drink even though this problem is sometimes rediscovered
from time totime.166Most experiments on the influence of residual mouth alcohol on breathtest results have generally involved human subjects initially alcohol-free who are required to
hold solutions of alcohol (40% v/v) in their mouths for 1 to 2 min without swallowing, i*7*6*
Immediately after expelling the alcohol, the test subject undergoes a scries of breath tests at
1- to 2-min intervals for 20 to SO min. The results show that within 15 to 20 min after ejecting
a strong solution of alcohol from the mouth, the response of the breath-alcohol analyzer is
always less than 0.01 g/210 L which is generally considered the threshold for baseline readings.
Other study designs have involved measuring breath-alcohol in subjects after they drink alcohol
to reach a certain BAC level.169 After drinking more alcohol, breath-tests are made repeatedly
until the results recover to the pre-drinking BrAC. Under these test conditions, the time
needed to dear the residual alcohol from the mouth was even less than 10 min. 169
Accordingly, on the basis of experiments such as these, rules and regulations for evidential
breath-alcohol testing stipulate a 15 to 20 min observation period before conducting an
evidential breath-alcohol test. During thistimethe suspect should not be allowed to smoke or
drink or place any material in the mouth, and if he or she regurgitates or vomits, the
observation period must be started again. Although a 15-min observation period is not
mandated prior to conducting roadside breath-alcohol screening test, in practice, a considerably longer time will usually have elapsed since the last drink was taken, unless the drinking
took place while the subject was driving. The time involved in stopping the vehidc, and
contacting the driver, as well as any necessaryfieldsobriety testing will usually take longer than
15 min. For reliable quantitative determinations however, the 15-min deprivation period
should be observed and documented.
Many mouth-wash preparations contain alcohol as well as other organic solvents, and the
* concentrations of ethanol sometimes are as high as 50 to 60% v/v. Obviously the use of these
materials prior to conducting a breath-alcohol test would produce similar disturbances on
breath-test results as having alcoholic beverages in the mouth. Provided that the 15 to 20 min
rth«ervaririn rime is maintained- use of breathfreshenerscontaining: alcohol will not have any
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negative impact on the reliability of the test result. 170 However, if these preparations are
intentionally or unintentionally consumed, this will be a source of alcohol just like drinking an
alcoholic beverage. In a recent study with commercial mouthwash products; Iisterine (29.6%
alcohol), Scope (18.9% alcohol), and Lavoris (6.0% alcohol) tests were made on a breathalcohol a&alyzcr after rinsing the mouth with these preparations. Within 2 min of rinsing the
mouth, breath-test results were as high as 240 mg/dL (expressed as BAC equivalent) but
within 10 min this had dropped exponentially and was well below the threshold limits for
driving (0.08 to 0.10 g/dL). By 15 min post-rinsing, the readings were below 0.01 g/dL.
Similar results, namely no significant response with an infiared breath-alcohol analyzer were
obtained 15 to 20 min or more after various mouthwashes, aftershave lotions, and perfumes
in common use were tested in Germany.1?l
13JL4s2 Regurgitation and Castro Esophageal Reflux Disease (CERD)
The pioneer work by Bogen 165 indicated that hiccuping, burping, and belching might present
a problem in connection with breath-alcohol analysis. Only very limited investigations of this
problem have been made, but these indicate that the risk of elevating breath-alcohol readings
is greatest shortly after the end of drinking as might be expected because the concentration of
alcohol in the stomach is then at its highest.172*173 A closely related problem is gastroesophageal reflux disease (GEBD).174rl77Many people suffer from acid-reflux disorders, known
as reflux esophagitis, whereby gastric secretions as well as other liquid contents erupt from die
stomach into the esophagus and sometimes reach the mouth.17*1*0 Indeed, this condition
might be aggravated after drinking certain alcoholic beverages.181482 The impact of GERD on
results of evidential breath-alcohol testing has not yet been investigated in .any controlled
studies. Nevertheless, this medical condition has been raised as a defense challenge from DUI
suspects who maintain they experienced a refluxfromthe stomach into the mouth immediately
prior to providing a breath-alcohol sample.183 The higher the concentration of alcohol prevailing in the stomach during a reflux, the greater the risk of contaminating the breath-sample in
a similar mechanism to the mouth-alcohol effect. From this follows the contention that GERD
is the cause of a person's BrAC being above the legal limit for driving, and medical experts have
testified to this effect which has led to the acquittal of a DUI suspect.184 However, the validity
of this defense argument was strongly questioned by another expert as being one of the least
convincing and he also noted that the doctors appearing for the defense "ignored one of the
basic maxims in the business" namely "what the subject says he has drunk is not evidence".185
Although most evidential breath test instruments feature "slope detection" to disclose the
presence of mouth alcohol, in some cases these may not detect small contributions caused by
belching or burping. A far better approach to counter the GEBD defense challenge is always
to observe the subjca carefully, and to perform duplicate breath-alcohol analyses, that is two
separate exhalations 2 to 3 min apart. 18S Obtaining dose agreement between the two
independent results speaks against the influence of regurgitation of stomach contents having
a high concentration of alcohol just prior to making the first breath-test or between the first
and the second test. Also the ride of GERD adding to the breath test results decreases as the
time after ingestion of alcohol increases because of the ongoing absorption of alcohol from the
stomach and the emptying of the stomach contents into the duodenum. Evidential breathalcohol programs that require a single breath-alcohol test are out of date and should be
abandoned especially if GERD is a recurring defense argument. The single chemical test for
alcohol has no place in jurisdictions where per se statutes operate, regardless of whether blood
or breath analysis is used for forensic purposes.
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13JLA3 Dentures and Denture Adbeshres
The question of whether people with dentures or individuals who might be-fitted with special
bridge-work where alcohol can be trapped has arisen as a possible cause of obtaining a falsely
elevated breath-alcohol reading,186*187,This challenge is therefore akin to having residual alcohol
in the mouthfromrecent drinking. The empirical evidence supporting the notion that alcohol
becomes trapped under denture plates or in other structures or cavities in the mouth for long
periods of time is not very convincing, although a few isolated case reports support this defense
argument.188 A person suspected for DUI in the U.K. was acquitted when expert testimony
raised a reasonable doubt about the validity of the evidential breath test performed using an
Intoximeter 3000 breath alcohol analyzer, owing to alcohol allegedly being trapped in cavities
in the mouth as a result of dental treatment.186 However, the eaqperiments and reasoning
presented to support lids defense argument were speculative, not very convincing, and were
easy to fault.187 An acquittal in a DUI case in the U.S. was obtained when expert evidence
suggested that the breath-test results were suspect because of alcohol being absorbed by the
particular kind of denture adhesive used by the defendant.188
The most convincing study appearing in a peer reviewed journal and dealing with breathalcohol testing and the use of dentures involved the participation of 24 subjects.189 They were
tested under various conditions; with dentures intact, with dentures removed, and with
dentures held loosely in place both with and without adhesives. The volunteers held 30 mL
of 80 proof brandy in their mouths for 2 miir without swallowing. After ejecting the alcohol,
breath-alcohol tests were made with an Intoxilyzer 5000 instrument at regular intervals. After
an elapsed time of 20 min, no results were above 0.01 g/210 L. 189 This argues convincingly
against the idea of people who wear dentures obtaining falsely elevated breath-alcohol concentrations. The widely practiced deprivation period and observationtimeof 15 to 20 min seems
adequate to eliminate the risk of mouth-alcohol invalidating results even in people with
dentures.190
A recent report described experiments in a person with dentures who was suspected of
DUI. The defendant alleged that the brand of denture adhesive used was responsible for the
breath alcohol reading being above the legal limit of 0.10 g/210L breath.188 In one set of tests
with a Breathalyzer model 900, which is not equipped with a slope detector, prolonged
retention of alcohol was observed remarkablyforseveral hours after 86 proof whisky was held
in the mouth and when a certain brand of dental adhesive was used. These results suggest that
some kinds of denture adhesives might retain alcohol for longer and lead to false high breathalcohol readings. However, no corroborative reports of this have been published, and more
controlled studies are necessary making use of duplicate measurements of blood and breathalcohol concentration, weaker solutions of ethanol, and monitoring the shape of the BrAC
exhalation profile in order to substantiate these surprising observations and conclusions.
Many of the latest generation of breath-alcohol analyzers usedforevidential purposes are
equipped with a slope-detector mechanism which is designed to monitor thetime-courseof
BrAC during a prolonged exhalation.191-192 If the BrAC is higher at the start of an exhalation
compared with at the end of the exhalation this causes a negative slope and suggests a possible
mouth alcohol effect or perhaps regurgitation of stomach contents or GERD. More work is
necessary to evaluate the effectiveness of the slope detectorsfittedto evidential breath-alcohol
analyzers over a wide range of concentration of alcohol in the mouth, and at various times after
the end of drinking.

13JL4A Alleged Interfering Substances in Breath
The alleged response of breath-alcohol instruments to interfering substances is a common DUI
defense argument in many countries.193 The interferents in question are either claimed to have
been produced naturally in the body, so called endogenous breath volatiles, or volatile organic
compounds (VOC) inhaled with the ambient air during occupational exposure. The question
of whether substances other than ethanol give a response on evidential breath-alcohol instruments escalated dramatically in die early 1970s after infra-red absorptiometry started tc
become the technology of choice for evidential purposes.194 Hitherto, the Breathalyzer model
900 dominated the field of breath-alcohol testing in the U.S. and this device incorporates wetchemistry oxidation with photometric endpoint for determination of BrAC.19S Although this
represents a non-specific chemical oxidation reaction for the analysis of alcohol, provided die
galvanometer on the Breathalyzer was read after exacdy 90 seconds as per the instructions, the
presence of acetone, toluene and other substances in the breath do- not present a serious
interference problem.196*197 Most infrared evidential breath alcohol devices provide some control for the presence of interfering substances with die use of either multiple filters, ot dual
technology, such as electrochemical oxidation in conjunction with infrared.
13.2.4.4 A Endogenous Breath Volatiles
Human expired air consists of a mixture of gases including oxygen, nitrogen, carbon dioxide,
water vapor and in extremely small amounts a multitude of volatile organic compounds
(VOCs).198*200 The major endogenous breath volatiles arc acetone, methane, and the unsaturated hydrocarbon isoprene (2-methyl-l,3-butadiene).201-204 The concentration of acetone
expelled in breath is usually between 0.5 and 5 Jig/L but this can increase appreciably if a
person is deprived of food or engages in a prolonged fast.205 Moreover, during ketoacidosis a
condition often associated with hyperglycemia or diabetes mellitus or alcohol withdrawal, the
concentration of ketone bodies (acetone, acetoacetate and beta-hydroxybutyrate) circulating
in the blood increases appreciably along with the concentration of acetone expelled in the
breath.205*20*
The question of whether VOCs other than ethanol might interfere with the results of
evidential breath-alcohol testing started to become an issue of debate and concern shordy after
thefirstIntoxilyzer instrument, a single wavelength (3.4 Jim) analyzer, appeared for use in law
enforcement.194 The Intoxilyzer measures the C-H bond stretching and vibrational frequencies
in ethanol molecules, which means that abnormally high concentrations of acetone (blood/air
distribution ratio approximately 300:1) in breath becomes a major candidate as an interfering
substance. However, this problem was quickly solved by monitoring the absorption of infrared
radiation at two wavelengths such as 3.39 and 3.48 \xm as currently used with the Intoxilyzer
5000.193 Another approach to enhance selectivity is to incorporate two independent methods
of analysis such as IR and electrochemical oxidation in the same unit as used with the Alcotcst
7110. 209
When properly adjusted, the Intoxilyzer 5000 instrument corrects the ethanol signal for
the presence of acetone in the breath. Moreover, ifthe concentration of breath-acetone exceeds
300 to 600 JJg/L, corresponding to a blood concentration of 0.009 to 0.018 g/dL, the
imbalance between die two filter signals exceeds a pre-set threshold value and the evidential
test is aborted.193 The instrument reports an interferant detected and the "apparent ethanor
concentration is stored in an internal memory of the software. If very high concentrations of
acetone are present in the blood, this ketone can be reduced by alcohol dehydrogenase in the
liver to produce isopropanol which also absorbs infrared radiation at the wavelengths used and
can masquerade as ethanol.163 Methanol, which has highly toxic metabolites, presents a special
problem ifhigh concentrations are present in blood and breath because infrared breath-alcohol
analyzers cannot easily distinguishing this one-carbon alcohol from ethanol if only two infrared
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wavelengths are used. The potential for methanol interfering with a breath test can best be
addressed by a consideration of its toxicological properties.**
Isoprene is another endogenous VOC expelled in the breath. In experiments with 16
healthy subjects, the breath isoprene concentration ranged from 0.11 to 0.70 Jig/L as
determined by thermal desorption gas chromatography and UV detection.201 These concentrations are much too low to interfere with the measurement of breath-alcohol with the
infrared technology currently used for evidential purposes. Methane is produced in the gut by
the action of colonic bacteria on disaccharides and this VOC can be detected in human expired
air. It seems that some individuals are more prone than others to generate methane in the large
intestine and the concentration of this hydrocarbon expelled in breath tinder different conditions requires more documentation.204 Methane should perhaps be considered as a potential
interfering substance in connection with forensic breath-alcohol testing by infrared methods,
but more research is necessaty on this topic before raising an alarm.203
Acetaldehyde is a VOC produced during the metabolism of ethanol by all known enzymatic pathways and is also a major constituent of cigarette smoke. The high volatility and low
blood/air partition coefficient of acetaldehyde (190:1), means that this substance crosses the
alveolar-capillary, membrane of the lungs and enters the breath.210 Because acetaldehyde
absorbs IK radiation in the same region as ethanol (3.4 to 3.5 Jim) this VOC might be
considered a potential interfering substances in connection with evidential breath-alcohol
testing. This problem was investigated empirically in tests with a single wavelength (3.39 Jim)
infrared analyzer under conditions when abnormally high concentrations of brearh-acetaldehyde (50 Hg/L) existed.211 This was accomplished by inhibiting the metabolism of acetaldehyde by pretreatment of subjects with Antabuse-like drugs before they drank alcohol. Even
under these .extreme conditions, no false-high apparent ethanol readings were obtained. In
recent reviews of the biomedical alcohol research literature, it seems that the concentrations
of acetaldehyde in blood are so low during oxidation of ethanol (< 88 Jig/L corresponding to
0.46 ixg/L in breath) that this metabolite of ethanol cannot be seriously considered an
interfering VOC when testing drunk drivers with the aid of infrared analyzers.210'212
13.Z4AJZ Occupational Exposure to Organic Solvents
A few studies have dealt with the response of infrared breath-alcohol instruments after
occupational exposure to solvent vapors, although no convincing evidence of an interference
problem has emerged, provided that at least 20 min elapses after leaving the work environment.213 In an effort to investigate the claimsfromtwo convicted drunk drivers that inhalation
of solvents causes false high readings on an infrared breath-alcohol instrument, the men
volunteered to spray cars with toluene/xylene/methanol based paint thinner under extreme
working conditions and without the use of protective clothing or face masks.214 They worked
for several hours in a small poorly ventilated room making use of 5 to 7 liters of paint during
the time. It was noted that their eyes were watering and they were suffering from severe
irritation coughing regularly and complaining of sore throats. Tests with one of the subjects
gave measurable apparent ethanol responses during the exposure. Results with an infrared
breath analyzer (Intoximeter 3000) were consistently higher than those obtained with an
electrochemical instrument (Aicolmeter S-D2). At times of 0 min, 15 min, and 30 min after
leaving the small working environment, one subject gave BrAC results of 0.019, 0.010, and
0.002 g/210 L on the IR analyzer. The lack of any instrument responsesforthe other subject
was explained by a considerably lower environmental temperature on the day of the testing, and
this presumably led to a less efficient vaporization of the solvents.
Inhalation of gasoline fumes as might occur if a person snifis this liquid or engages in
siphoning gasoline between cars can cause falsely-elevated readings on the Intoxilyzer 5000.2XW16
In an actual DUI case scenario, the Intoxilyzer reacted by aborting the test because an
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interfering substance or substances were detected293 Gasoline contains among other things, a
complex mixture of aliphatic and aromatic hydrocarbons and these were also qualitatively
identified in a blood sample taken from the suspect whose blood-alcohol concentration was
zero. Abuse of organic solvents such as thinner or glue is another source of interfering
substances in connection with evidential breath-alcohol testing.227 People who abuse these
materials often tend to smell of the solvents they inhale, and may display characteristic
symptoms of intoxication. If there is evidence to suggest solvent abuse, or extended exposure
to solvent fumes, arrangements should be made for obtaining blood samples instead.
Diethyl ether is another solvent capable ofinterfering with the response of dual wavelength
infrared breath-alcohol instruments and being mistakenly reported as ethanol.21* This solvent
is no longer widely used in industry or hospitals, so the risk of being exposed to ether in
everyday life is not very high, although it is present in carburetor or startingfluid.Several other
case reports have appeared suggesting that work-related inhalation of toluene and lacquer
fumes in conjunction with normal occupational exposure gives readings on IR analyzers
exceeding 0.10 g/210L. 229 ' 220 However the test subject who had been apprehended for DUI
sometimes showed behavioral manifestations of solvent inhalation or abuse and was chronically
exposed to these agents over a period of many years so accumulation of toluene in body fat
depots cannot be excluded. Some drunk drivers use technical spirits for intoxication purposes
and these solvents contain ethanol, methanol, methyl ethyl ketone, ethyl acetate, isopropanol
as well as other VOCs. These substances absorb IR radiation and can be mistakenly identified
as ethanol with some IR breath-alcohol analyzers.222 By comparing the resultsfroma pre-arrest
roadside test utilizing an electrochemical sensor for ethanol determination, with the results
from infrared evidential analyzers, information can be gleaned about the presence of an
interfering substance. The two detector systems (IR and Fuel cell) respond differently to
different VOCs in the breath; electrochemical sensors don't respond to acetone or hydrocarbons.222-223
A comprehensive series of experiments on the subject of evidential breath-alcohol testing
and the response to organic solvents was made in the UK, where two infrared analyzers have
been used for legal purposes since 1983 (Intoximcter 3000 and Camic).224-226 Human volunteers were exposed on different occasions to toluene, 1,1,1-trichlorethane, butane, white spirit,
and nonane under controlled conditions, and blood and breath were sampled at regular
intervals after ending the exposure. The volunteers were in a resting position talking and
playing cards during a 4-h period of exposure to the solvents at concentrations close to the
upper limits prescribed for the workplaces in UK After inhalation of butane vapor a response
was seen on the infrared breath analyzers lasting for 1 to 5 min after exposure, before rapidly
declining to zero.224 Exposure to toluene and 1,1,1-trichloroethane did not give any response
on the IR analyzers although these substances were identified in blood samples for up to 8 h
after exposure ended.224 The concentration of the solvents in blood and breath decreased
rapidly on ending the exposure, which supports the conclusion that normal occupational use
of solvents would be unlikely to contribute to false high results on IR breath-alcohol analyzers.
Similar negative impact on evidential breath-test results were reported after inhalation of
nonane and white spirit.223
Elevation of blood and breath-alcohol concentrations as a result of inhalation of ethanol
vapors by brewery or distillery workers or industrial workers required to handle ethanol-based
solvents has been a recurring argument in DUI trials.227 One of thefirstcontrolled studies was
done in 1951 with subjects being exposed to varying concentrations of ethanol vapor for up
to 6 h.227 The results showed that alcohol could be absorbed into the blood by inhalation
through the lungs, and that the BAC attained was proportional to the concentration of ethanol
in the inhaled air and the rate of ventilation. However, extreme conditions were necessary to
build-up a BAC exceeding 0.01 g/dL, and the methods of blood and breath-alcohol analysis
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were fairly primitive.227 Note that between 6 to 8 g of etfaanol can be metabolized per hour
so uptake by inhalation and absorption through the lungs must exceed this amount before
blood-alcohol will increase above base-line levels. Moreover, it was noted that inhalation of airalcohol concentrations of 10 to 20 mg/L caused coughing and smarting of the eyes and nose.
Untoward effects were more pronounced at concentrations of 30 mg/L, and at 40 mg/L the
situation was barely tolerable, making it impossible to remain in this atmosphereforany length
of time.
Several more recent studies have looked in theory and practice at the reality of generating
an elevated BACfrominhalation of ethanol vapor.228"230 From these experiments we conclude
that obtaining a BAC exceeding 0.003-0.005 g/dL is highly unlikely as a result of normal
occupational exposure owing to the metabolism of ethanol that occurs during and immediately
after ending the exposure.231 However, if a person already has an elevated BAC before entering
an atmosphere with a very high alcohol vapor concentration (simply sitting in a bar is not
sufficient!), then the metabolism of alcohol and clearance of BAC might be inhibited during
the inhalation period. This would lead to a shallower fi-slope than expected if the intake of
alcohol by inhalation is sufficient to balance the amount eliminated by metabolism.232 In short,
caution should be exercised in interpreting breath test results from subjects with extensive
solvent exposure immediately prior to the breath test. Most solvents are rapidly distributed and
eliminated following environmental exposure. There is no evidence that casual exposure to
solvents or solvent containing compounds will exert an effect on an evidential breath test
administered an hour or more later.
13JL4JS Variability in the Blood/Breath Alcohol Ratio
Historically, thefirstbreath-alcohol instruments were developed and used as an indirect way
of measuring a person's blood alcohol concentration. Breath-testing was considered more
practical than blood-testingfortraffic-law enforcement purposes,162 because of the noninvasive
sampling technique and the feet that an immediate indication of the person's blood-alcohol
concentration and state of inebriation were obtained.233 Conversion of a measured BrAC into
the expected BAC was accomplished by calibrating the breath-analyzers with a constant factor
(2100:1) which was known as the blood/breath ratio of alcohol. The figure of 2100:1 had
been determined empirically by equilibration of blood and air at constant temperatures in vitro
and also in vivo by taking samples of breath and venous blood at nearly the sametimefrom
a large number of volunteer subjects.234*235 In the post-absorptive phase of alcohol metabolism,
studies showed that the blood/breath ratio of alcohol was approximately 2100:1, and this
figure was subsequently endorsed by several meetings of experts with international representation.162 However, the blood/breath ratio is not a constantforall individuals and varies within
the same individualfromtime to time and during different phases of alcohol metabolism.236
This variability needs to be considered when the results of breath-alcohol testing are used in
criminal litigation to estimate a person's blood-alcohol concentration.
All analytical results have inherent uncertainty, resulting from a combination of human
error, systematic errors in calibration, random instrument error, etc. In a forensic context, the
extent of any error should be known by analysis of appropriate standards and controls, and the
contribution of error or uncertainty in the measurement should be considered when the result
is interpreted. When measurements are being made of dynamic systems, such as human breath
samples, further biological variation outside of the control of the analyst is introduced. The
inherent variability in the blood/breath alcohol ratio among different individuals is an excellent
example of this, and has emerged as a hot topic of discussion and debate in the scientific
literature and in the courts.17'22
For many years, the results of breath-alcohol analysis in law enforcement were overshadowed by inherent variations in blood/breath ratio and allegations that BAC had been overes-
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timated by use of breath-test instruments. Obtaining an estimated BAC that was too high was
more likely during the absorption phase, when BAC was still rising, because of the existence
of arterial-venous (A-V) differences in alcohol concentration. The time course of breathalcohol concentration follows more closely the arterial BAC than the venous BAC, with the
arterial BAC exceeding the venous during the absorptive phase, and vice versa during the
elimination phase. Moreover, the 2100:1 ratio was originally determined by comparing venous
BAC and BrAC in samples taken during the post-absorptive phase of alcohol metabolism when
A-V differences are small or negligible.234 The actual blood/breath conversion iactor is deariy
a moving target, and its value depends on many factors that are impossible to known or control
in any individual subject at the time of testing. Several more recent studies comparing blood
and breath-alcohol in DUI suspects show that in-the-field, the blood/breath ratio is closer to
2400:1 with a 95% range from 1900 to 2900, indicating a strong bias in favor of the suspect
being breath-tested in comparison with the same person providing a specimen of blood for
analysis at a forensic laboratory-237*240
In an attempt to quell much of the troublesome debate that was erupting over the
continued use of a constant blood/breath ratio, experts in the field of chemical tests for
intoxication met to discuss the scientific and legal issues involved. The fruits of this meeting
came in the form of a signed statement endorsing the continued use of the 2100:1 ratio for
clinical and forensic purposes. Several new studies had shown that the 2100:1 ratio gives a
generous margin of safety in favor of the subject by about. 10% compared with BAC analyzed
directly.241'242 In controlled laboratory studies, with blood and breath samples taken during the
post-absorptive phase of alcohol metabolism, a blood/breath ratio of 2300:1 was more
appropriate to give unbiased estimates of venous BAC.241 To eliminate the entire problem of
variability in the blood/breath ratio and the need to convert BrAC to BAC, Mason and
Dubowsld suggested that the threshold alcohol limit for driving should be defined in terms of
the person's BrAC at the time of the test.242This approach was dearly similar to the use of
UACs in Great Britain, where the statutory limits for motorists are 80 mg/dL in blood or 107
mg/dL in urine, which implies a UAC/BAC of 1.33:1.14 Because a blood-alcohol concentration limit of 0.10 g/dL was already widely accepted in the U.S., the corresponding threshold
BrAC limit was set at 0.10 g/210 liters of breath. By including the 210 liters in the wording
of the statute, the weight of alcohol (0.10 g) remained the same regardless of whether blood
or breath-alcohol were used for analysis. Much is often made over these units given die fact
that.210 L is a larger volume than any human could exhale. This is deariy a spurious issue
however, since only a portion of the breath (typically around 50 mL) is being tested, and die
units used arc g/210L. The results could equally well be expressed in Jig/L, mg/mL,
micromoles per liter, or any other concentration units. Any units can be used, provided that
the instrument is calibrated with the appropriate standards, having concentrations of alcohol
similar to the unknown breath samples.
Accordingly, a person's BAC or BrAC are now considered equivalent for the purpose of
generating evidence of impairment at the wheel. Eliminating the need to convert BrAC into
BAC in every single case led to a dramatic reductiou in spurious litigation concerning blood/
breath ratios of alcohol and inherent variability. Furthermore, the effects of alcohol on
psychomotor performance, as well as roadside surveys of the risk of involvement in traffic
accidents, have been conducted with breath-test instruments (e.g., the Grand Rapids survey)
and not by the analysis of BAC directly. However, several U.S. states, among others New
.Jersey, still persist in translating the breath-alcohol readings into a presumed BAC. Indeed, the
use of breath-alcohol testing was the subject of a vigorous defense challenge in 1989 in die
State of New Jersey, where the Breathalyzer was well established for testing drinking drivers.
The DUI statute in New Jersey stipulated that a person's blood-alcohol concentration should
be estimated indirectly by analysis of the breath. The gist of the defense argument was that the
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2100:1 blood/breath ratio was biased against the person being tested. Considerable expert
testimony was called to answer questions about variation in the blood/breath conversion factor
used. This "Downie case" was eventually settled by the supreme court of New Jersey ruling
in favor pf the continued use of the Breathalyzer 900 in law enforcement and also keeping the
2100:1 conversion factor unchanged. The bulk of the expert testimony and the most credible
witnesses took the stance that breath-tests involving a 2100:1 ratio tended to underestimate
the venous blood-alcohol concentration for samples taken in the post-absorptive phase of
alcohol metabolism and when results are truncated to two decimal places.
When the countries in Europe introduced evidential breath-alcohol testing in the early
1980s, the threshold BrAC limits were derived from the pre-existing BAC limits on the basis
of a presumed blood/breath ratio, either 2000:1, 2100:1, or 2300:1 depending on the
country.Thus, 0.50 mg/mL, which is die statutory BAC limit in the Netherlands, became 220
pg/Lin breatii, being derivedfrom0.50/2300 - 0.000217 and rounding to 0.00022, before
moving the decimal point to obtain appropriate units. The threshold BrAC limits corresponding to already established BAC limits in different countries are shown in Table 13.2.1.
13JZA.6 Pulmonary Function (Chronic Obstructive Pulmonary Disease)
The basic premise of breath-alcohol testing is that the concentration of alcohol in pulmonary
capillary blood equilibrates with alveolar air at normal body temperature.243 However, the air
in the upper airways and dead-space regions of the lungs also contains alcohol by a diffusion
processfromthe mucous membranes receiving alcoholfromblood supplying the tissue in the
upper respiratory tract. Furthermore, alcohol from the upper respiratory tract may be picked
up in the inspired air and deposited further down the tract during inspiration, only to be
redistributed again during expiration, with some of the alveolar alcohol being deposited back
into the depleted tissues ofthe upper airways.244 The net effect is that the alcohol which appears
on the expired breath does so as a result of a complex dynamic process, that varies in degree
from individual to individual. As indicted in the previous section, however, where the law
specifies a BrAC per se offense, the actual mechanism is not relevant, and die per se BrAC
ofiense is readily justified in terms of impairment associated with BrAC.
Modem breath-alcohol instruments are equipped with automated procedures for sampling
breath and these monitor the volume exhaled and the concentration of alcohol during a
prolonged exhalation. If a person manages to exhale a certain Trrimrnnm volume of breath for
a given length of time to satisfy the sampling requirements, a portion of the end-expired air
is captured for analysis of alcohol. Some individuals, particularly those with impaired lung
function, will genuinely be unable to satisfy the sampling parameters of some evidential breathalcohol analyzers currently being used.245'246 Indeed, even subjects with healthy lungs, especially women of small stature and those who habitually smoke cigarettes, might have insufficient lung capacity to exhale for the minimum required time. Moreover, at high blood-alcohol
concentration, the ability of a person to provide an approved sample of breath might be
reduced compared with the sober state.247
• The rules and regulations pertaining to evidential breath-alcohol testing should therefore
contain an option for the suspect to provide a blood sample if he or she fails to satisfy the
sampling requirements because ofpulmonary limitations. In Great Britain, where the Intoximcter
3000 is used for legal purposes, the policeman operating the instrument has to decide whether
the suspect is not cooperating properly in providing the required sample. If this happens, the
person can be charged with "failing to provide", as a separate offense which carries the same
punishment as if the BrAC had been above the legal limit for driving.14*245 Many people charged
and prosecuted for "failing to provide" in the UK have later been vindicated by seeking medical
advice and undergoing pulmonary function tests.248*249 This prompted the British Home Office
scientists to embark on a series of studies into the ability of people with small stature and

impaired lung function to satisfy die sampling requirements of various breath-alcohol testing
instruments.245'250 Those individuals with forced expiratory volume in one second (EEVL0) of
less than 2.0 liters and forced vital capacity (FVC) ofless than 2.6 liters were unable to use some
of the breath-testing equipment evaluated. In another study with healthy subjects less than 5
ft 5 in. (165 cm) tali, some were unable to provide die required breath sample.250 This report
however fails to specify the ages of the subjects, whether they were tested, under the influence
of alcohol, and whether they smoked cigarettes. These variables are important when the ability
of a person to provide an approved breath sample has to be judged.
Asthma is an inflammatory disease of die airways causing obstruction to breathing and a
reduction in air flow. Respiratory inhalers used by asthmatics contain salbutamol (^-adrenergic
bronchodilator) as the acrive ingredient. It is the mainstay treatment for acute attacks of
asthma. The use of this inhaled medication just prior to being breath-tested with Intoximeter
3000 (infrared) and Alcolmeter S-D2 (electrochiemistry) failed to produce a response of
apparent alcohol.251 A similar lack of response was reported for a number of nasal sprays used
by people with impaired lung function.252 Some asthma inhalers contain ethanol as an ingredient and this means that a response is more likely to occur immediately after their use.
However, within 2 to 9 min after using a wide range of inhalers and sprays, the small positive
response on the breath analyzers was eliminated. 25S
To test the influence of chronic obstructive pulmonary disease (COPD) on breath-alcohol
analysis, patients suffering from COPD received 60 to 70 g ethanol and their blood-alcohol
concentration was compared with results using the Breathalyzer model 900 at various times
after drinking. The resulting blood/breath ratios were consistently higher than the 2100:1
calibration faaor used with die Breathalyzer 900 instrument so breath-tests for alcohol are not
detrimental to those individuals who suffer from COPD.254 In a more recent study with 12
COPD patients as well as an age matched control group of subjects, alcohol (0.60 g/kg) was
given by intravenous infusion and blood and breath-alcohol concentrations were determined
for up to 4 h.255 The blood/breath ratios of alcohol in the control group and patients with
COPD varied with time after infusion of alcohol and in the post-peak phase of metabolism of
alcohol, the values were mosdy in excess of 2400:1.^ 5
Summing-up these experiments in patients with pulmonary disease, there is no solid
evidence to suggest that impaired lung function (asthma, COPD, emphysema) puts them at
risk of being unfairly prosecuted for drunk driving when per se limits operate.256'257 If people
with these pulmonary limitations'manage to provide an approved breath sample, there is no
reason to believe that the test result will be greater than for people wirii healthy lungs having
the same blood-alcohol concentration. On die contrary, because of the higher blood/breath
ratios in people suffering from COPD compared with age-matched control subjects, those with
COPD who might be breath-tested have an advantage.255
13-2L4.7 Breathing Pattern and Hypo- and Hyperthermia
For a given individual, the concentration of alcohol expelled in the breath depends on die
concentration existing in the pulmonary blood, which depends on the amount of alcohol
consumed and the time after drinking when breath-tests are made.243 However, the concentration of alcohol measured in the breath at a given blood-alcohol concentration depends on
numerous factors, especially the person's pattern of breathing prior to exhalation and core body
temperature. Also, various design features of die breath-alcohol analyzer such as the resistance
to exhalation and the geometry of the breadi-inlet tube and also the kind of mouthpiece and
spit-trap fitted to the instrument are important to consider when variations in test results have
to be explained.258"260
The influence of a person's breathing pattern prior to exhalation has been evaluated in
several studies and variables such as breath-holding, hyper- and hypo-ventilation, as well as
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shallow breathing were investigated253 Most changes in the pre-exhalation maneuver decrease
the BiAC in thefinalexhalation compared with a control sample comprising a moderately deep
inhalation and forced end-exhalation. However, breath-holding or hypo-ventilation before
providing breath for analysis increases the concentration of alcohol in the breath-sample by
about 10 to 20%.261'262 This higher BrAC is caused in part by a higher breath temperature and
the longer time available for equilibration of alcohol with the mucous surfaces in the upper
airways.263 Body temperature has an important influence on BiAC because the temperature
coefficient of alcohol solubility is ± 6.5% per degree centigrade.264 Local cooling of the mouth
and upper-airway by breathing cold air will decrease breath-temperature and breath-alcohol
concentration.265 Keeping ice in the mouth before and during exhalation leads to a marked
lowering in the person's BrAC, in part because of the high solubility of alcohol in water
condensing from the ice, and condensation of ethanol vapor in the mouth.266 Isothermal rebreathing devices have been described for use with breath alcohol equipment-267The net effect
of this device is to allow equilibriatipn of alcohol with all the tissues in the respiratory tract,
thus raising the breath test result by about 10%, and showing a closer agreement to the blood
alcohol result when a blood/breath ratio of 2100:1 is assumed.267
Controlled studies of the influence of hypo- and hyperthermia on breath-alcohol test
results with Breathalyzer model 900 were reported by Fox and Hayward.268'269 The deep-core
body temperature was raised by keeping volunteer subjects immersed up to their necks in water
at 42 °C for 45 min. This caused a 2.5°C rise in body temperature and a 23% distortion
(increase) in the breath-alcohol concentration. Immersion ofthe subjects up to the neck in cold
water at 10°C for 45 min caused mild hypothermia and the breath-alcohol concentration decay
curve was distorted downwards by 22%. When subjects were returned to normothernuc
conditions, the BrAC readings recovered to reach the values expected from past experience
with the Breathalyzer 900, that is, results were about 10% less than the corresponding bloodalcohol concentration direcdy determined.
13.2.5 CONCLUDING REMARKS
The widespread use of statutory alcohol concentration limits for motorists simplifies the
prosecution of drunken drivers and makes this process more effective. Accordingly, a person's
blood or breath-alcohol concentration has become the single most important evidence for
successfully prosecuting DUI suspects. It should however always be considered in the context
of'other evidence, such as observations about the subject's driving ability, outward behavior
and response to questions and performance infieldsobriety tests. This has meant that defense
arguments focus heavily on trying to discredit and cast doubt on the reliability of the result of
analyzing alcohol in blood and/or breath. Of the two, it seems that results of measuring bloodalcohol are much less frequently questioned than those obtained by analyzing the breath. This
probably stemsfromthe earlier tradition of translating a measured BrAC into a presumed BAC
for forensic purposes. The magnitude of variation in the conversion factor (blood/breath ratio)
from person to person and in the same person over time triggered many defense challenges,
which still persist today. The uncertainty in the sampling and analysis of breath and die
conversion factors used have attracted much debate in the scientific literature and in the courts.
The entire problem with blood/breath ratios should have been eliminated after defining the
statutory alcohol limits for driving as the BrAC per se and thus sidestepping the need to convert
BrAC into BAC.
Furthermore, mosdy under the control of a built-in microprocessor, evidential breathalcohol instruments are typically operated by police officers and not by chemists. This apparent
vested interest in the outcome of the test result tends to make breath-alcohol testing more
suspect according to some critics, and vulnerable to defense attacks compared with blood

alcohol measurements performed at a forensic laboratory. Much could be done to improve
forensic alcohol analysis by paying more attention to pre-analytical factors, in particular the
methods and procedures used to obtain samples of body fluids (blood, breath, or urine). The
responsibility for sampling, transport, and initial storage of specimens is usually in the hands
of the police and other personnel who lack training in clinical laboratory methods.270 The use
of a checklist to document certain key aspects of the sampling protocol and the various
precautions taken is highly recommended.271 Any mishaps or unusual incidents that occur
during sampling, as well as the behavior and appearance of the suspect, should be carefully
noted. These might become important later when die results of alcohol analysis are interpreted
by the court.
The trend towards accreditation of clinical and forensic laboratories will help to standardize
and document analytical procedures and establish acceptable standards of performance that
minimize the risk of laboratory blunders. Forensic tests for alcohol, however, should always be
held to a high standard, and where there is error, mistakes, or uncertainty, this should be
honesdy recognized and accrue to the dcfiaadants favor. As long as there is a lot of money to
be made in defending drunk drivers, or testifying on their behalf, there will always be lawyers
and expert witnesses prepared to embark on crusades to discredit the pohce, the laboratory or
both. To focus an attack on die scientific background of forensic alcohol testing a defense
lawyer requires the services of an expert witness.272 There are plenty of these individuals
available, many of whom can be located through professional directory listings of their names,
addresses, academic qualifications, experience, and often their fee. Most of these experts are
willing to testify for the defense, the prosecution, or both and will generally testify in either
criminal, or civil litigation.
During the highly publicized Daubert decision from the U.S. Supreme court, much was
written about the use of scientific evidence and how best to judge the testimony of expert
witnesses.273 At about this time, an editorial in the scientific journal Nature made the following
statement about expert witnesses:274
The so-called expert witness in court may be a hired-gun, willing to testify to anything for a
fee, or a crackpot whose insupportable ideas are masked by an advanced degree (PhJD.) often
from a respectable university.
William S. Lovell (chemist and district attorney) made the following observation about the
use and abuse of expert testimony in DUI litigation as long ago as 1972. 275
Courts are indeed plagued by the instant expert, who whether out of a misguided eagerness to
cam his fee or an overrcacrion to his own self-described credentials, may expound far reaching.
opinions.
The courtroom can be a cruel place and skillful use of expert testimony plays a much bigger
role in deciding the outcome of DUI trials held in the U.S. and Britain than in continental
Europe. In Britain and the U.S., the adversarial system of justice operates, which aims to
establish the truth by probing the strengths and weaknesses of defense and prosecution cases.276
This opens the door for selecting expert witnesses known for their strong opinions and
outspoken views about key elements of the scientific evidence crucial for the case. This is
somewhat different from the situation in continental Europe and Scandinavia where the
inquisitorial system operates and an investigating judge or judges appoint the necessary forensic
experts who conduct tests and make investigations independent of the prosecution.277'278 This
gives the impression that forensic experts evaluate the scientific evidence in a more impartial
way and arrive at an opinion based on their findings. This takes thte form of a written report
to the court, similar to a deposition, but occasionally the expert is also expected to appear in
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person to present his conclusions and receive questioning from the defense and prosecution
attomev.
As far as possible, expert witnesses should base their testimony on personal experience and
studies they have conducted themselves and the results of which have been published in the
peer-reviewed literature. But even peer-reviewers make mistakes and publication per se does
not make the results gospel. Scientists are not infallible and unsubstantiated opinion is no
substitute for personal experience and well designed experiments. If scientific evidence is
important in criminal or civil litigation, it might be better for the judge to appoint suitably
qualified experts instead of relying on witnesses chosen by the opposing sides.279 This was one
of the recommendations of the Daubert decision of the U-S. Supreme Court, and has already
been put into practice in Oregon, in a case concerning die health hazards of silicone breast
implants.280 Unfortunately, the demeanor and manner of the witness often determines whether
or not the evidence they present is accepted by the jury, rather than the validity of the science
on which the opinion is based.282 Complex scientific issues can usually not be satisfactorily
discussed and debated in the courtroom by lawyers posing set-piece questions to expert
witnesses, many of whom have poor or inappropriate qualifications and questionable motives.281* 282 Other complicating fectors are that the attorneys are often prepared to use any
available means, including confusing the jury, obfuscating the issues^ 2nd impugning the expert
testimony, in order to gain an acquittal, rather than pursuing an objective- search for the truth.
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Addendum K

Effects of Drugs on Human Performance - Fact sheets

Marijuana:
Leaves, stems, seeds and flowering parts of female plant, cannabis sativa. Dried, compressed resin is
hashish, extracted oil is hash oil.
Synonyms:
Grass, weed, shit, pot, blow, MJ, THC, Mary Jane, Maui wowie, joint, blunt, reefer, green
Potency/purity/dose:
2-20% of dry weight is tetrahydrocannabinol (THC). "User preferred dose" is around 300^ig/Kg. This
would be (15-30mg, 1-3 joints) in a typical individual
Route of administration:
Smoked, oral ingestion
Metabolism:
Tetrahydrocannabinol (THC) is active and mainly metabolized to 9-OH-THC, and 11-Carboxy-THC. The
former has some activity but is a minor metabolite, while the latter is inactive.
Kinetics:
The initial apparent half-life of THC is very short. The blood concentration falls rapidly, as the drug is
absorbed into tissues. After smoking a "user preferred dose", peak THC concentrations occur at about 10
minutes (~85ng/mL), and fall below 5ng/mL, less than three hours after smoking. Terminal elimination
rates appear longer, as the drug is slowly releasedfromthe tissues and metabolized, but plasma levels are
typically sub-nanogram. Terminal elimination half-life is listed as 20-57 hours in light users to 3 to 15
days in heavy users. The terminal elimination half-life of 11-Carboxy-THC in infrequent users was 30
hours, and 40 hours infrequentusers.
Drug Class:
Euphoria producer, soporific, sedative. Mild hallucinogen at high doses
Effects:
Psychological:

Physiological:

Euphoria, exhilaration, sedation, relaxation, mood elevation, disinhibition, talkativeness
and laughter, distortion of body image, time, and distance, perceived increase in auditory
and visual acuity, impairment of short term memory, mild confusion (e.g. past, present
and future) and disorientation, judgement is impaired. Synesthesia's (e.g. perceiving
sounds as colors) and lessfrequently,pseudo-hallucinations can occur.
Increased heart rate, slowed reaction time, increased appetite, dryness of mouth and
throat, increased/decreased blood pressure, red bloodshot eyes, lack of convergence,
rebound dilation. Pupils are normal to dilated, and there is no HGN.

Medical uses:
Anti-nausea properties advocated for use during chemo- or radiation therapies, lowers intra-occular
pressure in glaucoma, stimulates appetite in anorexics and cancer patients. Marinol® is prescription THC,
supplied in gelatin capsules. Nabilone® is a synthetic analog.
Performance effects:
Slowed reaction time, poor perception, distortion of time and distance, diminished attention, loss of
coordination in divided attention tasks. Note however, subjects can "pull themselves together" to
concentrate on simple tasks for brief periods of time.
Effects on Driving:
Inability to maintain headway (distance between vehicles), lateral travel, falling asleep, slowed reaction.
Tracking, motor coordination, and sustained vigilance are impaired. The degree of impairment following
typical recreational use (10-30mg, around 1 - 3 joints depending, on potency) is similar to a blood alcohol
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concentration of 0.04 to 0.08g/100mL. Some drivers may actually be able to improve performance for
brief periods by overcompensating for self-perceived impairment. The greater the demands placed on the
driver however, the more critical the likely impairment Mixing alcohol and marijuana tends to produce
effects greater than either on its own.
Interpretation of blood concentrations:
Blood concentrations of parent drug and metabolite are very dependent on pattern of use, as well as dose.
Blood concentrations are about 40% less than serum. Chronic users can have mean serum levels of
Carboxy-THC of 34ng/mL, 12 hours after use. Corresponding THC levels are however less than
2ng/mL. Peak serum THC concentrations after moderate single dose use are around lOOng/mL, declining
to less than 20ng/mL in less than two hours. It is inadvisable to try and predict effects based on blood
THC concentrations, and currently impossible to predict specific effects based on carboxy-THC
concentrations. The analytical cut-off for these two compounds is currently 2.5ng/mL for each. It is
possible for a person to be affected by marijuana use with levels of THC in their blood below 2.5ng/mL.
Interpretation of urine test results:
Positive test results generally indicate use within one to three days, depending on the sensitivity of the
method, however the detection window could be significantly longer following heavy, chronic, use. It
can take as long as 4 hours for carboxy-THC to appear in the urine at concentrations sufficient to trigger an
immunoassay (at 50ng/mL) following smoking.
Duration of effects:
Typically, feelings of intoxication following single dose use last about 45 minutes, however more typical
use is two to three joints over a few hours, whereafter the perceived effects last for about 2.5 hours. After
heavy or chronic use, effects can last longer, up to 6 hours. Psychomotor impairment can persist after the
perceived high has dissipated. Long term changes in performance in divided attention and behavior have
been documented, independent of concentration in the blood. In long term users, even after periods of
abstinence, selective attention (the ability to filter out irrelevant information) has been shown to be
adversely affected with increasing duration of use, and speed of information processing has been shown to
be impaired with increasingfrequencyof use. Other chronic changes after long term use can include
diminished drive, apathy, shortened attention span, loss of insight,fragmentationof flow of thought, loss of
effectiveness, and inability to carry out complex plans.
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Methamphetamine/Amphetamine:
White to light brown, occasionally pink/purple crystalline powder. Sometimes larger crystals are smoked.
Base is a liquid, but infrequently used. Rarely available as diverted pharmaceutical doses (Desoxyn®).
Considerations for amphetamine are similar, however
Synonyms:
Speed, crank, crystal, meth, chrissy, go, ice, rock candy, whizz
Potency/purity:
Purity is currently very high, 60-90%, and is predominantly d-methamphetamine, which has greater CNS
potency than 1- or d/1-methamphetamine. D-Methamphetamine is synthesizedfrom1-ephedrine or dpseudoephedrine.
Metabolism:
Methamphetamine is metabolized to amphetamine (-10%) (active), p-OH-amphetamine and norephedrine
(both inactive). Some other drugs, fenproporex, clobenzorex, selegeline, benzphetamine, are metabolized
to amphetamine and methamphetamine.
Kinetics:
Half-life is very dependent on pH, but rangesfrom5 to 15 hours. Average is around 10 hours. Peak
blood concentrations occur around three hours after oral dosing, instantaneously after injection, and a few
minutes after smoking. Peak effects occur 17 minutes after injection, 18 minutes after smoking, and 40
minutes after oral ingestion. Peak plasma amphetamine (metabolite) concentrations occur around 10
hours after administration.
Route ofAdministration:
Initiates generally begin with intranasal or, more commonly, oral use, and progress to intravenous, or
smoking use. In contrast to cocaine, the hydrochloride salt of methamphetamine can itself be smoked.
Doses range from lOOmg - 5000mg/day in recreational use. Methamphetamine is used sometimes with
alcohol or marijuana, during withdrawal.
Drug Class:
Euphorigenic, stimulant
Effects:
Early phasePsychological:

Physiological:

Late phasePsychological:

Physiological:

Euphoria, excitation, exhilaration, rapid flight of ideas, increased libido, rapid speech,
motor restlessness, hallucinations, delusions, psychosis, insomnia, reduced fatigue or
drowsiness, increased alertness, heightened sense of well being, stereotypes behavior,
feelings of increased physical strength, poor impulse control.
Increased heart rate, increased blood pressure, increased respiration rate, elevated
temperature, palpitations, irregular heartbeat, dry mouth, abdominal cramps, appetite
suppressed, twitching, palor, dilated pupils, HGN at high doses, faster reaction time,
increased strength, more efficient glucose utilization.
Dysphoria, residual stimulation, restlessness, agitation, nervousness, paranoia,
violence, aggression., lack of coordination, pseudo-hallucinations, delusions, psychosis,
drug craving.
Fatigue, sleepiness with sudden starts , itching/picking/scratching, normal heart rate,
normal/small pupils but light reactive.
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Side effects:

Viral hepatitis, STD, HIV, septicemia (poor needle hygiene), abscesses, collapsed blood
vessels, malnutrition.

Medical uses:
Used in treatment of attention deficit disorder (ADD) and attention deficit hyperactivity disorder (ADHD)
hyperactivity in adults, and narcolepsy (typical dose lOmg/day, up to 40mg possible). Infrequently used in
treatment of overeating disorders and weight loss, due to abuse potential. Course of greater than six weeks
not recommended. Some HIV positive patients believe that this drug boosts their T-cell count, however
there is no medical evidence of this.
Performance effects:
Early phase:
Agitation, inability to focus attention on divided attention tasks, restlessness, motor
excitation, faster reaction time, time distortion (seems to pass quickly), improved
performance in some simple tasks.
Late phase:

Depressed reflexes, inattention, incoordination, poor balance, inability to follow
directions, impaired self-perception of performance.

Effects on Driving:
Early phase:
Speeding, willingness to take on increased risk, inattentive driving, impatience.
Frequently involved in high speed chases.
Late phase:

Fatigue, sleepiness, inattention, falling asleep at the wheel, driving off the road, crossing
the median, or driving into fixed objects.

Interpretation of blood concentrations:
Blood concentrations can be used to distinguish therapeutic use from abuse. Concentrations of 0.02 0.05mg/L are typical for therapeutic use, and up to 0.2mg/L have been documented. Concentrations
greater than this represent abuse. Concentrations do not disclose phase of use. Normal concentrations in
recreational use are 0.01 to 2.5mg/L (median 0.6mg/L). Concentrations above this range will likely be
associated with severe, possibly life threatening, toxicity. There is no evidence for improved performance
in any task or test, following use of doses greater than 40mg (concentrations greater than 0.2mg/L).
Interpretation of urine test results:
Positive results generally indicate use within one to four days, but could be up to a week following heavy
chronic use. Rate of excretion into the urine is heavily influenced by urinary pH.
Duration of effects:
The long half-life of this drug results in a longer duration of effects than the other major stimulant cocaine.
Nature, intensity, and duration of effects are heavily dependent on dose, pattern of use, tolerance, route of
administration. Following oral and intranasal use, the effect onset more slowly (1-2 hours to peak). The
effects are less intense than following smoked or intravenous use, where a highly intense rush is
experienced (10-20 minutes) followed by a shoulder period with less intense but still powerful stimulation
(one hour). In binge use, the drug is often readministered at this point, and a repetitive cycle of binge use
begins. After hours or days of use, administration ceases and '^tweaking" or late phase effects can begin
within a few hours.
Late phase effects can last for several days, and be of variable degree.
References:
Forney R. Stimulants, drugs & driving, NIDA research monograph 11, ed by Willette, RE 1977;:73-76
Hurst PM. Amphetamines and driving. Ale Drugs and Driv 1987;3(1):13-16
Logan BK. Methamphetamine and driving impairment. J For Sci 1996(i);41(3):457-464
National Transportation Safety Board safety study: Fatigue, alcohol, other drugs, and medical factors in
fatal-to-the-driver heavy truck crashes (vol I and II). Accession* PB90-917002, report* NTSB/SS90/01/02, National Transportation Safety Board, Washington DC, 1990.
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Cocaine
Hydrochloride salt: White to light brown crystalline powder. Base: waxy/soapy toflakysolid lumps,
white to beige in color.
Synonyms:
Salt: Coke, snow, caine

Base: crack, rock

Potency/purity:
Rangesfrom5% to 90% depending on city and market.
Metabolism:
Cocaine is extensively metabolized to a variety of compounds, mostly centrally inactive (*).
Benzoylecgonine (*), ecgonine (*), and ecgonine methyl ester (*) are the major metabolites.
Norcocaine is a very minor metabolite, but is active, and neurotoxic. Cocaethylene, formed following congestion of cocaine and alcohol is also active, with about the same potency as cocaine.
Kinetics:
Apparent half-life for cocaine is short, about 1 to 3 hours, but terminal half life is longer (around seven
hours). Apparent half life of benzoylecgonine is 6Hrs.
Route of Administration:
Most commonly smoked as crack in a glass pipe, but snorting of salt form is also popular. Intravenous
injection of hydrochloride salt, often with heroin, is popular in some parts of the country. Subcutaneous
injection (skin-popping) occurs infrequently. Base cannot be injected, and salt cannot be smoked.
Drug Class:
Euphorigenic, stimulant
Effects:
Early phasePsychological:

Physiological:
Late phasePsychological:

Euphoria, excitation, general arousal, self-absorbed, increased talkativeness, rapid
speech, motor restlessness, offset of effects of fatigue, hallucinations, delusions,
psychosis (excited delirium), improved performance in some simple tasks.
Increased heart rate, increased blood pressure, increased body temperature, dilated pupils,
increased light sensitivity, faster reaction time.
Dysphoria, depression, agitation, nervousness, drug craving, general CNS depression,
fatigue.

Physiological:

Fatigue, sleepiness, itching/picking/scratching, normal heart rate, normal pupils.

Side effects:

Burnt lips andfingersfromcrack pipes arefrequentlyseen. Perforated nasal septum
from snorting is uncommon. Skin ulceration from skin popping is uncommon. Rashes
and skin reddeningfromscratching is common. Cocaine excited or agitated delirium is
a condition often caused by excessive cocaine use, and is associated with a dissociative
state, violence to persons and property (especially glass), exaggerated strength, and very
high body temperature . It is more common in overweight African American males. It
isfrequentlyfatal.

Medical uses:
Minor use as an anesthetic for ear nose and throat surgery. No other legitimate medical use.

Washington State Toxicology Laboratory

Effects of Drugs on Human Performance - Fact sheets
Performance effects:
Early phase:
Agitation, inability to focus attention on divided attention tasks, restlessness, faster
reaction time, diminished effects of fatigue, time distortion (seems to pass quickly), poor
balance and coordination
Late phase:

Depressed reflexes, inattentive, distressed, confused, tense, angry, uncoordinated, poor
balance, unable to follow directions

Effects on Driving:
Early phase:
Speeding, high risk behavior, inattentive driving, poor impulse control
Late phase:

Fatigue, sleepiness, inattention.

Interpretation of blood concentrations:
Very difficult to interpret with respect to effects because of artifactual changes in cocaine concentration on
storage, and tolerance. Wide range of concentrations have been associated with intoxication. Adverse
reactions reported after prolonged use, but with no measurable parent drug in the blood. Typical
concentrations in abuse rangefrom0 to Img/L. Concentrations up to 5mg/L and above are survivable in
tolerant individuals. There is no good evidence that blood concentrations can be related to a specific
degree of impairment.
Interpretation of urine test results:
Positive urine test for benzoylecgonine generally indicates use within one to two days, but could be longer
following heavy/chronic use.
Duration of effects:
Effects onset immediately after smoked/intravenous use, more slowly after oral ingestion (-1 hour).
Effects will generally persist for two to four hours depending on the dose. Due to shorter half life, effects
are generally of shorter duration than for other stimulants esp. methamphetamine, and runs or binges are
shorter also, morefrequentlyending in severe toxicity (see side effects). Late phase effects following
binge use may last several days.
References:
Gawin FH and Kleber HD Abstinence symptomatology and psychiatric diagnosis in cocaine abusers.
Arch Gen Psych 1986;43:107-113
Weddington WW, Brown BS, Haertzen CA, Cone EJ, Dax EM, Herning RI, Michaelson BS. Changes in
mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. Arch Gen Psych
1990;47:861-867
Satel SL, Price LH, Palumbo J, McDougle CJ, Krystal JH, Gawin F, Charney DS, Heninger GR, Kleber
HD Clinical phenomenology and neurobiology of cocaine abstinence: A prospective inpatient study.
Am J Psychiatry 1991;148(12): 1712-1716
Ellinwood EH, and Nikaido AM Stimulant induced impairment: A perspective across dose and duration
of use. Alcohol Drugs and Driving 1987;3(1): 19-24
Siegel R. Cocaine use and driving behavior Alcohol Drugs and Driving 1987;3(l):l-7
Stillman R, Jones RT, Moore D, Walker J, Welm S. Improved performance 4 hours after cocaine.
Psychopharmacology 1993; 110:415-420
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Carisoprodol/Meprobamate
Pills: Miltown, Equanil (meprobamate), and Soma, (carisoprodol).
Synonyms:
Muscle relaxants, downers, depressants
Potency/purity:
Pills; carisoprodol usual dose is 4 * 350mg doses daily. Meprobamate usual dose is 4*400mg/day.
Carisprodol is also available in combination products with phenacetin, caffeine, acetaminophen and
codeine.
Metabolism:
Carisoprodol is metabolized to meprobamate. The parent and metabolite are equipotent.
Kinetics:
Following acute administration of 7G0mg of carisoprodol reached peak plasma concentrations of
carisoprodol of 3.5 ±0.94mg/L in 45 minutes, and for meprobamate of 4.01±0.59mg/L in 220 minutes
respectively. The half-life of carisoprodol was 99±46minutes. Peak meprobamate concentrations of
15.6mg/L following the administration of 1200mg of meprobamate over four hours. Meprobamate
concentrations in the treatment of anxiety have been reported in the range 3 to 26mg/L. Some individuals
have impaired metabolism of carisoprodol, and exhibit a half life of 2-3 times that in normal subjects.
Route ofAdministration and patterns of use:
Oral,frequentlytaken with other muscle relaxants, benzodiazepines, or narcotic analgesics. Generally
use begins with prescription for muscular pain, and abuse develops for sedative, dissociative effects,
resulting in increased dosage without medical advice, or continued use after pain has subsided.
Drug Class:
Muscle relaxant (carisoprodol), antianxiety (meprobamate), both CNS depressants
Effects:
Early phasePsychological:
Physiological:

CNS depression, slowed thinking, slowed reaction time, disorientation, poor divided
attention, lack of comprehension, drowsy, comatose
HGN, poor balance and coordination, sluggish movements, gaze nystagmus, bloodshot
eyes,

Late phasePsychological:

Effects generally diminish with time. Withdrawal effects not known

Physiological:

Effects generally diminish with time. Withdrawal effects not known

Side effects
Agitation, depression, dizziness, drowsiness, facialflushing,fainting, headache, hiccups, sleep
disturbance, irritability, light-headedness upon standing up, loss of coordination, nausea, rapid heart rate,
stomach upset, tremors, vertigo, and vomiting. In abuse or overdose, subjects are consistently sedated and
obtunded,frequentlybecoming comatose.
Medicinal uses:
Carisoprodol is prescribed for the treatment of muscular pain, particularly lower back and skeltomandibular
pain. It is a skeletal muscle relaxant, without analgesic properties of its own, and acts centrally as a CNS
depressant. Meprobamate is its major metabolite, and is in its own right a CNS depressant and antianxiety
agent. Carisoprodol is usually taken in conjunction with other drugs, especially opiates, benzodiazepines,
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barbiturates, and other muscle relaxants.
contribute to impairment.

Combined effects of all these centrally acting drugs can

Performance effects:
Poor divided attention, poor coordination and balance, slowed reflexes and reaction time.
Effects on Driving:
Poor perception, poor reaction time, slow driving, poor coordination, inattentiveness, poor balance and
coordination, unsteadiness, slurred speech, slow responses, tendency to dose off or fall asleep, difficulty
standing, walking or exiting their vehicles, and disorientation.
Interpretation of blood concentrations;
Blood concentrations of carisoprodol in therapeutic use are between 1 and 5mg/L, and meprobamate
concentrations are between 2 and 6 mg/L. Following administration of meprobamate, concentrations are
typically around lOmg/L but can range between 3 and 26mg/L. Plasma meprobamate concentrations of
greater than lOOmg/L are associated with deep coma, light coma between 60 and 120mg/L, and patients
with levels below 50mg/L are invariably conscious. Impairment in drivers without other drugs involved
are typically associated with combined carisoprodol/meprobamate concentrations of around lOmg/L.
Impairment at levels below this has been documented. Note that contributions to impairment from other
drugs can be substantial.
Interpretation of urine test results:
Both drugs are excreted into the urine, and would likely be detectable for several days following cessation
of use. No information is available on urine concentrations.
Duration of effects:
Effects generally diminish with blood concentrations, and will generally dissipate within 5 to 18 hours
following cessation of use. In overdose, coma may last several hours to a day or more. Note that effects
of other longer lasting CNS depressant drugs taken in combination may persist.
References:
Good P. Soma (carisoprodol): A challenge to a DRE evaluation
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Reeves RR, Pinkofsky HB, Carter OS. Carisoprodol: A drug of continuing abuse. JAOA
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Alcohol:
Various fermented and distilled beverages.
Synonyms: beer, wine, spirits, liquor, alcohol, ethanol, ethyl alcohol,
Potency/purity/dose:
Alcohol content of beer can vary between 3% and 16%. Domestic lagers are around 4.7%v/v, light beers
are 4.1%v/v, ice beers are around 6.1%v/v, malt liquor is around 7.23%v/v. If the brand is unknown 5%
is a reasonable estimate. Wine is typically 12 to 14%, while hard liquor is 40% to 50% (80°-100° proof).
Route of administration:
Generally ingested orally, but can be absorbed by enema. Cannot be absorbed in sufficient quantities by
inhalation or transdermal absorption to produce CNS effects, since the elimination rate is faster then the
absorption rate. Food in the stomach may reduce bioavailability.
Metabolism:
Metabolized via two major routes, alcohol dehydrogenase in the liver oxidizes alcohol to acetaldehyde;
aldehyde dehydrogenase then converts this to acetate, where it enters the TCA. Some Asian individuals
deficient in AldDH have a flushing response, also seen in individuals taking antabuse. Microsomal
En2yme Oxidizing System (MEOS) operates at higher concentrations.
Kinetics:
Alcohol is absorbed rapidly following ingestion. A single drink is absorbed to equilibrium in about ten
minutes. Larger volumes (5-8 drinks) are initially absorbed more rapidly, but typically take up to 30
minutes to reach equilibrium. In extreme cases, particularly when there is food in the stomach, it may
take up to an hour or more. Alcohol is eliminated according to zero order kinetics (linearly) at an average
rate of 0.019g/100mL/hr in drinking drivers until concentrations of around 0.03g/100mL are achieved.
The 95% confidence interval is 0.010 to 0.029 g/lOOmL/hr. Morefrequentdrinkers will be towards the
top end of this range naive drinkers towards the bottom. Earlier studies suggest a mean elimination rate of
0.015g/100mL/hr. Blood concentrations can be reliably estimated, within a range, based on Widmark's
formula.
Drug Class:
Alcohol is a central nervous system depressant. It produces apparent paradoxical effects of stimulation by
depression of the reticular activating system. At very high concentrations it is a general anesthetic.
Effects:
Early phase:
Psychological:
Relaxation, suppression of inhibitions (this can result in a variety of moods being
exhibited, from lasciviousness, to anger and aggression, to withdrawal, and depression), well-being,
euphoria.
Physiological:
Lower blood pressure, lower heart rate, flushing of skin, loss of fine motor skills, loss of
coordination and balance, loss of attention, bloodshot eyes, suppression of peripheral vision, horizontal
gaze nystagmus (HGN), slurred speech
Late phase:
Hangover from alcohol is believed to be caused by accumulation of aldehydes of ethanol and other
congeners, which cause swelling of tissues including the brain. This results in headache, nausea,
irritability, and general dysphoria, lethargy, anergia and malaise.
Chronic effects: Withdrawal from alcohol dependency can produce nausea, convulsions, shaking, tremors,
hallucinations, delusions. Irreversible mental deterioration can result from long term chronic use.
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Medical uses:
Intravenously as a treatment for methanol poisoning.
Performance effects:
Loss of performance in divided attention tasks. Inattention, balance impaired, coordination impaired,
increased error rate in complex tasks, short-term memory deteriorates, learning ability deteriorates.
Effects on Driving:
Weaving, omitting tasks secondary to actual driving (lights, signals, monitoring speed, monitoring
environment), risk taking, misjudging time and distance, slowed reaction time, inattention, poor tracking,
diminished peripheral vision. As with any drug, effects are more pronounced the more complex the task,
such that in emergency situations even minor effects may be significant with respect to driving.
Interpretation of blood concentrations:
The effects described above progress from fairly benign at low concentrations, to profoundly impairing at
high concentrations, however, the degree and pattern of effects varies widely between individuals.
Impairment can be documented in special tests at levels as low as 0.02g/100mL. In critical or emergency
driving situations, this may be crucial. Effects on driving are present in most individuals at
concentrations of 0.05g/100mL, and in practically all individuals at 0.08g/100mL. During alcohol
withdrawal or hangover, extended effects of depressed reflexes and consciousness, nausea, and discomfort
may continue to affect driving once the blood alcohol concentration has returned to zero. Risk of accident
involvement with increasing blood alcohol concentration increases exponentially, with risk relative to zero
BAC, increasing approximately 4-fold at 0.08, 8-fold at 0.10, and 25-fold at 0.15g/100mL.
Interpretation of urine test results:
Urine alcohol concentrations reflect the average BAC over the time the urine was collecting in the bladder.
If urine is voided and a specimen collected within 20 minutes or so, the concentration will typically be 1.23
times the corresponding blood concentration.
Duration of effects:
Effects generally increase and decrease with changes in the blood concentration.
Acute effects are
generally relatively short lived after drinking stops. For example after achieving a BAC of 0.190, acute
effects would have diminished within about ten hours. The hangover may last for another three to twelve
hours however. Withdrawal in alcoholics may last several days and be profoundly disabling.
References:
Garriot JC (ed.) 1996 Medicolegal aspects of alcohol Lawyers and Judges Publishing Co., Tucson AZ
Holloway FA Low-dose alcohol effects on human behavior and performance: Alcohol, Drugs and Driving
1995;ll(l):39-56
MoskowitzH, Robinson CD Effects of low doses of alcohol on driving related skills: A review of the
evidence. 1988 DOT report # DOT HS 807 280
Martin CS Measuring acute alcohol impairment in Karch S (ed.) 1998 Drug Abuse Handbook CRC Press,
Boca Raton FL
Moskowitz H, and Burns M Effects of alcohol on driving performance.
World 1990;14(1):12-14
Simpson H The hard core drinking driver.
Ontario, Canada
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Jones AW and Andersson L, Influence of Age, gender and blood alcohol concentration on the
disappearance rate of alcohol from blood in drinking drivers. J Forensic Sci 1996;41(6):922-926
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Butalbital
A short to intermediate acting barbiturate, used for its sedative hypnotic properties, formulated with
analgesics as an analgesic/sedative
Synonyms:
Allylbarbital, allylbarbitone, itobarbital, 5-allyl-5-isobutylbarbituric acid, Sandoptal.
Potency/purity/dose:
Axocet, Sedapap, Phrenalin Forte (butalbital/acetaminophen 50mg/650mg), Phrenalin
(butalbital/acetaminophen 50mg/325mg), Esgic (butalbital, acetaminophen, caffeine, 50mg/500mg/40mg),
Fioricet (butalbital, acetaminophen, caffeine, 50mg/325mg/40mg), Fioricet w/ codeine (butalbital,
acetaminophen, caffeine, codeine phosphate 50mg/325mg/40mg/30mg), Fiorinal w/ codeine (butalbital,
aspirin, caffeine, codeine phosphate 50mg/325mg/40mg/30mg). Typically prescribed in divided doses,
not to exceed 300mg/day.
Route of administration:
Oral
Metabolism:
The metabolism of butalbital has not been studied in man. In dogs, only 3% is excreted unchanged.
Kinetics:
The half-life of butalbital has been reported as between 35-88 hours, dependant on age, liver function and
tolerance. Note that codeine has a much shorter half-life (1.9-3.5 hours), and will be completely
eliminated before butalbital.
Drug Class:
Barbiturate; sedative hypnotic, CNS depressant.
Effects:
Psychological: Relaxation, tranquility, well-being, reduced interest in external environment, CNS
depression ranging from slight sedation to general anesthesia. As with alcohol, release of inhibitions, and
mood swings are reported. Level of consciousness is depressed, lethargy, confusion, disorientation,
dizziness, drowsiness and impairment of thought and short term memory are present. Also reported are
lack of emotional control and aggressive behavior. Pain perception and reduction are not affected by
butalbital alone. Total sleep time is increased, sleep latency is decreased. In overdose, hypotension,
shock, coma and respiratory depression occur.
Physiological: Barbiturates in normal therapeutic use, cause a slight reduction in respiration rate, blood
pressure and pulse. In overdose, all are reduced more noticeably. Symptoms are dose-dependant and
consistent in nature with alcohol, including impairment offinemotor skills, loss of coordination and
balance, diminished judgment and attention, slowed reaction time, horizontal gaze nystagmus (HGN),
ataxia and slurred speech.
Medical uses:
Butalbital is no longer prescribed on its own as a sedative hypnotic, but in formulations with narcotic and
non-narcotic analgesics for the treatment of migraine, and tension headaches. Abuse is common, and can
in fact cause headaches. Butalbital lacks a phenyl substitution and has no anticonvulsant activity at
therapeutic doses.
Performance effects:
There are no known reports of studies of performance specifically using butalbital or butalbital containing
products. Barbiturates in general produce decrements in psychomotor performance, and performance
decrements in computer administered tests, circular light tests, and card sorting tests for examples.
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Effects on Driving:
Anecdotally, numerous subjects have been arrested for impaired driving and subsequently tested positive
for butalbital. Typically several other drugs are present in combination. The Physicians Desk Reference
notes that patients should be warned to avoid driving or using heavy machinery while taking this drug.
Interpretation of blood concentrations
Following a single oral dose of lOOmg in five adults resulted in peak concentrations of 2.1mg/L (1.72.6mg/L). In 64 persons arrested for driving under the influence had mean concentrations of 8.5mg/L
(0.1-28mg/L). Concentrations of 26mg/L and 13mg/L have been reported in 2 cases of suicide.
Interpretation of urine test results:
Some unchanged butalbital is excreted in the urine.
reported.
Duration of effects:
Onset of action occurs in 10 - 60 minutes.
prolonged after overdosage or abuse.

Urinary butalbital concentrations have not been

Duration of effects is typically two to four hours but more

References:
Butalbital. Warner, A. AACCTDM/Tox 1993;14(10):243-245
Butalbital in Disposition of Toxic Drugs and Chemicals in Man.
Biomedical Publishers, 5th edition, 1999.

Baselt RC, Cravey RH (eds).

Barbiturates and Driving. Sharma S., Accident Analysis and Prevention 1976;3:27-31
Effects of Abused Drugs on Psychomotor Performance. Pickworth WB, Rohrer MS, Fant RV.
Experimental and Clinical Psychopharmacology 1997;5(3):235-241
Drugs and Drug Abuse. A Reference Text. Jacobs MR, and Fehr KO (eds) Second Edition. Addiction
Research Foundation, Toronto, 1987
Loomis TA, West TC Comparative sedative effects of barbiturates and some tranquillizing drugs on
normal subjects. J Pharmacol Exp Ther 1958; 122:525-531
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Gamma-Hydroxybutyrate (GHB):
White powder (powdered soap-like texture), white tablets or clear liquid (salty, soapy, plastic taste).
NB: Precursor drugs such as gamma-butyrolactone (GBL), 1,4 butanediol (1,4-BD), and tetramethylene
glycol (TMG) rapidly convert to GHB within the human body following oral administration
Synonyms:
GHB: Liquid = Liquid Ecstasy, Liquid X or E, Salt water Powder = Scoop, Soap .
Sodium oxybate, Grievous Bodily Harm, Georgia Home Boy, G, G-caps, GIB, Easy lay, Everclear
Vita G, Gamma-OH, Degreaser plus lye, Smart Drag, Oxy Sleep, Natural Sleep 500, Somatomax
GBL: 2(3)-furanone dihydro, Renewtrient, Revivarant, Blue Nitro, Midnight Blue, Firewater, Invigorate
1,4-BD: FX, Thunder Nectar, SomatoPro, Serenity, Revitalize, Enliven
TMG: NRG-3
Sources/Illicit Manufacture:
GHB: mix GBL + water + base (Lye/NaOH), heat, add acid (vinegar) to I pH. Add acetone and dry for
GHB powder.
GBL: oily liquid; commercially available; ingredient in cleaners, solvents, paint removers, engine
degreasers
Potency/Purity/Dose:
Illicit manufacture often introduces impurities and wide variations in potency. Recreational use of GHB
often involves doses of one teaspoon (-2.5 g, or 35 mg/kg in a 70 kg adult) of the powder dissolved in
water/alcohol, or one capful of liquid. For anesthetic induction, dose > 100 mg/kg.
Route ofAdministration: Oral ingestion.
Medical and Recreational Uses:
Medicinal: (Europe) anesthetic adjunct and hypnotic agent; used to suppress symptoms of alcoholdependence and opiate withdrawal syndrome. (USA) only legal use is in FDA approved clinical trials for
the treatment of narcolepsy.
Recreational: used for its intoxicating effects (euphoria, reduced inhibitions, sedation); used by
bodybuilders as an alternative to anabolic steroids; marketed as an anti-aging drug and for weight loss.
Pharmacology/Metabolism:
GHB is a naturally occurring substance produced by the metabolism of the CNS neurotransmitter GABA;
present in most mammalian tissues at nM concentrations. GHB is metabolized to succinic semialdehyde
(SSA) by GHB dehydrogenase, and eventually enters the Krebs cycle. GHB is also produced postmortem
(possibly via metabolism of GABA or SSA).
Kinetics:
Onset of effects within 15 min. Peak plasma concentrations 20-45 min. Steep dose-response curve. Large
subject variability. Rapidly eliminated and has a half-life of 27 min (range 20-53 min), which appears to
increase with higher doses.
Drug class:

CNS Depressant

Effects: (NB: some effects may be caused by contaminants introduced in the illicit manufacture of GHB)
Psychological: At low doses, effects similar to those seen with alcohol. Effects include relaxation,
reduced inhibitions, euphoria, confusion, dizziness, drowsiness, sedation, inebriation, agitation,
combativeness, hallucinations
Physiological: Nausea, vomiting, profuse sweating, somnolence, visual disturbances, nystagmus, loss of
peripheral vision, short-term amnesia, muscle flaccidity, uncontrolled shaking or seizures, bradycardia,
hypothermia, suppression of gag reflex, Cheyne-Stokes respiration, respiratory depression, unarousable
unconsciousness.

Washington State Toxicology Laboratory

Effects of Drugs on Human Performance - Fact sheets
Duration of Effects: Effects usually last 2 - 4 h. Complete recovery from GHB overdose occurs within 3 6h.
Withdrawal Syndrome:
Insomnia, muscular cramps, agititation, tremor, anxiety, confusion, paranoia, delerium, hallucinations
(visual and auditory), occasional schizophrenic-like state, hyperadrenergic.
Adverse effects:
Apnea, incontinence, severe ataxia, hypotension, sinus bradycardia, respiratory depression, seizures,
unarousable unconsciousness.
Drug Interactions:
Potential additive effect between GHB and ethanol and other CNS depressants.
Performance effects:
Relaxation, euphoria, confusion, dizziness, drowsiness, disorientation, agitation, combativeness, severe
ataxia, seizures, somnolence, unconsciousness. Visual disturbances, nystagmus, loss of peripheral vision,
hallucinations, lack of balance and coordination, muscle flaccidity, short-term amnesia.
Effects on driving:
Confusion, dizziness, drowsiness, somnolence, agitation, seizures. Horizontal gaze nystagmus
(occasionally VGN), loss of peripheral vision, short-term amnesia. Slow to respond, slurred speech,
unsteady gait, lack of coordination. Poor performance in SFSTs.
Interpretation of blood/plasma concentrations:
Peak plasma concentrations at 20-45 minutes. GHB undetectable in plasma/blood after 8 hr.
Following single oral in 10 alcohol dependant patients (25 mg/kg) mean peak serum 55 (24-88) mg/L.
Single oral 50 mg/kg dose mean peak plasma 80 mg/L, in 8 healthy subjects.
Couper&Logan: Impaired drivers (n=3), blood GHB = 33, 34 and 65 mg/L; Non-fatal overdoses (n=2),
blood = 130 and 221 mg/L. Pan et al: Drivers (n=2), blood 33 and 73 mg/L.
Interpretation of urine test results:
Peak urine observed within 4 hr of administration. Overall, GHB is undetectable in urine after 12 hr.
Legal Issues:
In 1990, the FDA federally banned O-T-C sales of GHB in the U.S. In most states (including WA),
possession of GHB is legal, however, manufacture and distribution of GHB for human use, other than by
FDA approved companies, is a federal offence. 23 states have scheduled GHB (schedule I-IV).
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Zolpidem:
Zolpidem:
White to off-white crystalline powder; sold in capsule shaped tablets (pink or white)
Synonyms:
Ambien®, Zolpidem tartrate
Potency/purity/dose:
5 mg and 10 mg strength tablets; dose of 10 mg (or 5-20 mg) immediately before bedtime
Route of administration:
Oral ingestion
Metabolism:
Converted to inactive hydroxylated metabolites via CYP3A4 + CYPl A2 isoenzymes; eliminated via renal
excretion
Kinetics:
Rapid absorption, short elimination half-life (2.6 h), half-life prolonged in elderly and in patients with
hepatic cirrhosis. Single oral 5mg and 10 mg - mean Cmax 59 ng/mL and 121 ng/mL at 1.6 h. Mean
Cmax decreased with food.
Drug class:
CNS depressant; non-benzodiazepine hypnotic, GABAA agonist, sleeping aid
Effects:
Early phase:
Psychological:
Physiological:
co-ordination

drowsiness, dizziness, lightheadedness, amnesia, confusion, somnolence
headache, nausea, diarrhea, ataxia, slow and slurred speech, slow reflexes, difficulty with

Late phase:
Hangover effects unlikely, however performance decrements may persist into next day. Memory
impairment (anterograde amnesia) may occur. Sedation may last for 8-16 h following acute intoxication.
Adverse effects:
Frequent: ataxia, confusion, euphoria, insomnia, vertigo
Infrequent: agitation, decreased cognition, detachment, concentration difficulties, hallucination, illusion,
leg cramp, paresthesia, somnolence, speech disorder, abnormal vision
Drug Interactions:
Imipramine - additive effect of decreased alertness
Chlorpromazine - additive effect of decreased alertness and decreased psychomotor performance
Medical uses:
Short-term treatment of insomnia.
Performance effects:
Early phase:
Unsteady gait, confusion, disorientation, significant cognitive and psychomotor impairment (includes
picture recall, digit entry and recall, digit symbol substitution task, circular light tasks, balance, time
estimation)
Impaired coordination, reactive and cognitive skills
Ataxia, double vision, dizziness, nausea
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Effects on driving;
Early phase (1-3.5h):
Psychomotor impairment = sleepiness, impaired divided attention, recall, immediate memory, sustained
attention (symbol digit substitution test, tracking error severity index, reaction time, body balance, visual
analogue scale). Memory and learning impairment = acute memory and learning, and delayed memory
Additive effect on psychomotor performance between alcohol and Zolpidem, and potentially additive
effects with other CNS depressant drugs
Late phase (5h):
Psychomotor impairment = symbol digit substitution test, tracking error severity index, tracking still
impaired
Memory and learning impairment = anterograde amnesia
No next-day effects on psychomotor function.
Interpretation of blood concentrations:
Therapeutic doses:
Single 5 mg
Single 10 mg

59 ng/mL (29-113 ng/mL)
121 ng/mL (58-272 ng/mL)

Interpretation of urine test results:
Zolpidem is excreted unchanged in the urine, however urine concentrations cannot be meaningfully
interpreted.
Duration of effects:
Following single oral doses of 10-15 mg Zolpidem, effects typically last up to 4 h. Anterograde amnesia can
occur the following morning. Sedation may last 8-16 h following acute intoxication.
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